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ABSTRACT
Efficient control of sea lice is a major challenge for the sustainable production of farmed 
Atlantic salmon (Salmo salar (Linnaeus, 1758)). These marine ectoparasites feed on mucus, 
skin and blood of their hosts, thereby reducing the salmon’s growth rate and overall health. In 
the northern hemisphere, the most prevalent species is Lepeophtheirus salmonis (Krøyer, 1837). 
In 2006, global costs of sea lice infections are estimated to have exceeded €300 million, with 
the majority spent on a limited number of chemical delousing agents. Emamectin benzoate 
(EMB; SLICE®), an avermectin, has been widely used since its introduction in 2000, due to its 
convenient administration as an in-feed medication and its high efficacy against all parasitic 
stages of L. salmonis. 
However, over-reliance on a single or limited range of medicines favours the emergence of drug 
resistance and, as a result, the efficacy of this compound in treating L. salmonis has decreased in 
recent years, as reported from e.g. Chile, Norway, Scotland and Canada. Declining efficacy 
underlines the need for an improved understanding of the molecular mechanisms underlying
EMB drug resistance in L. salmonis. Elucidation of these mechanisms would allow for 
improved monitoring tools, earlier detection of developing resistance, extended usability of 
current delousing agents and development of new parasiticides.  
The work described in this thesis sets out to examine the molecular mechanisms underlying 
EMB resistance in L. salmonis. In earlier studies, research in nematodes and arthropods has 
linked drug efflux transporters belonging to the family of ATP-binding cassette (ABC) 
transporters to ivermectin (IVM) resistance, a parasiticide with high chemical similarity to EMB. 
ABC transporters such as permeability glycoprotein (P-gp), transport a wide range of substrates,
including drugs, and have been suggested to provide a potential molecular mechanism through 
which EMB resistance might be mediated in sea lice. As an example of such mechanisms, 
increased expression of P-gp is one of the causative factors for drug resistance in human cancer 
cells and avermectin resistance in nematode parasites such as Caenorhabditis elegans or 
Haemonchus contortus.
Initial research involved screening for novel salmon lice P-gps that might contribute to EMB 
resistance. A novel P-gp, SL-PGY1, was discovered using a combined bioinformatic and 
molecular biological approach. The expression was compared in two well-characterised L. 
salmonis strains differing in their susceptibility to EMB (S = susceptible, R = resistant). Prior to 
EMB exposure, mRNA levels did not differ from each other, while, after 24 h exposure, a 2.9-
fold increase in SL-PGY1 mRNA expression was observed in the R strain. SL-PGY1 appears 
not to be a major factor contributing to reduced EMB susceptibility, although it could play a 
role, as expression levels increased upon exposure to EMB. A further four additional drug 
transporters (ABC C subfamily) were also discovered showing high homology to multidrug-
resistance proteins (MRP). The relative expression levels of each MRP was compared in the
strains S and R, before and after exposure to EMB. No significant changes were found in their 
expression patterns. 
If ABC drug transporters mediate the efflux of EMB and thereby reduce the intracellular
concentrations of the drug in exposed animals, the inhibition of those ABC drug transporters
was expected to lead to higher intracellular levels of EMB. This could result in an enhanced 
toxic effect when EMB is co-administered with an inhibitor. Two known inhibitors of human P-
gps and MRPs, cyclosporin A (CSA) and verapamil (VER), were co-administered with EMB. 
CSA increased the toxic effect of EMB in both tested strains, implying that the targets of CSA 
are expressed at comparable levels and that they may be part of the mechanism conferring EMB 
resistance. VER increased the toxic effect of EMB in the R strain, but had no significant effects 
on the S strain. This implies that the expression of factors inhibited by VER differs between the 
two L. salmonis strains. It is hypothesised that a number of ABC transporters with distinct, yet 
overlapping patterns of inhibitor specificity are affected by those inhibitors.
The search for drug-resistance conferring genes was complemented with a systematic, genome-
wide survey of ABC transporters in L. salmonis to find additional members of this important 
gene family. Next-generation high-throughput RNA sequencing (RNA-seq) was employed to 
assemble a reference transcriptome from pooled total RNA of salmon lice at different 
development stages. The transcriptome was assembled against the L. salmonis genome and
annotated. Thirty-nine putative ABC transporters were found. Of further interest were 
transcripts of the subfamily B, C and G, as they contain drug-transporting ABC proteins. For the 
ABC B subfamily, one full (SL-PGY1) and three half transporter transcripts were found. Only 
full transporters are known to transport drugs and SL-PGY1 is apparently not a major factor 
contributing to EMB resistance. Fourteen ABCC sequences were found – 11 MRPs and 3 
homologues to sulfonylurea receptors. Of interest are MRPs, as they contribute to drug 
detoxification in humans and invertebrates. Four MRPs had been identified previously and their 
expression ratios did not differ between S and R strain parasites. Seven sequences belonging to 
ABCG subfamily were found. However, none of the L. salmonis ABCG transcripts identified 
showed sufficient homology to known drug transporters in other species.
With the currently limited understanding of the mechanisms conferring EMB resistance, 
monitoring the susceptibility of L. salmonis subpopulations is essential. Dose-response 
bioassays are currently widely used. Tests with pre-adult II or adult parasites requires relatively 
large numbers of parasites (~150) to conduct this type of bioassay, which may not always be 
available. Addressing this issue, we tested the feasibility of a single-dose bioassay (requiring 
fewer test animals than dose-response bioassays) to discriminate between L. salmonis strains 
with differing EMB susceptibility. This alternative approach uses time-course toxicity analysis, 
where the toxic effect of EMB is monitored over time. After clearly defining the effect criteria, 
we found that it is possible to discriminate between those L. salmonis strains. However, while 
requiring fewer test animals, time course toxicity analysis is more labour-intensive, but the 
alternative design can be suitable under certain circumstances. 
The work reported here has provided new knowledge concerning the mechanisms of EMB 
resistance in sea lice. Several novel putative drug transporters have been identified, an important 
first step toward unravelling the complex interactions of genes involved in EMB resistance in 
this commercially important parasite. 
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1 INTRODUCTION
Atlantic salmon (Salmo salar) has become a highly valued and intensively farmed fish in recent 
years due to increasing worldwide demand for fish-derived protein and associated health 
benefits. Major production centres of farmed salmon are currently found in Norway, Chile, 
Scotland, Canada and Ireland (Lees 2008). Global production was 1.84 million tonnes of farmed 
salmon in 2013 (Marine Harvest 2014), with Norway being the largest producer with 1.165 
million tonnes (Norwegian Fish Directorate 2013), while in Scotland 163,000 tonnes were 
produced (Marine Science Scotland 2013). Output on such an industrial scale requires large 
farming operation, for example, Norwegian farms can accommodate up to 2 million fish (equals 
10,000 tonnes) for the 18 to 20 months of seawater the production phase. 
However, as the marine phase of salmon farming takes place in open cages exposed to the 
ocean, there is a continuous chance for infection with sea-borne diseases. Commercial salmon 
farming is particularly affected by ectoparasites commonly known as sea lice. First outbreaks 
occurred on Norwegian farms in the 1960s  (Pike & Wadsworth 1999). Infection with sea lice 
can affect the growth rate of salmon and reduce their feed conversion ratio (Mustafa et al.,
2001). In 2006, global costs due to sea lice infections were estimated to exceed €300 million 
(approximately £240 million in 2014), a figure including treatment costs and economic losses 
due to impaired growth (Costello 2009). Furthermore, apart from direct costs associated with 
sea lice infections, the salmon farming industry incurs a negative perception by consumers, 
especially during major outbreaks (Hansen & Onozaka 2011).
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Infections of farmed and wild Atlantic salmon are mostly caused by two species -
Lepeophtheirus salmonis (Krøyer, 1837) and Caligus elongates (Johnson et al., 2004; Costello 
2006). Integrated pest management (IPM) strategies have been implemented in all production 
areas to keep infection levels below pre-defined thresholds. The intention is to avoid serious 
economic and environmental impact from sea lice infections, while improving profitability and 
sustainability of salmon farming. IPM combines various approaches to reducing infection 
levels, including biological control with predators such as wrasse (Deady et al., 1995), fallowing
(Bron et al., 1993), vaccine development (Carpio et al., 2011) and treatment with anti-parasitic 
drugs (Denholm et al., 2002). 
Amongst different chemical substance classes used for salmon delousing, the latest generation 
of drugs belongs to the group of avermectins, which are macrocyclic lactones (ML). 
Avermectins exert their toxic effects in nematodes and arthropods by binding to and activating 
neuronal glutamate-gated chloride channels, resulting in disrupted neurotransmission, followed 
by paralysis and death. Avermectins are usually administered orally o fish as feed additives, 
thereby avoiding immersion bath treatments, which are potentially stressful for the fish and can 
pose logistical problems under adverse weather conditions (Stone et al., 2000).
The first avermectin derivate used for salmon louse control was ivermectin (IVM); however, it 
was not used widely due to its narrow therapeutic index (Davies & Rodger 2000). Another 
avermectin drug, emamectin benzoate (EMB), displays a wider therapeutic index (Stone et al.,
1999; Horsberg 2012) and is the active ingredient of the salmon delousing agent SLICE®, 
marketed by Merck Animal Health. EMB is well tolerated by the fish and highly effective 
against all stages of sea lice at different water temperatures (Armstrong et al., 2000). EMB 
confers protection against lice for up to nine weeks after administration of a one-week course of 
50 µg EMB per kg fish biomass (Stone et al., 1999). The convenient application method, high 
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efficiency and the low environmental risk exerted by EMB are factors that have contributed to 
this drug becoming one of the most commonly used salmon delousing agents since the early 
2000s (Lees et al., 2008). However, the overreliance on a single product can favour the 
formation of drug resistance in the parasite. After several years of EMB use, decreased efficacy 
of treatment was observed with Caligus rogercresseyi (Bravo et al., 2010) in Chile and with L. 
salmonis in Europe (Hjelmervik et al., 2010) and Canada (Westcott et al., 2010). These reports 
of shifts in parasite susceptibility to the drug are likely early signs of resistance to EMB.
1.1 Sea lice and salmon lice
“Sea lice” is the common name for marine ectoparasites of the family Caligidae (Subclass: 
Copepoda; Order: Siphonostomatoida). Different Caligidae species have become a problem for 
the global salmon industry: Caligus elongates Nordmann for fish farmers in the Northern 
Atlantic, Lepeophtheirus salmonis (Kroyer, 1837) for salmonid farming in the Northern Atlantic 
and Pacific region and Caligus clemensi for salmon farms located in the Northern Pacific 
region. In the Southern Pacific, Caligus rogercresseyi is a major problem for salmon farmers in 
Chile (Bravo et al., 2013). L. salmonis, also called salmon louse, has the greatest economic 
impact on intensive aquaculture as this parasite infects commercially important salmonids of the 
genera Oncorynchus, Salmo and Salvelinus, (Costello et al., 2004). 
Salmon lice are capable of finding and attaching themselves to their host, where they scrape 
away layers of mucus and skin to feed on. Eventually they can also feed on blood, when the 
continuous abrasions expose deeper lying tissues (Bron et al., 1993b). This is a stressor for the 
infected host (Pike & Wadsworth 1999; Tully & Nolan 2002), which then has a higher potential 
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for secondary infections by bacteria or fungi and increased osmoregulatory problems (Boxaspen 
2006). The result is a diminished growth rate of infected fish, a reduction of their food 
conversion ratio and compromised immune status.
While L. salmonis is found in the Atlantic as well as the Pacific, recent studies demonstrate 
there are genetic differences within the species. Comparison of microsatellite DNA at six loci 
found distinct differences between the Atlantic and Pacific variety (Todd et al., 2004) and a 
study of expressed sequence tags (ESTs) and mitochondrial DNA by (Yazawa et al., 2008; 
Messmer et al., 2011) found a 3.2% difference for nuclear genes and 7.1% difference for the 
mitochondrial genome of Atlantic and Pacific salmon lice. This is in agreement with the genetic 
divergence of their salmonid hosts, which occurred at least 20 million years ago (McKay et al.,
1996). It might also provide a clue to understanding the wider range of hosts for Pacific L. 
salmonis, which includes the three-spined stickleback (Gasterosteus aculeatus) (Jones & 
Prosperi-Porta 2011).
1.1.1 Life cycle
Salmon lice go through several developmental stages and infection of a host is required early on 
in order to progress through the full cycle of eight developmental stages:
After hatching from eggs dispersed in the water column, there are two planktonic non-feeding 
nauplius larval stages, which are pelagic and disperse in the water column. The next stage is the 
infective copepodid stage, which requires finding a host in order to survive and continue 
development (Johnson & Albright 1991). During these first stages, the larva feeds either on 
other plankton (planktotrophic) or relies on its lipid reserves in the yolk sac (lecithotrophic) 
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(Fast 2014) but can only survive for up to seven days, with an average survival of 40 to 50 
degree days (Tucker et al., 2000). Temperature (Heuch et al., 2000), salinity (Bricknell et al.,
2006), light intensity and host velocity (Genna et al., 2005) as well as local water currents (Bron 
et al., 1991) affect survival and settlement chance of copepodids. For example, lower settlement 
rates were observed at 7°C when compared to rates at 12°C and for a salinity of 24 ‰ compared 
to 34 ‰ (Tucker et al., 2000).
A number of behavioural traits assist sea lice in the process of host-finding. These include 
positive rheotaxis, allowing the parasite to detect currents caused by the host, positive 
semiotaxis, whereby a gradient of kairomones excreted by the host is detected (Ingvarsdóttir et 
al., 2002), and positive phototaxis, allowing the sea louse larva to migrate closer to the surface 
in a daytime-dependent manner (reviewed by Mordue et al., 2009). 
The majority of copepodids initially attach to the fins and gills, but they can be found anywhere 
on the host (Bron et al., 1991). Here, the parasite moults into the first chalimus stage. While 
older studies suggest there are four chalimus stages separated by ecdysis (Johnson & Albright 
1991; Pike & Wadsworth 1999), a recent publication observed only two molts for chalimus 
stages I and II, thereby reconciling L. salmonis’ number of developmental stages with that of 
other copepodids  (Hamre et al., 2013). The chalimus larval stages are characterised by a 
prominent frontal filament attaching the parasite to the host skin and rendering it immobile 
(Johnson & Albright 1991). The development of salmon lice then proceeds through two pre-
adult stages (I and II), which can move freely over the host’s skin, followed by a final moult to 
mobile adults. For reproduction, adult male salmon lice engage in a pre-copula with virgin pre-
adult II females. Copulation occurs directly after the female moults to the adult stage and 
involves cementing spermatophores to the copulatory pores of the ventromedial side of the 
female’s genital complex, followed by extensive mate guarding by the male (up to 48 h) (Pike 
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& Wadsworth 1999). Still, this does not fully prevent polyandry from occurring and while 
relatively rare, genetic contributions from several males have be found in fertilised eggs (Todd 
et al., 2005). The stored spermatophores allow female L. salmonis to fertilise several batches of 
eggs and to produce six to eleven pairs of uniseriate egg strings over her lifetime, containing on 
average 285 eggs/string (Heuch et al., 2000). Eggs are released from egg strings into the water 
column and the next generation of nauplii hatches.
Figure 1: Life cycle of Lepeophtheirus salmonis (not to scale, from Igboeli et al., 2014)
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1.1.2 Host-lice interactions
Once infected, fish hosts will display a number of physiological and pathological signs, 
depending on the intensity of the infection and the developmental stage of the attached parasite. 
They can range from stress and depressed appetite to death (Boxaspen 2006).  In general, the 
damage caused increases with parasite development; earlier stages are less damaging than later 
ones. Recently attached copepodids cause a localised inflammatory response, visible as a dark 
area around the attachment site. Similarly, the sessile chalimus stages cause only limited and 
localised inflammation (Jones et al., 1990). However, once the parasite has moulted into pre-
adults and adults, their increased feeding activity can further erode the upper skin layers and, in 
severe cases, expose underlying skeletal muscle. The consequences are osmoregulatory 
problems for the host (Wagner et al., 2003) and an increased susceptibility to secondary 
infections, including salmon anaemia virus (Finstad et al., 2000; Barker et al., 2009; Nylund et 
al., 1994). Furthermore, negative effects result from increased stress levels related to infection, 
leading to physiological changes like altered electrolyte and blood glucose levels, reduced red 
blood cell count, as well as behavioural changes. These include reduced appetite, increased 
irritability, flashing (fish attempts to remove the parasites by rubbing against surfaces or 
occasionally leaping out of the water) and poor swimming performance (Wagner et al., 2008). 
Ultimately, biomass production is reduced, which translates into direct financial losses for the 
salmon farmer (Costello 2009).
The severity of L. salmonis infections varies when comparing the range of their Pacific salmon 
hosts (Oncorhynchus spp.). Pink salmon (O. gorbuscha) and coho salmon (O.kisutch) have a 
higher capacity to purge lice from their skin, while Chinook salmon (O. tshawytscha) and chum 
salmon (O. keta) are more susceptible in comparison (Johnson & Albright 1992; Jones et al.,
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2007). Coho salmon reacts with rapid inflammatory infiltration a few days after infection, 
leading to epithelial hyperplasia and parasite encapsulation, effectively shedding more than 90 
per cent of the lice within 14 days (Johnson & Albright 1992). Furthermore, when comparing 
Pacific coho salmon and rainbow trout (O. mykiss) with Atlantic salmon, Fast et al. (2002)
observed that Atlantic salmon has the lowest activity of low molecular weight proteases 
investigated, lowest mucous lysozyme levels and overall the thinnest epidermal layers of the 
three species. In addition, lice matured faster on Atlantic salmon and were generally not 
rejected. Different mucus biochemistry could be a factor in why Atlantic salmon is more 
susceptible to salmon lice infections (Johnson & Albright 1992; Fast et al., 2003). 
A comparison of the metabolic response of Atlantic, pink and chum salmon yielded a similar 
result. Sutherland et al. (2014) co-habited these three species when carrying out infection trials 
with L. salmonis. Post-infection blood cortisol concentration and haematocrit were recorded and 
samples of the blood, anterior kidney and skin were collected and analysed for their 
transcriptomic response. Chum salmon showed the highest susceptibility, followed by Atlantic 
salmon and pink salmon, with the lowest susceptibility. These differences in susceptibility were 
observed as early as three days post infection and were paralleled by transcriptional changes. 
They included altered expression patterns of acute phase proteins, cellular protection
mechanisms and parts of the immune system of the host. Furthermore, a localised increase in 
pro-inflammatory cytokines interleukin-1 beta and tumour necrosis factor alpha were observed 
at infection sites of pink salmon, but not in Atlantic or chum salmon.   
Knowledge about host-parasite interaction is still fragmentary. While a limited number of 
genetic markers has been published for L. salmonis (SNPs and microsatellite markers for less 
than 30 loci) (Glover et al., 2011), there is no comprehensive genetic map available for this 
parasite. Additional insight could be derived from screening the parasite’s full genome. L. 
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salmonis’ genome contains approximately 600 Mbp and has been sequenced to a significant 
degree of coverage at the Institute of Marine Research, Bergen, Norway, with the publication of 
the full assembly in progress (as of 2014, http://sealouse.imr.no/). This will most likely allow 
researchers to improve their understanding of the underlying genetic differences between 
different host species and their susceptibility to salmon lice. 
1.2 Control and treatment strategies
Several different approaches are used to reduce the number of sea lice on salmon farms: They 
include adherence to best management practices, which comprises area management and 
coordinated fallowing, stocking with single-year classes, removal of sick and dead fish (Bron et 
al., 1993), supported by continuous reporting and tracking of infection levels (North Atlantic 
Salmon Conservation Organization 2010). The co-habitation of farmed salmon with natural 
predators (e.g. wrasse) of salmon lice (Treasurer 2002) and administration of chemical 
delousing agents (Roth et al., 1996; Stone et al., 2000) is also important to control the infection 
levels.
Wrasse (family Labridae) can be added to salmon cages, where they prey on ectoparasites and 
dead skin from other fish. Currently, there are five species used in aquaculture, and they can 
provide effective control of sea lice (Groner et al., 2013). However, this strategy, while being 
cost effective and having little environmental impact, has disadvantages: Some wrasse are lost 
during winter (Sayer et al., 1996; Treasurer 2002) or tend to prefer fouling on cages and salmon 
food over L. salmonis.  Selective breeding intends to exploit the different susceptibilities to sea 
lice infections within Atlantic salmon families (Glover et al., 2004; Glover et al., 2005), which 
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could produce hosts with a reduced susceptibility to infection (Gjerde et al., 2011). However, it 
can be a challenging and time-consuming task (Glover et al., 2004) as many factors related to 
salmon’s susceptibility to infection with L. salmonis in the wild, on fish farms or under 
laboratory conditions, are not fully understood yet (Glover et al., 2004; Hamre & Nilsen 2011). 
These include geographical (e.g. Europe or Canada), environmental (hydrology of sites, 
temperature) or farm management differences. Furthermore, differences in parasite strains and 
host families have to be taken into account, too. 
Another attempt for sea louse control was a change in salinity.  L. salmonis’ settlement success 
and development was found to be reduced at lower salinity (Tucker et al., 2000), however, 
immersing salmon in fresh water for three hours did not reduce infection levels (Stone et al.,
2002). Most likely, it would require a longer period of low salinity to substantially affect salmon 
lice; however, this is not feasible, as the host will suffer from reduced oxygen uptake. Also, the 
use of common disinfectants does not prevent L. salmonis eggs from hatching and developing 
(Pietrak & Opitz 2004). At the moment, the most common and effect measure is chemical 
delousing. 
1.2.1 Chemotherapeutants
Since the beginning of large-scale salmon farming in the 1970s, veterinary drugs have been 
crucial in controlling salmon lice infections. As salmon lice reproduce all year round, effective 
control intends to decimate juvenile and pre-adult lice, ultimately preventing the appearance of 
gravid females (Treasurer & Grant 1997). 
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The earliest attempts to control sea louse infections employed formaldehyde baths, but these did 
not show the required efficacy (Johannessen 1974). The first generation of effective anti-salmon 
louse drugs contained organophosphates (OPs), which have been used since the 1970s as bath 
treatments. Early examples of fish medicines of this drug class are dichlorvos in Scotland and 
metriphonate in Norway (Rae 1979; Bruno et al., 1990). However, resistance to OPs developed 
during the 1980s and was widespread by the early 1990s (Jones et al., 1992; Fallang et al.,
2004). In turn, hydrogen peroxide was used as an alternative bath treatment (Treasurer & Grant 
1997). However, the narrow safety margin and temperature dependence of its effects make this 
treatment difficult to control. Similarly cumbersome were natural pyrethrins, extracted from 
chrysanthemum flowers, which were administered as a top dressing oil on the surface of cages 
(Jakobsen & Holm 1990). The range of antiparasitic drugs tested for suitability as anti-sea louse 
agents further included the macrocyclic lactone, ivermectin (Johnson et al., 1993), which had 
sufficient and long-lasting effects on salmon lice, but also presented a rather narrow safety 
margin (Palmer et al., 1987). In contrast, benzoylphenylureas such as diflubenzuron (Horsberg 
& Hoy 1991)  and teflubenzuron (Branson et al., 2000) were found to have a wide safety margin 
and be suitable for in-feed administration. However, a disadvantage of benzoylphenylureas is 
related to the action of these compounds as chitin synthesis inhibitors, which means they are 
only effective against moulting stages of salmon lice and ineffective against adult parasites. The 
mid 1990s saw the introduction of pyrethroids, synthetic derivates of the pyrethrins (e.g. 
cypermethrin and deltamethrin) (Hart et al., 1997). These compounds have a sufficient safety 
margin, are effective against all developmental stages of salmon lice, but have to be applied as 
bath treatments, which is labour-intensive.
The last major release of a delousing agent was in 1999, when EMB was introduced (Stone et 
al., 2000). This macrocyclic lactone can be orally delivered, which is less labour-intensive, and 
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has a wider safety margin than ivermectin. As it is effective against all developmental stages 
and confers protection of up to ten weeks (Stone et al., 2000), it became the first choice of fish 
farmers.
1.2.1.1 Modes of action 
The majority of veterinary drugs used to control salmon lice numbers disrupt neuronal signal 
transmission in the parasite (Roberts & Hudson 1999). 
OPs (e.g. dichlorvos, azamethiphos) are inhibitors of the enzyme, acetylcholinesterase. This is a 
carboxylesterase found at cholinergic synapses and neuromuscular junctions, where it 
hydrolyses the neurotransmitter acetylcholine, thereby terminating synaptic transmission. 
Organophosphates prevent the enzyme from cleaving acetylcholine, which leads to an 
accumulation of acetylcholine in the synaptic cleft, leading to paralysis and death (Corbett 
1974). The effect of OPs can be observed within hours on pre-adults and adults, but they are 
less effective against chalimus stages (Wootten et al., 1982).
Pyrethroids, such as deltamethrin and cypermethrin (Hart et al., 1997), prevent neuronal 
voltage-gated sodium channels from closing, thereby stimulating permanent excitation, which 
leads to muscle paralysis, starvation and death. 
Hydrogen peroxide is a strong oxidiser, which peroxidises lipids, damages enzymes, disrupts 
the parasite’s membrane integrity, and provokes gas bubbles to form within their bodies. While 
treatment results are quick to observe, bath treatments clear about 85 to 100 per cent of pre-
adult and adult lice, but are much less effective against chalimus stages (Thomassen 1993). 
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Benzoylphenylureas (like diflubenzuron and teflubenzuron) are insect growth inhibitors acting 
as chitin synthesis inhibitors. As chitin is a main component of the exoskeleton in arthropods, 
exoskeleton formation in treated parasites will be defective, leading to death. While 
benzoylphenylureas are effective against eggs, larval and all immature parasite stages, adult sea 
lice do not undergo further moults and, therefore, remain unaffected (Branson et al., 2000).
Avermectins are neurotoxins, which bind with high affinity to the neuronal ligand-gated 
chloride channels of arthropods and nematodes and their target sites include channels gated by 
glutamate and γ-amino butyric acid (GABA) (Cully et al., 1994). Drug binding leads to the 
opening of these channels, resulting in hyperpolarisation of the postsynaptic membrane. As a 
result, neurotransmission is disrupted, leading to paralysis, starvation, and death (Arena et al.,
1995). The avermectin emamectin benzoate (EMB) can be added to fish food and the ingested 
drug will disperse throughout the host’s body. EMB will build up to concentrations in the 
mucous of the skin (Stone et al., 2000) sufficient to affect parasitizing sea lice. While EMB is 
very effective against all parasite stages, it takes two to three weeks for the effect of the 
treatment to emerge (Stone et al., 2000).
1.2.1.2 Treatment methods
The delivery method and the type of chemotherapeutant used can influence treatment outcome.
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1.2.1.2.1 Immersion bath treatments
Bath treatment involves immersing infected fish in a solution containing the delousing agent 
(e.g. organophosphates, pyrethroids, hydrogen peroxide) for a pre-defined period. Advantageous 
is that all parasites can be exposed at the same time to a similar concentration of delousing 
agent, especially when well boats are used. Less efficient is skirting of sea cages with tarpaulin 
and subsequent drug administration to the enclosed volume, as the drug concentration will 
rapidly decrease due to water exchange with the surrounding ocean (Corner et al., 2011). 
Furthermore, bath treatments are labour-intensive and thereby costly (Costello 2009). In 
addition, they cannot be applied in bad weather, which could interfere with an effective 
application regime (Robbins et al., 2010) and only one cage can be treated at a time. Therefore, 
as a farm with multiple cages cannot clear the infection at once, an increased risk of reinfection 
exists for recently treated cages. In fact, modelling of salmon lice spread indicates that two 
thirds of the L. salmonis abundance originates from within the same farm (Aldrin et al., 2013), 
which highlights the limitations of bath treatments. 
1.2.1.2.2 Treatment using in-feed drugs
In-feed treatments make use of fish food that is medicated with delousing agents. Following oral 
uptake by the fish, the drug will accumulate in tissues and mucus, and sea lice feeding on skin 
and mucus will be exposed by ingesting the drug. However, as fortified feed has to be 
consumed by the host, failure to reach therapeutic levels can occur, as fish appetite is difficult to 
predict and depends on factors like health status or hierarchy of salmon within the cage (Martins 
et al., 2012). Sick individuals will suffer from depressed appetite, while those at the lower end 
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of the hierarchical order will feed less due to social intimidation (Martins et al., 2012). 
Furthermore, drug residues in tissue have to be below Maximum Residue Limits (MRL). In 
Europe, Annex I recommends MRLs of 100 µg/kg for salmonids (European Communities 
1990). To ensure MRL are not exceeded, only one treatment with EMB within 60 days prior to 
harvest is recommended (MSD Animal Health 2013). Still, in-feed administration offers the 
advantages of reducing handling and occupational health risk for farm workers, being less 
labour-intensive than bath treatments and not requiring expensive equipment such as well boats 
(Ramstad et al., 2002). Furthermore, compared to bath treatments, the in-feed administration of 
drugs is less stressful for the fish (Stone et al., 2000). Moreover, in-feed treatments can be 
applied regardless of weather conditions and be delivered to all cages at the same time, allowing 
for the farm-wide and even management area-wide simultaneous treatment, thereby reducing 
risk of reinfection from within the farm or from nearby farms (Stone et al., 1999). 
1.2.1.3 Avermectins and emamectin benzoate
In 1978, Japanese researchers from the Kitasato Institute in Tokyo, isolated a new actinomycete 
from a soil sample taken from Itou City, Shizuoka Prefecture. Researchers at the Merck Sharp 
and Dohme Research Laboratory, New Jersey, USA, found that extracts of the microbe had 
long-lasting anthelmintic properties (Burg et al., 1979). The actinomycete was identified as 
Streptomyces avermitilis (later renamed Streptomyces avermectinius (Takahashi et al., 2002))
and the antibiotic-acting compounds identified as polyketides, which later became known as 
avermectins, a group of closely related hydrophobic macrocyclic lactones (Burg et al., 1979). 
By the 1980s, avermectins were used in human and veterinary medicine. A wide range of 
gastrointestinal nematodes, lungworms, as well as important ectoparasites such as lice, mites, 
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ticks and crop-damaging insects can be treated with avermectins (Leibee et al., 1995). For 
example, the avermectin, ivermectin (IVM), is used to treat the canine heartworm, Dinofilaria 
immitis (Geary et al., 2011) or the filarial worm, Onchocerca volvulus, the causative agent of 
onchocerciasis (river blindness) (Green et al., 1989). 
IVM  (22,23-dihydroavermectin B1a + 22,23-dihydroavermectin B1b), was tested as a 
delousing agent (Johnson et al., 1993) and used for some time on salmon farms in Scotland, 
Ireland, Canada and Chile. However, IVM is poorly absorbed by the fish and, due to a high 
toxicity in salmon, displays a low safety margin (Johnson et al., 1993). 
Emamectin is a semi-synthetic derivate of the macrocyclic lactone abamectin. It is a mixture of 
the two homologous compounds 4”-deoxy-4”-epimethylaminoavermectin B1a and B1b, they 
differ on the C25 side chain by a single methylene group (Figure 1); B1a carries a sec-butyl 
group, while B1b has an isopropyl group. For commercial applications, emamectin is usually 
prepared as the benzoic acid salt  emamectin benzoate (EMB), where the specified ratio of 
compound B1a to B1b is 90:10 (w/w) (Velde-Koerts 2011).
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Figure 2: Chemical structure of the macrocyclic lactone emamectin. Emamectin is a mixture of 
the two homologous compounds 4”-deoxy-4”-epimethylaminoavermectin B1a and B1b 
(modified from (Burg et al., 1979))
EMB has a wider therapeutic margin than IVM and has proven to be very effective for salmon 
lice control  (Stone et al., 1999; Stone et al., 2000; Armstrong et al., 2000). Stone et al. (1999)
recommend a therapeutic dose of 50 µg of the drug per kg fish biomass and day to be orally 
administered over the course of seven days. Subsequent field studies on commercial farms 
showed that treatment with EMB is very efficient in clearing salmon lice. Thirty-five days after 
EMB administration, treated fish had up to 89 per cent fewer parasites than untreated fish and it 
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was found that EMB conferred protection against sea louse re-infection for up to nine weeks 
(Stone et al., 2000). Due to emamectin benzoate’s convenient application in-feed, relatively low 
occupational health hazard, high efficacy against all developmental stages of salmon lice and 
long-term protection after treatment, it is now widely used on salmon farms in Scotland, Ireland, 
Norway, Canada and Chile (Saksida et al., 2010).
1.2.1.3.1 Pharmacological considerations of avermectin treatments
Avermectins are lipophilic and will accumulate in fatty tissues, from where they are slowly 
released to become systemically available, leading to long-lasting biologically active 
concentrations. Following a one week course of in-feed treatment, EMB remains in the host’s 
system for up to nine weeks (Sevatdal et al., 2005), conferring prolonged protection against 
salmon louse infections (Stone et al., 1999).
SLICE® is a commercially available premix distributed by Merck Animal Health, Whitehouse 
Station, New Jersey, USA. It contains 0.2 per cent EMB per gram (w/w) and is used to coat 
standard salmon food prior to treatment. The drug-fortified food is then consumed and digested 
by the fish. EMB is absorbed from the gut via diffusion due to high lipophilicity. It gets widely 
distributed throughout the host’s body, with high concentrations found in blood, skin, kidney
and liver, while lower concentrations are found in muscle tissue (Sevatdal et al., 2005). As the 
skin cells secrete mucus, EMB reaches significant concentrations in the mucus layer as well, 
and is eventually ingested by feeding salmon lice. While ingestion is the main route of exposure 
to EMB, cuticular absorption due to contact with EMB-infused mucus could also be a way for 
the drug to enter the parasite, although to a lesser extent. Very limited metabolism of EMB 
(Kim-Kang et al., 2004) and enrichment in fatty tissue ensures high persistence in the host’s 
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body, and this is beneficial for long-term protection. However, as medicated salmon are
intended for human consumption, EMB treatment must be timed appropriately to ensure MRLs 
remain below the recommended 100 µg/kg (European Communities 1990). Therefore, it is 
suggested to use SLICE® only once within a 60-day period before salmon is harvested (MSD 
Animal Health 2013). 
EMB pharmacokinetics depend also on the water temperature. At 6°C, the EMB concentration 
in salmon muscle tissue fell below the detection limit within 77 days since the end of oral 
SLICE® administration, but at a water temperature of 15°C, EMB was undetectable after 49 
days (Roy et al., 2006). This is in concordance with observed seasonal variations in EMB 
efficacy (Lees et al., 2008).
1.2.1.4 Avermectin toxicity
Blood-tissue barriers such as the blood-brain barrier (BBB) or the placenta, are highly selective 
barriers, restricting free movement of substances between the bloodstream and the brain’s 
extracellular fluid. The barrier is formed by the capillary endothelia being connected by tight 
junctions, thereby becoming a barrier virtually impenetrable to fluid. Matter exchange is 
facilitated via selective transporters, which supply molecules required for brain function such as 
glucose, amino acids and hormones. However, the BBB permits passage of gases and lipophilic 
substances by passive diffusion.
To prevent lipophilic and potentially neurotoxic substances from entering the brain, an array of 
drug efflux transporters, like P-glycoprotein (P-gp), multidrug resistance proteins (MRPs) or 
organic anion transporting polypeptides (OATPs) are located at the apical side of endothelial 
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cell membranes (Loscher & Potschka 2005). Their role is to prevent a wide range of lipophilic 
and chemically very different molecules from entering the brain by actively extruding them 
back into the bloodstream. Avermectins, as lipophilic molecules, can enter the plasma 
membrane of endothelial cells, where they are quickly sequestered and removed by drug 
transporters, thereby protecting the central nervous system. For example, mice lacking either the 
mdr1a or combined mdr1a/b genes (equivalent to human ABCB1/P-gp), display enhanced brain 
accumulation of P-gp substrates, among them IVM (Schinkel et al., 1995). Also, certain dogs of 
the Collie breed are deficient in P-gp and show hypersensitivity when treated with IVM (Roulet
et al., 2003). Here, toxicity arises when IVM accumulates in the brain, where it interferes with 
GABA-gated chloride channels (Kiki-mvouaka et al., 2010).
In Atlantic salmon, IVM is used to control infections with sea lice. It has a narrow therapeutic 
margin; single oral doses of 0.2 mg IVM per kg fish did not cause treatment-related mortality, 
while a single 0.4 mg per kg dose caused significant mortalities (Palmer et al., 1987). It 
accumulates in the central nervous system of salmon, which indicates that the BBB of S. salar is 
less efficient in preventing neurotoxic IVM from accumulating than mammalian systems (Hoy 
et al., 1990). The chemically similar compound EMB has a wider therapeutic margin. Roy et al. 
(2000) fed different doses of EMB to Atlantic salmon to study potential toxic effects. At the 
highest dose of 500 µg per kg fish, signs of EMB intoxication (skin discolouration, reduced 
appetite, poor swimming performance and lethargy), but no mortality were found (Roy et al., 
2000). The recommended dose for treating salmon is much lower, at 50 µg EMB per kg fish 
(Stone et al., 2000).
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1.2.1.5 Environmental concerns regarding EMB
EMB is administered under veterinary prescription to treat salmon lice infections. However, the 
compound is ultimately released into the environment through uneaten fish food and  salmon 
excreta (Nash 2003). Accordingly, potential effects of EMB on non-target organisms are of 
concern (Burridge et al., 2010). 
EMB has a low solubility in water and a relatively high octane-water partitioning coefficient 
(Kow = 5.0), therefore it is more likely to bind to sediments, where it is retained for prolonged 
periods. The half-life of EMB in the environment is estimated to be 193.4 days under aerobic 
conditions and 427 days under anaerobic conditions (McHenery & Mackie 1999). Adverse 
effects of EMB have been reported for a number of non-target species, among them American 
lobster (Homarus americanus) (Waddy et al., 2002) and four common marine copepods, 
Acartia clausi, Pseudocalanus elongatus, Temora longicornis and Oithona similis (Willis & 
Ling 2003). However, negative effects were only observed at much higher doses than predicted 
environmental concentrations around treated fish farms (Willis & Ling 2003). In a field study, 
for one year, Telfer et al. (2006) monitored, for one year, large mobile fauna, sediment-dwelling 
and sentinel animals on a commercial salmon farm on the West coast of Scotland regularly 
administering EMB as an in-feed treatment. The authors found a maximum concentration of 
2.73 µg EMB/kg wet weight in sediments collected four months after treatment. At this 
concentration and 10 metres distance from sea cages, they did not observe any acute toxic 
effects on indigenous species like common whelks (Buccinum undatum), hermit crab (Pagurus 
spp.), common shore crab (Carcinus maenas) and brown swimming crabs (Liocarcinus 
depurator).  
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With the current usage practice of EMB in the salmon farming industry, there is no evidence for 
negative environmental impacts of the pesticide. However, due to its long half-life and tight 
association with sediments (McHenery & Mackie 1999), it is possible that EMB might 
accumulate near fish farms. Hence, it is imperative to use EMB sparingly and with tight 
monitoring, as the drug could possess the potential to accumulate to higher concentrations,
which could subsequently pose a risk to non-target marine organisms.
1.2.2 Antiparasitics resistance in sea lice
The term resistance describes the heritable ability of a parasite to survive treatment with anti-
parasitic drugs at concentrations that would normally kill parasites of the same species and 
developmental stage (Sangster 2001; Prichard et al., 1980). Cross-resistance describes the loss 
of efficacy of anti-parasitic drugs with different modes of action (Prichard et al., 1980), while 
multiple resistance is used to describe the situation, when a parasite population becomes 
insensitive to several anti-parasitic agents with different modes of action (Wrigley et al., 2006).
Subpopulations of L. salmonis have become resistant to several classes of anti-parasitics. In the 
early 1990s, Norwegian and Scottish lice populations became resistant to organophosphates 
(Jones et al., 1992; Fallang et al., 2004), hydrogen peroxide (Treasurer et al., 2000) and later to 
pyrethroids (Fallang et al., 2005; Sevatdal et al., 2005). Subsequently, their use declined, and 
salmon farmers switched to other delousing agents. Introduced in 2000, EMB, due to high 
efficacy and convenient administration, became widely used in Scotland (Lees et al., 2008) and 
elsewhere (Westcott et al., 2008). In fact, over-reliance by salmon farmers on EMB quickly
became a concern (Westcott et al., 2004).
The potential role of ABC transporters as factors influencing drug susceptibility in the 
salmon louse, Lepeophtheirus salmonis (Krøyer, 1837)
Jan Heumann - May 2015
36
1.2.3 Salmon louse resistance to EMB
Resistance to the antiparasitic avermectins has developed not only in salmon lice (Denholm et 
al., 2002), but also in parasites of ruminants like sheep (Swan et al., 1994; Sangster et al., 1999)
and cattle (West et al., 1994; Condi et al., 2009) or the causative agent of onchocerciasis in 
humans, the parasitic nematode O. volvulus (Osei-Atweneboana et al., 2007). It reflects that 
antiparasitic drugs often lose their capacity to control parasites after a certain period of use 
(Prichard et al., 1980). 
A limited variety of treatment options has exacerbated the resistance problem in salmon lice 
(Denholm et al., 2002). Over-reliance on a single antiparasitic agent needs to be avoided 
(Wolstenholme et al., 2004), yet this tendency still exists when it comes to delousing agents for 
salmon farms. This could be related to difficulties in developing and licencing new drugs 
(Denholm et al., 2002) and that farmers are more likely to use tried and tested treatments. 
For several years, it was a major concern that resistance to EMB would emerge and bioassays 
were developed to monitor sensitivity of sea lice to EMB treatment (Sevatdal & Horsberg 2003; 
Westcott et al., 2008). Resistance to EMB did develop and in the late 2000s, European 
(Hjelmervik et al., 2010; Lees et al., 2008) and Canadian salmon farms (Westcott et al., 2010; 
Jones et al., 2013) reported treatment failure of L. salmonis infections, while Chilean farmers 
observed reduced efficacy of EMB against C. rogercresseyi (Bravo et al., 2008).
The observed decreased efficiency of EMB treatments highlights the need for continuous and 
reliable monitoring of EMB susceptibility in L. salmonis (Westcott et al., 2008; Treasurer & 
Pope 2000). For example, a study examining the trends of EMB efficacy used to treat salmon 
lice infections in New Brunswick between 2004 and 2008 found decreased treatment efficacy
(Jones et al., 2013). The authors found that EMB susceptibility varied between farms, but 
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overall decreased at a faster rate compared with Scottish farms between 2002 and 2006 (Lees et 
al., 2008). In Chile, IVM was used for ten years prior to the introduction of EMB in 2000 and 
until 2007, EMB was the only approved delousing agent (Bravo et al., 2013). Chilean farmers 
also exceeded the recommended EMB doses in an attempt to counter declining treatment 
efficiency (Bravo et al., 2008). Therefore, over-reliance on avermectins for more than 15 years
is the most likely factor which has contributed to the observed reduced EMB susceptibility of C. 
rogercresseyi (Bravo et al., 2008). 
1.2.3.1 Resistance mechanisms
Intimate knowledge of resistance mechanisms and markers linked to resistance is beneficial for 
tracking resistance emergence and development in parasites, particularly at a molecular and 
receptor level (Blackhall et al., 1998; Prichard & Roulet 2007). It would allow for a better 
understanding of drug interaction with their targets and would be useful for developing 
diagnostic tools. Subsequently, this would the use of antiparasitics with different modes of 
action, thereby possibly extending their shelf life (Geary et al., 1999). Drug resistance is usually 
associated with drug-target interaction and drug concentration at target site.
Target site
Mutations of the drug target can alter the ability of drugs to bind, e.g. steric changes, alteration 
of important side chains for binding or electrostatic conditions. Modification of a single amino 
acid changed the spatial properties of acetylcholinesterase, the target site of organophosphates, 
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in salmon lice, thereby rendering those parasites resistant to treatment (Jones et al., 1992; 
Fallang et al., 2004). Alternatively, reduced expression of the drug target was associated with 
avermectin resistance in H. contortus (Wolstenholme et al., 2004). Knockdown resistance has 
been observed for deltamethrin, where point mutations modify the pyrethroid’s target, para-type 
sodium channels of nerve membranes (Fallang et al., 2005); and cross-resistance to
cypermethrin, which is structurally similar, is likely to occur (Denholm et al., 2002). Increased 
metabolism, e.g. higher activity of cytochrome P450 monooxygenases, results in an increased 
detoxification capacity for drugs, which was observed in pyrethroid-resistant L. salmonis 
(Sevatdal et al., 2005). 
Numerous studies regarding avermectin resistance in parasites have been carried out with a
focus on nematodes infecting humans or economically important animals such as sheep and 
cattle  (Wolstenholme & Kaplan 2012). Two biochemical mechanisms are believed to be 
involved in avermectin resistance – altered ligand-gated chloride channels and increased 
expression of drug transporters belonging to the ABC transporter superfamily.
The neurotoxic effect of avermectins is believed to be associated with their capacity to bind and 
block glutamate-gated (GluCl) and GABA-gated chloride channels, found in the invertebrate 
nervous system (McCavera et al., 2007; Wolstenholme & Rogers 2005). Glutamate-gated 
chloride channels have also been suggested as a target for IVM in free-living and parasitic 
nematodes (Dent et al., 2000; Njue et al., 2004). However, it appears to require multiple 
mutations in different genes coding for GluCl channels before IVM resistance is observed (Njue 
et al. 2004). There is not much evidence linking genetic alterations of GluCl channels to IVM 
resistance (El-Abdellati et al., 2011; Williamson et al., 2011).
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Hence, attention was given to another potential resistance mechanism - drug extruding ABC 
proteins such as P-glycoprotein (P-gp) (Lespine et al., 2012). These proteins are involved in the 
rapid removal of drugs, thereby reducing intracellular concentrations (Prichard & Roulet 2007).
ATP-binding cassette (ABC) transporters 
ABC transporters belong to one of the largest protein superfamilies, with members found in all 
organisms, from bacteria to humans (Dassa & Bouige 2001). While prototypical ABC proteins 
transport molecules by coupling ATP hydrolysis with substrate translocation across biological 
membranes, the ABC superfamily also contains ion channels, regulators of ion channels, 
receptors, and proteins with roles in ribosome assembly and translation (Dean et al., 2001). In 
ABC transporters, at least two transmembrane domains (TMDs) and two nucleotide-binding 
domains (NBDs) are required to constitute a functional pump. In full transporters, all required 
domains are found in a single polypeptide, while half transporters possess only one TMD and 
one NBD, and thereby require homo- or heterodimerisation for functionality (Dassa & Bouige 
2001). Metazoan ABC transporters are currently divided into eight subfamilies (A-H) and drug 
transport is facilitated by members of the subfamilies B, C and G (Dean et al., 2001; Sheps et 
al., 2004; Sturm et al., 2009)
Permeability-glycoprotein (P-gp)
P-glycoprotein (P-gp, MDR1 or ABCB1) is a full transporter of the ABCB subfamily and was 
first observed in tumour cells showing increased expression of this protein and resistance to 
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several cytotoxic agents, a phenomenon known as multidrug resistance (MDR) (Dano 1973). P-
gp is a major contributor to this clinically important phenomenon, as it interacts and transports a 
large array of structurally and functionally unrelated substrates. P-gp’s substrates are usually 
hydrophobic compounds, for example cytotoxic drugs, steroid hormones, immunosuppressants, 
calcium channel blockers and cardio-active glycosides. Increased expression of P-gp has been 
observed in MDR cancer cells (Chen et al., 1986). Thereby, P-gp’s broad substrate spectrum, 
combined with increased expression, has the potential to limit bioavailability and retention time 
of drugs (Varma 2003), which subsequently can exacerbate MDR, resulting in chemotherapy 
becoming less effective (Bansal et al., 2009). 
In non-cancerous tissues, P-gp improves the barrier function of protective tissues such as the 
placenta and BBB (Ma et al., 2010) by rapidly extruding toxic compounds (Fortuna et al.,
2011). Furthermore, it plays an important role in the secretion of xenobiotics and metabolites 
into bile, urine or the gut lumen and in the biochemical defence against toxicants in general 
(Schinkel et al., 1994).
Ivermectin is a high-affinity substrates of P-gp and is transported by this protein to the outer 
layer of the cell membrane (Lespine et al., 2007; Bain & LeBlanc 1996). Mice lacking 
expression of this transporter in the gut and the brain, as the result of targeted gene disruption, 
are hypersensitive to IVM (Schinkel et al., 1994). While no data are available for emamectin, 
IVM and five other avermectins affected MDR P-glycoprotein-dependent ATPase activity at 
low micromolar concentrations, suggesting that they may also be P-gp substrates (Lespine et al.,
2009). Accordingly, P-glycoprotein has been suggested as a potential factor contributing to 
avermectin resistance in a number of parasites. For example, IVM-selected strains of the 
gastrointestinal nematode Haemonchus contortus (Rudolphi 1803) showed a higher mRNA 
expression of P-gp, which coincided with an enrichment of a certain allele at the locus coding 
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for the transporter (Xu et al., 1998; Blackhall et al., 1998). Furthermore, evidence for possible 
genetic selection around a P-glycoprotein locus also exists in the human parasitic nematode, O. 
volvulus (Ardelli et al., 2006).
For marine invertebrates, P-gp has been implicated as an important factor protecting them from 
harmful xenobiotics, such as pollutants (Smital & Kurelec 1998).
Multidrug resistance-associated proteins (MRP)
MRPs are full transporters belonging to the ABCC subfamily. They act as organic anion 
transporters with broad substrate-specificity and can translocate a wide range of substances, 
including sulphate, glucoronyl and glutathione conjugates of steroid hormones and bile salts, 
cysteinyl leukotrienes (Kruh & Belinsky 2003) and the mycotoxin aflatoxin B1 (Lorico et al.,
2002). MRPs are another contributing factor to MDR observed in tumours (Borst et al., 1999). 
Breast Cancer Resistance Protein (BCRP/ABCG2)
This half-transporter is a member of the ABCG subfamily and cells expressing this transporter 
show a drug resistance profile that is similar, yet not identical, to P-gp-expressing cells (Doyle 
& Ross 2003). BCRP is found alongside P-gp in barrier tissues like the blood-brain barrier, 
placenta and intestine (Vlaming et al., 2009; Prouillac & Lecoeur 2010). During lactation, it is 
also expressed by mammary glands, where BCRP secretes its substrates into the milk (Jonker et 
al., 2005). 
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These drug transporters are an important component of the hosts’ biochemical defence system 
against toxins and contaminants; the tenacity and complexity of the system is rooted in a) the 
ubiquitous presence of multiple transporters being expressed at various locations and b) in the 
considerable overlap of their substrate spectra (Jones et al., 2009). This redundancy provides an 
efficient barrier, which protects organisms from toxic effects of xenobiotics, but also limits the 
internal concentration of drugs and therefore their efficacy (Marquez & Van Bambeke 2011). 
Furthermore, the activity of drug transporters plays a clinically relevant role in drug interactions 
when several drugs are co-administered (Sarkadi et al., 2006)
1.2.3.2 Reduced drug uptake
Efficient efflux of toxic drugs prevents their accumulation inside the cell, thereby those drugs 
will not reach therapeutic levels and hence their intended effect will not be observed. As drug 
efflux is a major contribution to antineoplastic resistance in cancer cells, research is focussing 
on those transport proteins with the intention of selectively influencing their activity (Modok et 
al., 2006). Various strategies have been employed to counteract drug efflux transporter activity 
in cancer cells with the purpose of increasing cytotoxic drug uptake and retention times. These 
strategies include attempts to bypass transporters with targeted drug delivery systems (peptide 
conjugates (Mazel et al., 2001), liposomes (Goren et al., 2000)) as well as the use of inhibitors
(Lespine et al., 2008; Bartley et al., 2009). Particularly inhibitors hold great potential for 
altering pharmacokinetics of drugs and enhance their bioavailability (Varma 2003).
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P-gp, the first drug transporter discovered, can be inhibited in several ways: a) competitive/non-
competitive or allosteric blockage of the drug binding site; b) decreasing activity by interfering 
with ATP hydrolysis (Shapiro & Ling 1997) or c) changing cell membrane fluidity (Drori et al.,
1995; Werle 2008).
Enzyme inhibitors are molecules able to bind to enzymes and thereby decrease their activity, 
resulting in lower turnover or even complete stoppage.
Types of inhibitors
Reversible inhibitors are interacting temporarily with their target enzymes (Gillet & Gottesman 
2010). Non-covalent bonds like hydrophobic interactions, hydrogen or ionic bonds facilitate the 
association. Multiple weak bonds between the inhibitor and the target site allow for sufficient 
binding strength and specificity. If the inhibitor has an affinity for the active site, it is termed
competitive inhibition as the inhibitor and the substrate compete for access to the same space on 
the enzyme, whereby less substrate can be processed (Alberts et al., 2007). If the inhibitor 
requires the substrate-enzyme complex to be formed, it is a case of non-competitive inhibition. 
Here, the binding of the inhibitor decreases the overall turnover rate of the enzyme (Alberts et 
al., 2007). Allosteric inhibitors bind to a different site of the enzyme, thereby inducing a 
conformational shift, which will decrease affinity of the substrate towards the active site, 
resulting in a reduced turnover rate (Berg et al., 2002). Non-competitive inhibitors will bind to 
the enzyme and reduce overall reaction rate without decreasing substrate affinity to the active 
site (Alberts et al., 2007).
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Most irreversible inhibitors covalently modify their target enzymes and the effect is permanent
(Berg et al., 2002). Often, this involves electrophilic functional groups of the inhibitors to react 
with amino acid side chains forming covalent bonds. This will modify the active site, reducing 
or even preventing access for the substrate, while the enzyme’s functionality remains intact
(Alberts et al., 2007).  
Inhibitor generations
Since the discovery of drug transporting proteins like P-gp, the number of inhibitors has grown 
and it is possible to distinguish different generations.
The first inhibitor of P-gp was discovered in 1981. The calcium channel blocker, verapamil, was 
shown to reverse MDR in vincristine-resistant P388 leukaemia cells (Tsuruo et al., 1981). It was 
part of the “first generation” P-gp inhibitors like cyclosporin A and quinidine, which were not 
specifically developed to inhibit P-gp (Amin 2013). These exhibited other pharmacological 
activities and had relatively low affinities for P-gp. Therefore, their usefulness was limited as 
high serum concentrations were necessary to achieve relevant P-gp inhibition, these were often 
toxic (Lomovskaya & Bostian 2006). 
Second generation inhibitors, like dexverapamil and valspodar, were more potent, but had a 
number of unwanted side effects (Pusztai et al., 2005). They often interacted with several ABC 
transporters, not only P-gp, or with CYP3A4, a crucial enzyme for drug metabolism. This often 
led to complicated pharmacokinetic interactions, which were undesirable and often toxic
(Malingré et al., 2001; Pusztai et al., 2005). 
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Improved knowledge and better understanding of structure-affinity relationships between 
inhibitors and P-gp allowed the development of third generation inhibitors. They display higher 
in vitro potency, increased selectivity at nanomolar concentrations and generally lower toxicity 
(Kwak et al., 2010). However, some inhibitors still showed cross-reactivity with BCRP, another 
ABC transporter (Ahmed-Belkacem et al., 2005) and, in one case, CYP3A4 (Dantzig et al., 
1999). Furthermore, several third-generation inhibitors did not increase therapeutic efficacy as 
anticipated (Bardelmeijer et al., 2004). Hence, alternative strategies are sought for designing
fourth generation inhibitors, such as investigation of natural compounds, design of dual activity 
ligands or peptidomimetics (Palmeira et al., 2012). For example piperine, an alkaloid 
responsible for the pungency of black pepper, is a known P-gp inhibitor (Singh et al., 2013). It 
competes with ATP/ADP for the same position at the NBD site and could be used as starting 
point to develop novel P-gp inhibitors with fewer negative side effects (Singh et al., 2013).
1.2.3.3 Inhibitor-mediated reversal of drug resistance 
Resistance to avermectins has been reduced in H. contortus using inhibitors such as verapamil 
(Molento & Prichard 2001), thereby confirming the role of ABC drug transporters in resistance 
to IVM and moxidectin. Decreasing the transport activity of ABC transporters has the potential 
to enhance the bioavailability of avermectins (Bartley et al., 2009). Yet, possible toxic side 
effects, differences in pharmacokinetics of avermectins and inhibitors, potential withdrawal 
periods and costs of the respective inhibitors have to be considered as well (Lespine et al.,
2008). 
However, as IVM has been shown to be transported by ABC transporters in invertebrates (Xu et 
al., 1998; Sangster et al., 1999), it would be reasonable to use inhibitors to investigate the role 
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of ABC transporters identified in the course of this study with regard to their potential role in 
EMB resistance. 
1.2.3.4 Metabolic changes and resistance
Drug resistance can also be related to enhanced detoxification systems (Denholm et al., 2002), 
such as cytochrome P450 monooxygenase-mediated resistance to pyrethroids in salmon lice 
(Sevatdal et al., 2005). Whether there is significant metabolism of EMB in L. salmonis, it is 
currently unknown. Very limited metabolic breakdown occurs in Atlantic salmon (Kim-Kang et 
al., 2004), so if one would assume a similar metabolic turnover for salmon lice, it is unlikely 
that changes in EMB metabolism would be sufficient to overcome EMB toxicity. Furthermore, 
concentration of EMB within Atlantic salmon declines slowly due to sustained enterohepatic 
recirculation (Kim-Kang et al., 2004), therefore it is unlikely that changes to EMB metabolism 
in salmon would significantly affect the drug concentration of tissue ingested by the parasite.
1.2.4 Drug resistance monitoring
Detecting resistance to parasiticides in nematodes infecting livestock involves in vivo (e.g. 
reduction of egg numbers in faeces) and in vitro methods (e.g. monitoring of hatching success 
or larval development) (Coles et al., 1992). These methods were also employed to study 
avermectin efficacy when treating river blindness caused by human filarial nematode O.
volvulus (Churcher & Basáñez 2009) and ruminants infected with parasitic nematodes (Coles et 
The potential role of ABC transporters as factors influencing drug susceptibility in the 
salmon louse, Lepeophtheirus salmonis (Krøyer, 1837)
Jan Heumann- May 2015
Introduction 47
al., 2006). There is evidence for avermectin resistance in O. volvulus (Osei-Atweneboana et al.,
2007) and nematodes parasitizing ruminants (Kaplan 2004; Wolstenholme et al., 2004).
Constant monitoring is important to detect reduced sensitivity to a parasiticide, which will help 
to ascertain when treatment should be continued with a different class of chemicals, thereby 
delaying the development of resistance (Zhao et al., 2006). Monitoring of salmon lice is 
conducted with the same intention: Assessing the optimal treatment regime for salmon 
production areas, while taking local differences into consideration (Brooks 2009), as the 
emergence of resistance to currently used delousing agents is a constant threat to the farmer’s 
ability to control salmon lice infections. Therefore, it is vital to constantly collect information 
regarding treatment success and efficacy of the chemicals employed.
To obtain this information, bioassays are widely used to assess the sensitivity of a salmon louse 
test population to a parasiticide such as EMB, deltamethrin and cypermethrin (Sevatdal & 
Horsberg 2003; Bravo et al., 2008; Westcott et al., 2008). Bioassays can also be employed to 
investigate the effects of toxicants like EMB with regard to gene expression in surviving 
parasites (Tribble et al., 2007; Heumann et al., 2012; Heumann et al., 2014). However, the 
current bioassay design is labour-intensive, does not allow for high-throughput and lacks 
simplicity (Westcott et al., 2008). It requires testing pre-adult or adult salmon lice, which have 
been removed from their hosts. While bioassays are useful for monitoring the susceptibility of 
salmon lice to parasiticides, they suffer from limitations: Firstly, the collected parasites have to 
be used quickly, usually within 2 days after removal from their natural environment, because 
their vitality gradually declines. Secondly, to ensure consistency and comparability of 
bioassays, it is important to define endpoints and effects. This can be difficult, particularly when 
assessing sublethal effects of delousing agents, as the parasite can remain moribund for 
prolonged periods (Denholm et al., 2002). Thirdly, the currently used dose-response protocol 
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suggests to test at least five different concentrations of toxicant. This should include 
concentrations which were previously effective (Westcott et al., 2008), but it may not always 
possible to choose useful concentrations and a second bioassay, with adjusted concentrations, 
would be necessary.
Monitoring of drug resistance in salmon lice should be efficient and quick. The bioassays used 
for monitoring should be simple, robust, sufficiently sensitive to detect changes in susceptibility 
and easy to replicate, with clearly defined endpoints. However, these requirements are hard to 
meet in practice. In addition, the use of different chemicals makes it even harder to develop a 
suitable bioassay suitable for all circumstances. The difficulty is rooted in the parasiticides 
different life stage specificity, speed of effect and their general physical and chemical properties 
(Denholm et al., 2002). 
Once the biochemical causes for drug resistance have been discovered, in vitro tests of the 
respective resistance mechanisms could be developed, which would lead to easier, faster and 
potentially cheaper resistance monitoring (Denholm et al., 2002; von Samson-Himmelstjerna & 
Blackhall 2005). With only a limited number of delousing agents licenced for treatment and the 
capacity of salmon lice to develop resistance to delousing agents, it is important to better 
understand their response to parasiticides (Walsh et al., 2007). Knowledge of the molecular 
basis of the respective resistance mechanism could help to develop biochemical assays 
measuring the quantity of resistance-conferring enzymes or molecular (e.g. RT-PCR-based) 
methods to detect qualitative differences in drug resistant salmon lice (von Samson-
Himmelstjerna & Blackhall 2005). Development of additional tools to monitor drug resistance 
would contribute to the overall success in controlling salmon lice (Denholm et al., 2002).
Changes detected in the expression pattern and the structure of P-gp (Sangster et al., 1999) or β-
tubulin (Eng et al., 2006) could be the first step towards the development of genetic markers 
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allowing for the monitoring of resistance, which can develop in parasites continuously selected 
with avermectins (Eng & Prichard 2005). Changes in  β-tubulin have been studied as potential 
markers for IVM and moxidectin resistance in nematodes, but additional research is required 
(Prichard & Roulet 2007). Prolonged use of IVM to treat river blindness appears to have 
reduced the genetic diversity of a P-gp homolgue in O. volvulus (Ardelli et al., 2006). Tracking 
this decrease could be useful for monitoring IVM resistance (Bourguinat et al., 2008). 
Analysing differential gene expression in L. salmonis could also contribute to drug resistance 
monitoring. Molecular biological methods such as real-time quantitative PCR could be 
employed to investigate how genes of interest are regulated and if there are changes in 
expression as a reaction to parasiticide exposure. Expression is compared to constitutive genes 
required for maintenance of metabolism and other fundamental cellular processes, which are 
unlikely to be regulated in response to drug exposure (Frost & Nilsen 2003). Frost and Nilsen 
(2003) tested the suitability of several reference genes, which could be used to identify 
transcription changes that occur during the development of L. salmonis. They found that 
structural ribosomal protein S20 (RPS20) and the eukaryotic elongation factor 1 alpha (eEF1a) 
showed less than two fold variation in their transcription levels in samples covering the whole 
life cycle of L. salmonis (Frost & Nilsen 2003). Therefore, these two genes could be used as 
reference genes when investigating transcriptional changes in salmon lice triggered by EMB 
exposure (Frost & Nilsen 2003). 
Over the years the costs of molecular biological analyses has fallen, while their sensitivity, 
reliability and potential for automation has increased (Bass et al., 2004). Once the mechanisms 
for drug resistance are better understood and the implicated genes identified, it is likely that 
molecular biological assays will become an important tool for resistance detection and salmon 
louse management (Sangster 2001; von Samson-Himmelstjerna 2006). This could be 
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particularly useful if the resistance mechanisms involve changes to the drug’s target site, as seen 
for drug-resistant cat fleas, Ctenocephalis felis (Bass et al., 2004). Molecular biological tools 
will also become essential to study host-parasite interactions. This would contribute towards 
developing new therapeutic or prophylactic strategies aimed at decreasing salmon louse 
infections. 
1.3 Aims and objectives
EMB is the last of a number of delousing agents, where loss of efficacy has occurred (Torrissen 
et al., 2013). This highlights the urgency for a better understanding of EMB resistance
mechanisms, particularly at a molecular level. This could pave the way for developing  
diagnostic markers capable to reliably predict the susceptibility of subpopulations, a more 
timely rotation of parasiticide classes and possibly could prolong the shelf life of EMB. The 
overall aim of this project is to expand our knowledge of potential factors contributing to EMB 
resistance in L. salmonis. 
Drug resistance can be caused by qualitative or quantitative changes to drug detoxification 
mechanisms or target sites. As the salmon louse genome was not fully sequenced at the 
inception of this project, we planned to use a bioinformatics approach to screen publicly 
available ESTs of salmon lice for candidate genes putatively involved in drug resistance. Of 
particular interest were ABC transporters, a gene family that contains members functioning as 
drug efflux pumps. Increased expression of ABC transporters has been linked to drug resistance 
in humans (Cole et al., 1992), agricultural parasites (Sangster et al., 1999; Blackhall et al.,
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2008), and marine invertebrates (Luckenbach & Epel 2008). We intended to test the hypothesis 
that ABC transporters are major factors in EMB resistance in L. salmonis. Available genomic 
resources were searched and candidate genes for ABC drug transporters isolated. The sequences 
were incomplete; therefore, for selected candidates, full-length coding sequences were to be 
established. Real-time quantitative PCR was used to measure the relative expression ratios of 
the candidate genes in two well-characterised salmon lice strains differing in their susceptibility 
to EMB. These strains were reared at the University of Stirling for several years and their 
susceptibility to EMB has remained relatively constant (personal communication Dr A 
Tildesley). Expression was to be observed before and after aqueous exposure to EMB in 
bioassays. Furthermore, bioassays were performed during the course of this project, with the 
intention to monitoring EMB resistance in both strains; acquiring genetic material before and 
after exposure to the pesticide and for improving the current bioassay protocol.
Bioassays are used to monitor changes of a parasite subpopulation exposed to different toxicants 
(ffrench-Constant & Roush 1990). In the standard bioassay for monitoring EMB resistance, 
multiple concentrations are used for 24 h aqueous exposure, after which the parasite’s response 
is recorded (SEARCH Consortium 2006; Sevatdal et al., 2005). However, a large number of 
parasites of the same developmental stage (~150 animals) is required and the standard bioassay 
cannot be replicated in rapid succession; it lacks simplicity and results can differ substantially 
depending on the season (Westcott et al., 2008). This means that the current standard bioassay 
might not be suitable at all times of the year for assessing resistance, given varying 
circumstances like developmental stage of the parasite (Westcott et al., 2008; Heumann et al.,
2012) and speed of the drug action (Denholm et al., 2002). We intend to test the feasibility of an 
alternative bioassay design, which could be more suitable under some circumstances, as it 
requires only half the animals needed for a standard bioassay. The response of animals exposed 
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to EMB will be monitored over time. We intended in confirming that it is possible to 
differentiate between susceptible and resistant lice using time course toxicity analysis. 
Furthermore, bioassays require labour-intensive detachment of salmon lice, resulting in low 
throughput and require human assessment of the parasite’s condition. This is disadvantageous 
for large-scale testing and automation. Furthermore, lice must be used soon after collection, as 
prolonged separation from the host will induce additional stress; hence, bioassays must 
commence within a relatively short period. In addition, it can be challenging to define endpoints 
and which observed behaviour represents an effect caused by treatment (Denholm et al., 2002). 
These are inherent disadvantages of the aqueous bioassay system. Alternative methods for 
monitoring resistance in salmon lice should be developed; these should be simpler, cheaper, 
allow for higher throughput and possibly partial automation. Molecular biological methods like 
real-time quantitative PCR could be a welcome addition to the toolbox for resistance 
monitoring. Better understanding of resistance mechanisms would allow for the identification of 
resistance-associated genes. Their expression could be monitored and developing resistance 
might be discovered earlier, ideally before resistance in many individuals of a subpopulation 
appears (Eng & Prichard 2005). For example, it was shown that avermectins can induce 
overexpression of  resistance-associates genes such as P-gp and other ABC transporters in C. 
elegans (James & Davey 2009). Therefore, we identified several putative ABC drug transporters 
from the salmon louse and measured their expression levels before and after EMB treatment. 
Expression changes of resistance-related genes could be used to detect EMB resistance 
developing in L. salmonis subpopulations on salmon farms, with the development of on-site 
monitoring tools as a long-term objective.
Identifying ABC transporters in L. salmonis and their potential role in EMB resistance was the
main purpose of this project.
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Abstract
The salmon louse, Lepeophtheirus salmonis, is a crustacean ectoparasite of salmonids. At 
present, sea louse control on salmon farms relies heavily upon chemical treatments. Drug efflux 
transport, mediated by ABC transporters such as P-glycoprotein (Pgp), represents a major 
mechanism for drug resistance in parasites. We report here the molecular cloning of a new Pgp 
from the salmon louse, called SL-PGY1. A partial Pgp sequence was obtained by searching sea 
louse ESTs, and extended by rapid amplification of cDNA ends (RACE). The open reading 
frame of SL-PGY1 encodes a protein of 1438 amino acids that possesses typical structural traits 
of P-glycoproteins, and shows a high degree of sequence homology to invertebrate and 
vertebrate P-glycoproteins. In the absence of drug exposure, SL-PGY1 mRNA expression levels 
did not differ between a drug-susceptible strain of L. salmonis and a strain showing a~7-fold 
decrease in sensitivity against emamectin benzoate, the active component of the in-feed sea 
louse treatment SLICE® (Merck Animal Health). Aqueous exposure of the hyposensitive 
salmon  louse strain to emamectin benzoate (24 h, 410 g/L) provoked a 2.9-fold up-regulation 
of SL-PGY1. Adult male lice of both strains showed a greater abundance of SL-PGY1 mRNA 
than adult females.
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2.1 Introduction
Caligid copepods, also called sea lice, are common ectoparasites on wild and farmed marine fish 
(Costello, 2006). With the expansion of marine and brackish water aquaculture, sea lice have 
become increasingly important as disease-causing agents (Johnson et al., 2004; Pike & 
Wadsworth, 1999). The species most problematic for farmed salmonids are the salmon louse 
Lepeophtheirus salmonis (Krøyer, 1837) and Caligus elongatus (Nordmann, 1832), which occur 
principally on salmonid hosts in the Northern hemisphere, and Caligus rogercresseyi, which has 
been reported on farmed salmon in the Southern hemisphere (Costello, 2006). While heavy sea 
lice infections have the potential to cause high levels of mortality on salmon farms (Pike & 
Wadsworth, 1999), treatment and management strategies in place today have greatly reduced 
infection levels (Costello, 2006). The annual costs of sea louse infections to the global salmon 
industry have been estimated to exceed 300 million euros, which includes the costs of 
treatments as well as economic losses due to impaired growth and carcass downgrading 
(Costello, 2009).
As part of integrated pest management strategies and in the absence of effective vaccination
procedures, chemical treatments currently have a central role in sea louse control. At present, 
one of the most common anti-sea louse treatments is the in-feed fish medicine SLICE® (Merck
Animal Health), which contains the avermectin drug, emamectin benzoate (4”-deoxy-4” 
epimethylaminoavermectin B1) (Stone et al., 1999). Advantages of SLICE are the convenient 
in-feed administration, the effectiveness against all host-attached life stages of sea lice, the 
prolonged protection achieved by a standard one-week treatment, and a favourable 
environmental profile (Stone et al., 1999; Telfer et al., 2006). However, the continued reliance 
The potential role of ABC transporters as factors influencing drug susceptibility in the 
salmon louse, Lepeophtheirus salmonis (Krøyer, 1837)
Jan Heumann- May 2015
Molecular cloning and characterisation of a novel P-glycoprotein in the salmon louse, 
Lepeophtheirus salmonis (Krøyer, 1837) 77
on few licensed anti-sea louse medicines potentially promotes the risk of development of drug 
resistance in the parasite. Decreased treatment efficacies have been reported for a number of 
drugs used to treat L. salmonis infections (e.g. organophosphates (Jones et al., 1992), 
pyrethroids (Sevatdal & Horsberg, 2003), H2O2 (Treasurer et al., 2000)) and C. rogercresseyi
(emamectin benzoate (Bravo et al., 2010)), while for other compounds used as anti-sea louse 
agents, resistance formation has been reported in insect pests (Kristensen & Jespersen, 2003; 
Oppenoorth & Van der Pas, 1977).
Drug resistance in parasites can result from a number of different molecular mechanisms, 
including changes in the molecular target of the drug that disrupt the drug’s action, changes in 
drug metabolism that inactivate the drug or prevent its activation, changes of drug distribution 
in the parasite, and amplification of targets to overcome drug action (Wolstenholme et al., 
2004). Avermectins are also used to control helminths, and resistance against this class of drugs 
has been reported in a number of parasitic gastrointestinal nematodes of livestock (Kaplan, 
2004). Two main biochemical mechanisms are currently thought to provide the basis of 
avermectin resistance in parasitic nematodes; changes in ligand-gated chloride channels that 
constitute the molecular target of the drug (Wolstenholme & Rogers, 2005), and increased 
expression of drug transporters of the large class of ABC (ATP-binding cassette) proteins, 
which are thought to decrease internal exposure of the parasite to the drug by efflux pumping 
activity (Prichard & Roulet, 2007).
ABC proteins constitute one of the largest protein superfamilies, with members in all organisms 
from bacteria to humans (Dassa & Bouige, 2001). While prototypical ABC proteins are 
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transporters coupling ATP hydrolysis with substrate translocation across biological membranes, 
the ABC superfamily also contains ion channels, regulators of ion channels, receptors, and 
proteins with roles in ribosome assembly and translation (Dean et al., 2001). In ABC 
transporters, two transmembrane domains (TMDs) and two nucleotide-binding domains (NBDs) 
are required to constitute a functional pump. In full transporters, all required domains are 
combined in a single polypeptide, while half transporters possess only one TMD and one NBD, 
and require homo- or heterodimerisation for function (Dassa & Bouige, 2001). Metazoan ABC 
transporters are currently divided into eight subfamilies (A-H), of which subfamilies B, C and G 
contain pumps capable of mediating drug transport (Dean et al., 2001; Sheps et al., 2004; Sturm
et al., 2009). MDR (multidrug resistance) P-glycoprotein (ABCB1) is a full transporter capable 
of mediating the cellular efflux of a large array of structurally and functionally unrelated drugs. 
Expression of ABCB1 can cause MDR in cancer (Chen et al., 1986). In normal tissues, ABCB1 
has important roles in the biochemical defence against toxicants (Schinkel et al., 1994). The 
avermectin drug, ivermectin, is transported by ABCB1 (Bain & LeBlanc, 1996), and mice 
lacking expression of this transporter in the gut and the brain as the result of targeted gene 
disruption are markedly hypersensitive to ivermectin (Schinkel et al., 1994). While no data are 
available for emamectin, ivermectin and five other avermectins affected MDR P-glycoprotein-
dependent ATPase activity at low micromolar concentrations, suggesting that they may also be 
substrates (Lespine et al., 2009). Accordingly, P-glycoprotein has been investigated as a 
potential factor in the resistance against avermectins in a number of parasites. Ivermectin-
selected strains of the nematode helminth, Haemonchus contortus (Rudolphi 1803), showed a 
higher mRNA expression of P-glycoprotein, which coincided with an enrichment of a certain 
allele at the locus coding for the transporter (Blackhall et al., 1998; Xu et al., 1998). Evidence 
for a possible genetic selection around a P-glycoprotein locus also exists in the human parasite,
Onchocerca volvulus (Bickel, 1982) (Ardelli et al., 2006).
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The aim of this study was to isolate cDNA sequences coding for P-glycoprotein in the salmon 
louse, Lepeophtheirus salmonis, and to explore the usefulness of this gene as a potential 
molecular marker for drug resistance. While the free-living model nematode, C. elegans,
possesses at least 15 P-glycoproteins (Sheps et al., 2004; Zhao et al., 2007) and the parasitic 
model nematode, H. contortus, possesses ten P-gps (Laing et al., 2013), only two P-glycoprotein 
sequences were found in the genome of the crustacean, Daphnia pulex (Linnaeus 1758) (Sturm 
et al., 2009). Using the conserved nucleotide binding domains of Daphnia ABC transporters as 
queries, we searched publicly available EST databases for sequences encoding sea louse ABC 
transporters. By this approach, one partial cDNA coding for a salmon louse P-glycoprotein was 
isolated, which was called SL-PGY1, and the entire open reading frame (ORF) of the 
transporter was obtained by rapid amplification of cDNA ends (RACE). The constitutive 
expression of SL-PGY1 and effects of emamectin benzoate exposure were examined in drug 
susceptible salmon lice, and lice populations showing a decreased susceptibility to emamectin 
benzoate. The present study is the first report of an authentic P-glycoprotein sequence in sea 
lice.
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2.2 Material and methods
2.2.1 Salmon lice 
A susceptible salmon louse (L. salmonis) strain S was established eight years ago in our 
laboratory, originating from a farm isolate obtained from the West coast of Scotland, where no 
control agents had been used except for hydrogen peroxide. The sea louse strain R, which 
showed decreased susceptibility to emamectin benzoate, was established in December 2008 
from animals obtained from another salmon farming site of the West coast of Scotland with 
reports of variable clearance rates following treatment. Following isolation, both strains have 
been maintained in the laboratory under identical conditions in the absence of exposure to any 
sea louse treatments. To maintain the lines, gravid female lice are removed from fish under 
anaesthesia (2-phenoxy ethanol), egg strings are hatched and incubated to the infective 
copepodid stage, which are then used to re-infect Atlantic salmon (Salmo salar). All laboratory 
infections were carried out under UK Home Office licence and appropriate veterinary 
supervision. Host fish typically had an initial mean weight of 500-1000 g, and were held in 
circular tanks provided with a continuous supply of fresh seawater at ambient temperature and 
at flow rate of 0.5-5 L min-1 per kg fish, and with a photoperiod corresponding to natural day 
length and adjusted weekly. During copepodid infection challenges, water flows were 
suspended and copepodids were introduced to the tanks from the incubation vessels. When 
water flows were restored, fish were inspected for lice settlement and infection rates were 
maintained at levels that were unlikely to compromise the welfare of the fish.  Fish were then 
inspected regularly to ensure that no re-infections occurred due to the parasite cycling in the 
tanks.
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2.2.2 Emamectin benzoate bioassay
Technical grade emamectin benzoate was donated by Merck Animal Health®. The
susceptibility of sea lice to emamectin benzoate was determined in bioassays using 24 hour 
aqueous exposures (Sevatdal et al., 2005). Salmon lice were collected by anaesthetising host 
fish with 2-phenoxy ethanol and removing lice using fine forceps. Test solutions were prepared 
using aerated filtered sea water equilibrated to a temperature of 12°C, the temperature being 
maintained throughout the assay. PEG300 was used to solubilise the emamectin benzoate 
(maximum final concentration 0.01%). Seven concentrations of emamectin benzoate and a 
PEG300 control were tested, using three replicate beakers, each containing 450 mL of testing 
solution and ten sea lice per treatment. Labelling of test containers was coded to ensure 
unbiased rating of sea louse motility at the end of exposures, when lice were recorded as 
normally motile or immotile upon visual examination and stimulation with a fine brush. To 
confirm exposure concentrations, water samples from selected bioassays were sent to a 
commercial laboratory for emamectin benzoate residue analysis (Eclipse Scientific, Chatteris, 
UK). Samples were extracted with acetonitrile before being subjected to liquid chromatography 
with detection by MS-MS.
2.2.3 On-host exposure of sea lice to emamectin benzoate
An experiment was carried out to assess potential effects of emamectin benzoate on gene 
expression in sea lice following administration of the drug by treatment of host fish with 
SLICE. In late May 2010, L. salmonis egg strings were obtained from a Scottish salmon 
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production site with reports of decreased treatment efficacies, and incubated in seawater until 
development reached the infective copepodid stage. Fifty naïve Atlantic salmon were infected 
with copepodids and maintained for four weeks, which allowed lice to develop to the adult 
stage. The obtained louse population, from here on called SF, was removed from anaesthetised 
fish, and male adults used for performing an emamectin bioassay. Remaining lice of both sexes 
were used to infect another batch of naïve fish, which were then randomly allocated to two 
tanks (20 fish per tank). From day 13 to day 19 post infection, one group of fish was treated 
with SLICE-containing feed, while the other group continued to be fed a control diet. Uneaten 
pellets were collected and the estimated average emamectin benzoate delivery was 52.1 µg/kg
fish biomass/day for the treated tank. Fish were maintained for a further three weeks until day 
40 post infection, when they were anaesthetised and lice counted and preserved pending RNA 
extraction. Individual lice were sampled into tubes containing RNAlater® and stored at -20°C.
2.2.4 Molecular cloning of sea louse P-glycoprotein 
Total RNA was isolated from adult salmon lice of both sexes using a commercial reagent 
(TRIzol™, Invitrogen). Prior to extraction, lice were ground in liquid nitrogen using a pestle 
and mortar. The initial protocol (used in all cloning experiments and expression analyses in 
control lice) used this homogenisation step only. In an improved protocol (used in experiments 
on the effects of drug exposure on SL-PGY1 expression), the sample was further homogenised 
for 10 seconds in an Ultra-Turrax® device after addition to the TRIzol® reagent. RNA integrity 
was confirmed by agarose gel electrophoresis and ethidium bromide staining. RNA 
concentration and purity were assessed by UV spectroscopy (NanoDrop 1000 
spectrophotometer, Thermo Scientific).
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Salmon louse (L. salmonis) ESTs available in the GenBank database were searched for 
sequences showing homology to nucleotide binding domains (NBDs) of Daphnia pulex P-
glycoproteins (Sturm et al., 2009) using the TBLASTN algorithm. From the hits obtained in this 
search, a minimum set of contiguous sequences (contigs) was obtained using the Lasergene 
SeqMan version II software (Lasergene, Madison, U.S.). The contigs were allocated to ABC 
subfamilies according to their best BLAST hit. One contig, based on two ESTs (GenBank
accession numbers: EX483668, EX483669 (Yazawa et al., 2008)), showed a high similarity to 
MDR P-glycoproteins in other species, but did not resemble published salmon louse P-
glycoprotein sequences (Tribble et al., 2008). To obtain the complete open-reading frame of this 
novel salmon louse P-glycoprotein, called SL-PGY1, rapid amplification of cDNA ends 
(RACE) was used. 5’ and 3’ RACE reactions were performed using commercial kits (5’RACE 
System, Invitrogen or SMART RACE, Clontech) and high quality reverse transcriptase 
(SuperScript II, Invitrogen) and DNA polymerase (Expand Long Template PCR System, Roche 
Applied Science). RACE products were subcloned using a commercial T-vector (Promega) and 
chemo-competent Escherichia coli (DH5alpha strain). Plasmids were sequenced with a CEQ 
8800 sequencer (Beckman Coulter). To confirm that the obtained RACE products and the 
contig derived from ESTs corresponded to the same cDNA, the total cDNA sequence of SL-
PGY1 was amplified in one PCR (primers: TGGATCCACAAATCATCATCA and 
TTTTATGATGCGAACAATTGAAT), and subcloned. The sequence reported here was derived 
from at least three plasmid clones containing the total SL-PGY1 sequence, which were from 
independent RT-PCRs using different total RNA samples.
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2.2.5 Quantitative real-time RT-PCR
The mRNA expression of SL-PGY1 was compared between the two aforementioned salmon 
louse strains S and R, differing in emamectin benzoate susceptibility. Adult males and females 
were considered. For each combination of strain and sex, total RNA was obtained from 4-7 
pools of five lice each. Subsequent experiments investigating the effects of emamectin benzoate 
exposure on SL-PGY1 expression were restricted to adult male lice, as they are less susceptible 
to EMB (Westcott et al., 2008). In a first experiment, animals were pooled prior to RNA 
extraction as above. Two further experiments performed total RNA extraction and subsequent 
analyses on single adult lice, taking advantage of an improved extraction protocol (see above).
SL-PGY1 mRNA levels were assessed by quantitative real time RT-PCR, using the SYBR 
Green method and relative quantification (Pfaffl, 2001). Ribosomal protein S 20 (RPS20) and 
eukaryotic elongation factor 1 alpha (eEF1α) were used as reference genes, as these have been 
validated in a previous study (Frost & Nilsen, 2003). 4,000 ng salmon louse total RNA were 
reverse transcribed with SuperScript II (Invitrogen) using oligo dT primers in a total volume of 
20 l. Quantitative PCRs were carried out using a commercial kit (ABsolute QPCR SYBR 
Green Mix, Thermo) and a Quantica Real Time Thermal Cycler (Techne). The product of the 
reverse transcription was diluted 1:20, and 5 l of this dilution was used per PCR reaction (final 
volume of 20 μL). Primers were used at 70 nM. Each run comprised of an initial 15 min 
activation cycle at 95°C, followed by 40 cycles of 15 sec denaturation at 95°C, 30 sec annealing 
at 60°C and 30 sec elongation at 72°C. Fluorescence was read during the 72°C elongation step. 
A melting curve analysis was performed following the completion of the PCR programme to 
confirm that single products had been amplified. Crossing points were analysed using the PCR 
cycler software. Internal controls included in each run comprised samples in which either the 
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reverse transcriptase or the cDNA template were omitted. Standard curves were derived from 
serial dilutions made from a reference cDNA pool. Each measurement was performed in 
triplicate. Relative expression ratios (RER) (Pfaffl, 2001) were calculated using the following 
formula: 
(E target)^(ΔCP target (control - sample))
RER = ------------------------------------------------------
(E reference)^(ΔCP reference (control - sample))
2.2.6 Bioinformatic analyses
The cloned sea louse P-glycoprotein sequence was examined for the presence of conserved 
domains using InterProScan version 4.6 with standard settings, as implemented on the ExPASy 
(Expert Protein Analysis System) proteomics server of the Swiss Institute of Bioinformatics 
(http://expasy.org). Further ExPASy programs used in this study were ScanProsite, which was 
employed to elucidate the extension of NBD (prosite profile PS50893) in different ABC 
transporters, and TopPred, which served to predict the topology of sea louse P-gp. Evolutionary 
analyses were carried out using the software package MEGA 4 (Tamura et al., 2007), using the 
neighbour-joining algorithm and employing 5,000 bootstrapped replicates to derive phylogenies 
(Tamura et al., 2007). 
2.2.7 Statistics
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Median effective concentrations (EC50s) describing the toxicity of emamectin benzoate were 
derived by probit analysis using the statistical software minitab 15.1 (Minitab Inc). Relative 
expression ratios of SL-PGY1 mRNA were compared between different groups of lice by one-
way ANOVA followed by post-hoc comparisons with the Tukey-Kramer test using the program 
InStat 3.05 (GraphPad Inc.). Data were log-transformed prior to ANOVA, and the homogeneity 
of variances after transformation was confirmed by Bartlett’s test. In all tests, the significance 
level was set at 0.05.
2.3 Results
To isolate cDNA sequences coding for P-glycoproteins in the salmon louse, L. salmonis, we 
used sequences of conserved NBDs of D. pulex P-glycoproteins (Sturm et al., 2009) as the 
query statement in TBLASTN searches of L. salmonis ESTs available in the GenBank database. 
The obtained L. salmonis ESTs were assembled into contigs and assigned to ABC subfamilies 
according to their best BLASTX hit. Three contigs fell into the ABCB subfamily (Table 1). 
Within the ABC superfamily, the ABCB subfamily is unique in that it contains both full 
transporters targeted to the plasma membrane called P-glycoproteins, and half transporters 
locating to intracellular membranes (Dean et al., 2001). Contig 1 was highly homologous to 
metazoan P-glycoproteins and named SL-PGY1, while contigs 2 and 3 showed a high 
homology to mitochondrial ABCB subfamily half transporters (Table 1). Contig 3 contained a 
region corresponding to SL-Pgp1, a partial L. salmonis cDNA previously described as a P-
glycoprotein (Tribble et al., 2007), with 97.8% sequence identity in the shared region. A further 
sequence previously annotated as sea louse P-glycoprotein, named SL0525, showed a high 
homology to ABCF subfamily proteins in BLASTX searches (Table 1).
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Table 1: Sea louse (L. salmonis) ABCB proteins isolated in this study and sequences previously 
published as putative sea louse P-glycoproteins. cDNA sequences were subjected to BLASTX 
searches at the National Center of Biotechnology Information website 
(http://www.ncbi.nlm.nih.gov) using default settings.
Sequence Length 
(bp)
ESTs
(GenBank accession nos.)
Best blastx hit1 E-value
Contig 1 
(SL-MDR1)
921 EX483668 
EX483669
Multixenobiotic resistance 
protein [Crassostrea virginica]
5 e-76
Contig 2 1080 EX480766
EX480767
FK903290
FK919647
FK919648
ATP-binding cassette sub-
family B member 7, 
mitochondrial [Camponotus 
floridanus]
1 e-73
Contig 3 1245 FK917819
FK933430
FK933431
ATP-binding cassette sub-
family B member 8, 
mitochondrial precursor 
[Salmo salar]
1 e-134
SL-Pgp12 642` N/A ATP-binding cassette, sub-
family B (MDR/TAP), 
member
8 [Xenopus tropicalis]
1e-76
SL05252 717 N/A ATP-binding cassette sub-
family F member 1 [Culex 
quinquefasciatus]
9e-103
1 Excluding inconclusive databank entries such as “hypothetical protein” etc.
2 From Tribble et al., 2007; GenBank accession numbers EF093796 and DQ458787.
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The evolutionary relationship of sea louse sequences SL-PGY1 and SL-Pgp1 to ABCB 
subfamily transporters from other organisms was elucidated in a phylogenetic analysis (Figure 
3). The sea louse sequence isolated in this study, named SL-PGY1, grouped in one well-
supported clade (bootstrap value of 90%) with Drosophila, Daphnia and human P-glycoproteins 
(Figure 3). In contrast, SL-Pgp1, an L. salmonis cDNA previously described as a P-glycoprotein 
(Tribble et al., 2007), clustered together with hABCB8, a human mitochondrial transporter, and 
similar Drosophila and Daphnia proteins (Figure 3).
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Figure 3: Phylogenetic tree of ABCB transporters. The analysis took into account available 
sequences from the sea louse L. salmonis (SL), the water flea Daphnia pulex (dp), the fruit fly 
Drosophila melanogaster (dm) and human (h). Human ABCC was included to root the tree. 
Predicted amino acid sequences of C-terminal nucleotide binding domains were aligned using 
ClustalX, and a phylogenetic tree generated using the neighbour joining method (Tamura et al., 
2007). Bootstrapping was used to determine the relative support of the various branches (5,000 
replicates, support expressed as percent).
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The partial SL-PGY1 cDNA sequence obtained from EST database entries was expanded in 5’-
and 3’-RACE reactions using total RNA from adult sea lice, which yielded further sequences 
that together with the sequence identified in silico covered the putative full open reading frame 
of a SL-PGY1 mRNA (GenBank accession no. HQ684737), with a predicted protein product of 
1438 amino acids (Figure 4). 
Figure 4: Cloning strategy to obtain L. salmonis P-glycoprotein (SL-PGY1). The SL-PGY1 
cDNA sequence is represented in the middle, with light grey (coding) and dark grey (non-
coding) regions. Lines indicate the relative position of fragments obtained by TBLASTN 
searches (EST, solid) or rapid amplification of cDNA ends (RACE, dashed). Bars below the SL-
PGY1 sequence indicate the position of regions encoding transmembrane (TMD) and nucleotide 
binding domains (NBD).
The conceptual translation of the SL-PGY1 cDNA sequence was examined for the presence of 
conserved domains using InterProScan. This analysis detected ABC-transporter transmembrane 
domains (TMDs) and nucleotide binding domains (NBD), arranged in an N-terminal to C-
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a greater ability to upregulate the transporter upon exposure to the drug. Alternatively, 
populations with lower susceptibilities may be enriched in allelic polymorphisms of SL-PGY 
affecting the transporter’s affinity for substrates and thus increasing its efficacy to function as a 
drug pump. To investigate these possibilities, experiments were carried out with two laboratory 
strains of L. salmonis differing in emamectin benzoate susceptibility (Table 2).
Table 2: Susceptibility of two L. salmonis strains to emamectin benzoate. Adult females and 
males were used in 24 h bioassays with motility as the readout. 
Strain Stage EC50 (g/L) (95% confidence 
limits)
S Adult female 82 (63-108)
S Adult male 145 (106-207)
R Adult female 524 (360-813)
R Adult male 1211 (766-2442)
SF Adult male 615 (502-754)
Compared to a susceptible strain S, which had been isolated before the onset of 
chemotherapeutant use and maintained in the laboratory since, susceptibility to emamectin 
benzoate was decreased in the more recently isolated R approximately 7- fold (Table 2). We 
first compared SL-PGY1 mRNA expression levels between the S and R strains in the absence of 
emamectin, using quantitative real time PCR and employing either eEF1 or RPS20 as 
reference genes (Figure 6).
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Figure 6: SL-PGY1 mRNA expression in two salmon louse strains. Quantitative real-time RT-
PCR was used to analyse mRNA levels of SL-PGY1 by relative quantification using eEF1α or 
RPS20 as reference genes (Frost & Nilsen, 2003). Columns show the median and standard 
deviation of relative expression ratios determined in pools (n = 4-7) of 5 adult salmon lice of 
both sexes (M = male, F = female) from two strains (S = susceptible; R = 6.4 to 8.4-fold 
reduced sensitivity to emamectin benzoate). Groups did not differ significantly when columns 
share a common letter, with the significance level set at 0.05.
Relative mRNA expression levels of SL-PGY1 tended to be higher in male than female lice; 
however, this difference was not significant for the drug susceptible S strain when eEF1 was 
used for normalisation. Regardless of the reference gene used, SL-PGY1 mRNA relative 
expression levels did not differ significantly between the two strains within males or females 
(Figure 6). Next, we investigated the effects of acute aqueous exposure of sea lice to emamectin 
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benzoate on SL-PGY1 mRNA expression. In a first experiment, adult male sea lice of the S and 
R strains were exposed for 3 h to a nominal concentration of 200 g/L of emamectin benzoate 
(measured concentration at the end of the assay: 99.5 ± 5.2 g/L). In both louse strains, 
emamectin benzoate exposure had no effect on SL-PGY1 mRNA levels determined using 
eEF1 (Figure 7A) or RPS20 (data not shown) as a reference gene. 
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Figure 7: Effect of emamectin benzoate exposure on SL-PGY1 mRNA expression. A, B. Adult 
male salmon lice of two strains (S, R) differing in emamectin benzoate susceptibility (Table 2) 
were subjected to waterborne EMB exposure. PEG 300 was used to solubilise EMB (final 
concentration 0.01%). C. Salmon louse egg strings were obtained from a salmon farm (SF) with 
reports of decreased SLICE treatment efficiencies, and allowed to develop to the adult stage in 
the laboratory. Salmon were infected with adult lice, maintained under standard conditions for 
12 days, and then given a feed containing SLICE or a control diet for 7 days, followed by a 
further three weeks of maintenance under standard conditions. Male lice were then collected for 
gene expression analysis. SL-PGY1 expression was analysed by RT-qPCR using eEF1α as a 
reference gene. Columns show the average and standard error of relative expression ratios 
determined in pools of 4 lice (A: n = 3) or in single lice (B: n=4-6; C: n=12). Asterisk indicates
that expression differed significantly from the appropriate control (P<0.05).
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In a second experiment, SL-PGY1 mRNA expression in the R strain was assessed following 24 
h of exposure to emamectin benzoate at concentrations of 240 g/L and 410 g/L, i.e. a more 
severe, but still sub-lethal exposure scenario. The mRNA expression of SL-PGY1 (eEF1 as 
reference) was significantly enhanced by 2.9-fold following exposure to 410 g/L emamectin 
benzoate (Figure 7B). However, when RPS20 was used for normalisation, in the same treatment 
a 1.7-fold increase in expression levels was not statistically significant (data not shown). 
Potential drug effects on SL-PGY1 expression might depend on the exposure route. Therefore, a 
further experiment investigated SL-PGY mRNA expression in sea lice exposed to emamectin 
benzoate through treatment of their salmon hosts with the oral fish medicine SLICE, using 
salmon lice grown in the laboratory from egg strings of a salmon farm (SF), where decreased 
treatment efficacies with SLICE had been reported. SF salmon lice showed a moderate decrease 
in emamectin benzoate susceptibility in the bioassay (Table 2). Atlantic salmon were infected 
with adult SF lice. Fish were then randomly assigned into two groups, one untreated control 
group and one experimental group which was treated with SLICE from day 12 to 18 after 
infection, mimicking the recommended use of the medicine SLICE as a seven-day treatment 
course. This is known to result in sustained emamectin benzoate concentrations in the fish and 
thus protection against sea lice for several weeks. Sea lice were maintained on the fish for a 
further three weeks after the end of SLICE treatment, before lice were collected and subjected to 
analyses. SLICE treated fish had 38.4% fewer lice than control fish. No differences in SL-PGY1 
mRNA levels were found between lice from untreated and SLICE treated hosts (Figure 7C). 
Finally, we explored the possibility that the two sea louse strains S and R might show different 
haplotype frequencies of polymorphisms of SL-PGY1. RT-PCR was used to amplify cDNAs 
comprising the entire open reading frame of the transporter from four male lice of each strain, 
and following the subcloning of the amplicon into a suitable T-vector, we sequenced the inserts 
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of 2-3 plasmid clones per individual. A number of nucleotide polymorphisms was observed, but 
with none of the polymorphisms was there a clear difference in haplotype frequencies between 
the two strains (data not shown). 
2.4 Discussion
We report here the molecular cloning of a P-glycoprotein from the sea louse, L. salmonis, called 
SL-PGY1 (GenBank accession number HQ684737), and demonstrate that two sequences 
previously published (Tribble et al., 2007) and deposited in databases as salmon louse P-
glycoproteins (GenBank accession numbers EF093796 and DQ458787) are misannotations of 
ABC transporters unrelated to P-glycoprotein. The high homology of SL-PGY1 to vertebrate 
and invertebrate P-glycoproteins suggests a role for the transporter in the detoxification of 
xenobiotics. Two sea louse strains differing in susceptibility to emamectin benzoate did not 
show distinct mRNA expression levels of SL-PGY1 in the absence of exposure to the drug. 
Exposure to emamectin benzoate had variable effects on mRNA expression in sea lice, 
depending on intensity and route of exposure and louse strain. An approximately 3-fold 
induction of SL-PGY1 mRNA expression was observed in the R strain of sea lice following 
water-borne exposure to a relatively high emamectin benzoate concentration (410 g/L). No 
sequence polymorphisms of SL-PGY1 correlating with emamectin benzoate susceptibility could 
be identified in this study. Together, the data suggest that SL-PGY1 is probably not the only 
causative factor responsible for decreased emamectin benzoate susceptibility in the studied sea 
louse strains, even though upregulation of the pump during acute emamectin benzoate exposure 
could contribute to the low susceptibility of the R strain. Adult male sea lice showed 
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significantly greater levels of SL-PGY1 mRNA than adult females. This could point to potential 
additional physiological functions of the transporter.
SL-PGY1 isolated in this study shows all the hallmarks of a P-glycoprotein, i.e. it encodes an 
ABCB subfamily full transporter having two TMDs and two NBDs. In contrast, SL-Pgp 
previously reported from L. salmonis (Tribble et al., 2007) has only one TMD and one NBD, 
suggesting it corresponds to an ABCB subfamily half transporter. Indeed, SL-Pgp1 grouped 
together with human and fruit fly mitochondrial ABC proteins in phylogenetic analyses, and 
showed a greater homology to these proteins than to P-glycoproteins (data not shown). ABCB 
half transporters are peptide pumps targeted to intracellular membranes (Herget & Tampé, 
2007), and have so far not been linked to drug transport. A further sea louse “putative P-
glycoprotein sequence” reported by the same laboratory (Tribble et al., 2007, 2008) was found 
to be an ABCF subfamily protein. ABCF subfamily members lack transmembrane domains and 
are not transporters, but are factors associated with the ribosome and are involved in the 
initiation of transcription (Kerr, 2004).
Mammalian MDR1 P-glycoprotein (ABCB1) is a well-known broad spectrum cellular efflux 
pump for hydrophobic organic chemicals. While originally discovered as a factor associated 
with multidrug resistance in tumours (Gottesman et al., 2002), the normal physiological role of 
ABCB1 is to contribute to the biochemical defence against endogenous and foreign toxicants 
(Leslie et al., 2005). However, further mammalian ABCB subfamily full transporters are 
unrelated to drug transport, and these include the bile salt efflux pump BSEP/ABCB11 (Gerloff, 
1998), the biliary phospholipid transporter MDR3/ABCB4 (Smith et al. 1994) and a protein of 
unknown function called ABCB5 (Annilo et al., 2006).
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The analysis of ABC transporter phylogeny between the vertebrate and invertebrate genomes 
revealed numerous lineage-specific gene duplications complicating the inference of function 
(Dean et al., 2001; Sheps et al., 2004). In the case of P-glycoproteins, however, available data 
seem to support the notion that the evolutionarily ancient role of these ABC transporters is that 
of broad spectrum toxicant efflux pumps (Epel et al., 2008). Among non-drug transporting 
mammalian ABCB proteins, ABCB4 and ABCB5 have arisen within the mammalian lineage 
and are lacking in birds and fish (Annilo et al., 2006), which strongly suggests they are also 
absent in invertebrates. While the bile salt efflux pump ABCB11 is found in all vertebrates 
(Annilo et al., 2006), evidence for bile salt transport by invertebrate P-glycoproteins is missing. 
In contrast, numerous studies demonstrate in invertebrates the presence of ABCB1-like P-
glycoproteins capable of drug transport. The presence of xenobiotic-transporting P-
glycoproteins in marine bivalves and sponges was demonstrated in early studies by the group of 
Kurelec (Kurelec & Pivcević, 1991; Smital & Kurelec, 1998), this being recently confirmed 
using molecular approaches (Goldstone et al., 2006; Luckenbach & Epel, 2008). In parasitic 
nematodes, indirect evidence for drug transport by P-glycoproteins is provided by data showing 
an increased expression of P-glycoproteins in an ivermectin-resistant strain of Haemonchus 
contortus (Xu et al., 1998), and by the fact that inhibitors of P-glycoprotein reverse ivermectin 
resistance in isolates of Teladorsagia circumcincta (Stadelman, 1894) and H. contortus (Bartley 
et al., 2009). In the free-living nematode, Caenorhabditis elegans Maupas, 1900, there are at 
least 15 P-glycoproteins (Sheps et al., 2004; Zhao et al., 2007), of which three (pgp-3, pgp-14 
and C44C10.3) were upregulated by pesticide exposure (Lewis et al., 2009), while pgp-1 had a 
protective role against toxic metals (Broeks et al., 1996) and showed increased expression in an 
ivermectin resistant strain (James & Davey, 2009). Similarly, in the fruit fly, P-glycoprotein 
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mdr49 is induced upon exposure to environmental toxicants (Tapadia & Lakhotia, 2005; Vache 
et al., 2007). 
In the present study, the upregulation of SL-PGY1 mRNA in the R sea lice strain in response to 
24 h of aqueous exposure to 410 g/L emamectin benzoate is in accordance with a hypothetical 
role for the transporter in the biochemical defence against toxicants. However, SL-PGY1 
mRNA was not upregulated in R sea lice exposed to 240 g/L emamectin benzoate, a 
concentration which would cause a 100% paralytic response in the S strain. Similarly, SF lice 
showed no upregulation of SL-PGY1 mRNA despite showing only a partial responsiveness to a 
SLICE treatment. Together this demonstrates that a phenotype of decreased emamectin 
benzoate susceptibility can be observed in the absence of SL-PGY1 mRNA upregulation. While 
we cannot exclude the possibility that SL-PGY1 protein levels were changed in exposed lice 
despite the absence of apparent regulation on the mRNA level, it appears likely that factors 
other than SL-PGY1 are involved in determing sea louse susceptibility to emamectin benzoate. 
Using a strategy that does not make prior assumptions regarding the number of Pgps in L. 
salmonis, we isolated one sequence called SL–PGY1 from this species. Similarly, only two P-
glycoprotein sequences were found in the genome of the crustacean D. pulex (Sturm et al., 
2009). However, among further ABC proteins that could potentially function as drug efflux 
transporters, Daphnia shows at least six ABCC proteins and 23 ABCG proteins (Sturm et al., 
2009). Accordingly, a promising direction for future research in sea lice will be to extend the 
search for potential markers of drug resistance to other ABC families.
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Abstract
The salmon louse Lepeophtheirus salmonis (Krøyer, 1837) is an ectoparasite of salmonid fish 
severely affecting cultured salmon production in the North Atlantic. Salmon louse control on 
farms currently relies in part upon the use of veterinary drugs, however, as only a limited 
number of salmon delousing agents is available, there are concerns about development of drug 
resistance in salmon lice. The common anti-salmon louse drug SLICE® (Merck Animal Health) 
contains the avermectin, emamectin benzoate (EMB). Members of this large gene superfamily 
of ABC (ATP-binding cassette) transporters have been identified as potential avermectin 
resistance factors in parasitic nematodes. In salmon lice, only three ABC transporters have been 
cloned and studied to date. We report here upon the isolation of four novel L. salmonis ABC 
transporters, and employ an inhibitor-based approach to assess the role of L. salmonis ABC 
transporters in the toxicology of EMB. To isolate salmon louse ABC transporters, publicly 
available L. salmonis expressed sequence tags (ESTs) were subjected to homology searches, 
and the retrieved ESTs assembled into contiguous sequences and annotated using the BLASTx 
algorithm. Potential ABC drug transporters isolated by this approach comprised four multidrug 
resistance-associated proteins (MRPs). In addition, five ABC proteins having likely roles 
unrelated to drug resistance were also obtained. Quantitative real time PCR (RT-qPCR) was 
used to analyse mRNA levels of the MRPs in L. salmonis strains differing in EMB 
susceptibility. In the absence of their EMB, all studied MRPs showed similar transcript levels in 
the drug-susceptible strain S and the moderately EMB-resistant strain PT. Moreover, mRNA 
expression of the four studied MRPs remained unaffected by exposure to EMB. Taken together, 
the results of RT-qPCR analyses did not provide evidence for roles of the studied MRPs as 
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factors affecting EMB susceptibility. Further experiments used an inhibitor-based approach to 
investigate the roles of ABC transporters in EMB toxicity. In immotility bioassays, salmon lice 
of the two strains were exposed to EMB, provided alone or in combination with cyclosporin A 
or verapamil, which are known inhibitors of P-glycoprotein and MRPs, respectively. 
Cyclosporin A increased EMB toxicity to a similar degree in both strains, suggesting the 
biochemical factors affected by this inhibitor show similar levels in both strains. In contrast, 
verapamil increased EMB effects only in the PT strain. This result could be indicative of 
enhanced expression of hitherto unknown ABC transporters in the moderately EMB-resistant 
PT strain. More research is required to identify the target of verapamil in salmon lice.
Keywords: ABC transporter, MRP, drug resistance, emamectin benzoate, sea lice
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3.1 Introduction
Sea lice (Copepoda: Caligidae) are marine fish ectoparasites feeding on their host’s skin, mucus 
and blood. Lepeophtheirus salmonis (Krøyer, 1837), the salmon louse, infects farmed and wild 
Atlantic salmon (Salmo salar L.), and can cause stress, lead to reduced growth and promote
secondary infections with water-borne viruses, bacteria and fungi in the host (Pike &
Wadsworth 2000). In addition to farm management strategies, the use of veterinary drugs 
constitutes a key component of sea louse control on fish farms. Globally, the cost of sea lice 
infections of farmed salmon is estimated to exceed €300 million (Costello 2009).
The avermectin compound emamectin benzoate (EMB, 4”-deoxy-4” epimethylaminoavermectin 
B1) is the active component of the delousing agent SLICE® (Merck Animal Health) (Stone et 
al., 2000). SLICE is conveniently administered through feed and confers up to nine weeks of 
protection to salmon ingesting the medicated feed (Stone et al., 2000). However, losses of EMB 
efficacy in L. salmonis have been recently reported from Scotland and New Brunswick (Lees et 
al., 2008; Jones et al. 2013), and this could be indicative of the early stages of drug resistance. 
Similarly, reductions in EMB sensitivity have been reported for the Chilean sea louse species
Caligus rogercresseyi (Bravo et al., 2008; Bravo et al., 2010).
Drug resistance in parasites can be based on several molecular mechanisms including structural 
changes of the molecular drug target, as well as the up-regulation of detoxification pathways 
involving drug metabolising enzymes and drug transporters (Wolstenholme et al., 2004). Drug 
transporters of the ABC gene family mediate the cellular efflux of a diverse range of substrates 
through an ATP-dependent mechanism (Shimabuku et al., 1992). Among the eight known 
metazoan ABC subfamilies (Dean et al., 2001), subfamilies B, C and G contain drug 
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transporters including P-glycoprotein (P-gp/MDR1/ABCB1), the multidrug resistance-
associated proteins MRP1-3 (ABCC1-3) and the breast cancer resistance protein 
(BCRP/ABCG2) (Leslie et al., 2005). In mammals, avermectins are transported by P-gp (Bain 
and LeBlanc, 1996; Igboeli et al., 2012) and MRPs (Lespine et al., 2006). ABC transporters 
have been proposed as factors potentially associated with avermectin resistance in nematodes. 
In ivermectin-resistant nematodes, an increased expression of P-gp has been reported for the 
parasite H. contortus (Xu et al., 1998), while an up-regulation of both P-gps and MRPs was 
found in free-living C. elegans (James & Davey, 2009).
In a previous study, we have reported the cloning and characterisation of the P-gp homologue 
SL-PGY1 in L. salmonis (Heumann et al., 2012). However, constitutive SL-PGY1 mRNA 
levels were similar between a moderately EMB-resistant and a drug-susceptible strain of salmon 
lice, suggesting that other factors may be involved in emamectin hyposensitivity (Heumann et 
al., 2012). In the present study, we set out to isolate further ABC drug transporters from L. 
salmonis and analyse their mRNA expression in two salmon louse strains differing in EMB 
susceptibility. In addition, potential roles of ABC transporters as biochemical factors 
modulating the effects of EMB in salmon lice were investigated using inhibitors of ABC protein 
function.
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3.2 Material and Methods
3.2.1 Bioinformatics
Nucleotide binding domains (NBD) of Daphnia pulex ABC transporters (Sturm et al., 2009) 
were isolated using the software tool ScanProsite (profile PS50893), as provided by ExPASy 
(Expert Protein Analysis System) proteomics server of the Swiss Institute of Bioinformatics 
(http://expasy.org, last accessed 28th May 2013). NBDs were used as queries to search ESTs 
available in the GenBank database for homologous sequences in L. salmonis using the 
TBLASTn algorithm. Hits were parsed and assembled into contiguous sequences (contigs) 
using Lasergene® SeqManTM software version 2 (Lasergene®, Madison, USA). To confirm 
contig identities, contigs were used to query non-redundant protein sequences using the 
BLASTx algorithm as implemented on the National Center for Biotechnology Information 
website (http://blast.ncbi.nlm.nih.gov/Blast.cgi?CMD=Web&PAGE_TYPE=BlastHome).
Phylogenetic analysis compared NBDs from Homo sapiens and L. salmonis. Sequences were 
aligned with ClustalX and subjected to phylogenetic analyses with the programme Molecular 
Evolutionary Genetics Analysis (MEGA) version 4 (Tamura et al., 2007), using the neighbour-
joining algorithm and limiting bootstrapping to 5,000 replicates.
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3.2.2 Salmon louse laboratory strains
Salmon louse laboratory strains used in this study have been described previously (Heumann et 
al., 2012). In brief, the strain S is susceptible to all current anti-sea louse treatments and has 
been in culture since 2003, when it was isolated from a Scottish salmon production site at which 
no delousing agents were used, except for hydrogen peroxide. The strain PT shows a 7-fold 
decrease in susceptibility to EMB (Heumann et al., 2012). It was obtained from egg strings 
collected in 2008 on another production site observing variable results for EMB treatments. The 
SF strain displays a 4-fold decrease in EMB sensitivity (Heumann et al., 2012), and was 
collected in 2010 from another fish farm also reporting variable clearances following EMB 
application.
The maintenance of salmon louse strains was carried out under standardised laboratory 
conditions in the absence of exposure to delousing agents, as described in detail before 
(Heumann et al., 2012). In brief, host salmon (weight 500-1,000 g) were kept in circular tanks 
with continuous seawater flow-through (0.5-5 L min-1 according to stocking density) at ambient 
temperature and photoperiod. In order to propagate the populations, louse-bearing salmon were 
anaesthetised with 2-phenoxy-ethanol and gravid females carefully removed with forceps. Egg-
strings were detached and allowed to hatch in aerated seawater. When larvae had developed into 
infective copepodids, they were used to re-infect salmon. For infection, water flow to the tanks 
was temporarily suspended and a limited number of copepodids was released into the tank 
which would lead to louse settlement rates unlikely to compromise the host’s health. After the 
water flow was restored, the fish were checked regularly for the number of settled lice and 
general welfare. All handling and experimental infections of host fish took place under 
veterinary supervision and in accordance with UK Home Office regulations.
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3.2.3 On-fish exposure of salmon lice to emamectin benzoate
SF strain lice were used to infect a batch of naïve Atlantic salmon, which were then randomly 
allocated to two tanks (20 fish per tank). From day 13 to day 19 post-infection, fish in one of the 
tanks were treated with SLICE®-containing feed, while fish in the other tank continued to be 
fed a control diet. The average emamectin benzoate delivery was estimated at 52.1 μg per kg 
fish biomass and per day for the treated tank, based on the amount of food given and the number 
of uneaten pellets collected. This dose is close to the recommended dose of 50 μg per kg fish 
biomass and per day (Stone et al., 2000). Both groups of fish were maintained on a control diet 
from day 20 to day 40 post infection. EMB shows a relatively long half-life in fish, and 
following a standard 7-day treatment with SLICE®, EMB will be detectable in mucus for 
several weeks (Sevatdal et al., 2005). At day 40, host fish were anaesthetised with 2-phenoxy-
ethanol, and salmon lice were carefully collected using forceps and stored in RNAlater® 
(Sigma-Aldrich, Dorset) for subsequent RNA extraction.
3.2.4 Salmon louse immotility bioassays
Seawater immotility bioassays were used to assess the susceptibility of adult male salmon lice 
to EMB (Westcott et al. 2008). Salmon lice were carefully collected from host fish anaesthetised 
with 2-phenoxy-ethanol and allowed to recover for 2 h in filtered (55 m), aerated seawater 
(referred to as ‘seawater’ from here on) at 12°C. Emamectin benzoate (EMB technical grade 
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donated by Merck Animal Health) was solubilised in PEG300 and a dilution series prepared in 
seawater directly before the bioassay. The final PEG300 concentration was 0.01% (v/v) for all 
EMB concentrations. In addition to seawater and solvent controls lacking toxicant (0.01 % 
PEG300), a serial dilution series of five EMB concentrations was included in each test, with the 
selection of concentrations depending on the sensitivity of the louse strain tested and whether 
inhibitors of ABC transport activity were included (see below). Ten adult male lice were used 
per 90 mm petri dish containing 60 mL of testing or control solution. Depending on the
availability of salmon lice, experimental treatments were run in duplicate or triplicate, while 
controls were run either as single replicate or duplicate. After 24 hours of incubation at 12°C in 
the dark, salmon lice were rated as normal or immotile (i.e. not swimming away when gently 
touched with a soft brush) (Westcott et al., 2008).
3.2.5 Seawater exposure of salmon lice to EMB
To investigate short-term effects of EMB on transporter mRNA expression, adult male salmon 
lice of strains S and PT were subjected to acute sub-lethal exposures to EMB. A first experiment 
involved exposure to 200 µg L-1 EMB, seawater, or solvent (0.01% PEG300, v/v) for 3 h. A 
second experiment used 24 h of exposure time and higher EMB (240 and 410 µg L-1) levels 
with adult male salmon lice of the PT strain. Seawater and solvent controls were also included. 
In both experiments, no effects on salmon louse motility were observed. At the end of 
exposures, animals were collected in RNAlater® (Sigma-Aldrich, Dorset, UK) and stored at -20 
ºC pending total RNA extraction.
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3.2.6 Co-administration of EMB and ABC transporter inhibitors
To investigate potential roles of ABC transporters in the toxicology of EMB, a motility bioassay 
with EMB was carried out in the presence or absence of the functional inhibitors of ABC 
transporters cyclosporin A (CSA, 10 μM, VETRANAL® analytical standard) and verapamil 
(VER, 20 μM, (±)-verapamil hydrochloride, pharmaceutical standard, Sigma-Aldrich, Dorset, 
UK). Immotility bioassays were carried out in the presence of one or other inhibitor as 
described above. While VER solutions were prepared in seawater, the solvent DMSO (0.01% 
v/v) was used as a vehicle for CSA. Seawater controls and appropriate solvent controls were 
included in all assays.
3.2.7 Total RNA extraction
Individual frozen adult male salmon lice were removed from RNAlater®, transferred to a pre-
chilled mortar and ground with a pestle while covered with a small amount of liquid nitrogen. 
TRIzol® (Life Technologies, Paisley, UK) was added to the ground sample, which was further 
homogenised with an Ultra-Turrax® for 30s. Total RNA was extracted following instructions 
given in the TRIzol® manual. The concentration and purity of the obtained aqueous RNA 
samples were determined by UV spectroscopy using a NanoDrop® ND-1000 photo 
spectrometer (Thermo Scientific, Delaware, USA). Integrity of RNA samples was assessed by 
agarose gel (1%) electrophoresis under denaturing conditions followed by staining with 
ethidium bromide. Samples were stored at -80°C until further use.
The potential role of ABC transporters as factors influencing drug susceptibility in the 
salmon louse, Lepeophtheirus salmonis (Krøyer, 1837)
Jan Heumann - May 2015
118
3.2.8 Reverse transcription quantitative real time PCR (RT-qPCR)
To assess the mRNA expression of L. salmonis ABCC transporters identified by the 
bioinformatic approach described above, RT-qPCR primers were designed with Primer3 
(http://frodo.wi.mit.edu/, accessed 28th May 2013) to yield 70-85 bp amplicons. Primer 
sequences are given in Table 3, which also compiles the GenBank accession numbers of ESTs 
corresponding to the transporters. 
Table 3: Overview of four novel ABCC transporters investigated in L. salmonis. ESTs 
assembled to contigs, their size, primer sequences for RT-qPCR and respective amplicon sizes
are given.
Name Accession 
numbers of 
ESTs 
assembled
Forward primer 
(5’-3’)
Reverse primer (5’-
3’)
Amplicon size 
(bp)
SL-MRP1 EX481436.1
EX481437.1
FK908937.1
FK908938.1
TTCGATGTGT
AGTGATGCT
GGTCTC
AAGTGCGAGTC
CTTTCAATCCTT
CC
97
SL-MRP2 FK904156.1 CGCTTTTCCG
TTTATCGAGT
TTTTC
ACAGCAAACTG
ACGACGGAAAT
CTA
100
SL-MRP3 FK917841.1
FK917842.1
TGGGACAAA
GACAGTTGA
TTTGCTT
CAGCAGCAGTA
GCTTCGTCCATT
AT
84
SL-MRP4 FK916336.1
FK916337.1
FK930382.1
FK930383.1
AATAGATCC
CTCTTGGCCA
AACAAA
ATGGACCTCCTT
GGTCATCGTAC
TT
80
For each salmon louse sample, 500 ng total RNA were reverse transcribed using the High 
Capacity cDNA RT Kit (Life TechnologiesTM) following the manufacturer’s instructions. The 
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obtained first-strand cDNA was stored at -20°C. RT-qPCR was carried out using the SYBR® 
Green method using a commercial kit (ABsoluteTM QPCR SYBR® Green Mix, Thermo 
Scientific, Loughborough, UK) according to the instructions provided. RPS20 (ribosomal 
protein S 20) and eEF1a (eukaryotic elongation factor 1 alpha were used as reference genes 
(Heumann et al., 2012). PCR reactions were performed in a Quantica® Real Time Thermal 
Cycler (Techne, Stone, UK). The thermocycling programme comprised an initial 15 min 
activation step at 95°C, followed by 40 cycles of 15 s denaturation at 95°C, 30 s annealing at 
60°C and 30 s elongation at 72°C. Fluorescence was measured during the 72°C elongation step. 
Following completion of the PCR programme, a melting curve analysis was performed to 
confirm that only single products had been amplified. Crossing points were analysed using the 
PCR cycler’s software Quantsoft®. Internal controls were included in each run, comprising 
samples where reverse transcriptase or the cDNA template had been omitted. Standard curves 
were derived from serial dilutions made from a reference cDNA pool. Each measurement was 
performed in triplicate and raw data quality checked. Relative expression ratios (RER) were 
calculated using the following formula (Pfaffl, 2001):
(E target)^(ΔCP target (control - sample))
RER = ------------------------------------------------------
(E reference)^(ΔCP reference (control - sample))
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3.2.9 Statistical analysis
Median effective concentration (EC50) of EMB was calculated by probit analysis using Minitab 
15 (Minitab Inc.). Relative expression ratios of MRPs were compared between different groups 
of salmon lice by one-way ANOVA followed by post-hoc comparisons with the Tukey-Kramer 
test using InStat 3.05 (GraphPad Inc., La Jolla, USA). Data were log-transformed prior to 
ANOVA testing and the homogeneity of variances confirmed by Bartlett's test. In all tests the 
significance level was set at p < 0.05.
3.3 Results
3.3.1 Identification of ABC transporter sequences in salmon louse
Nucleotide binding domains (NBDs) were extracted from Daphnia pulex ABC transporters 
(Sturm et al., 2009) using ScanProsite (profile PS50893) and used as query sequences in parallel 
tblastn searches of L. salmonis ESTs available at GenBank. The 127 EST hits found by this 
strategy were further analysed with SeqManTM (LaserGene®) to obtain a minimal set of 18 
contiguous sequences (contigs). Blastx searches were carried out to further characterise the 18 
sequences obtained. Five contigs were eliminated as they were not coding for eukaryotic ABC 
proteins. The remaining 13 contigs represented salmon louse ABC transporters (Table 4). The 
best hits from blastx comparison with well-characterised protein sequences 
(UniProtKB/SwissProt database) indicated the likely ABC subfamily affiliation of the isolated
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contigs (Table 4). To confirm the subfamily assignment, NBDs were extracted from the isolated 
contigs as described above and were subjected to phylogenetic analysis together with NBDs of 
human ABC transporters (Figure 8). 
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Table 4: Partial salmon louse ABC transporter cDNA sequences obtained by homology searches (TBLASTn) of ESTs in the GenBank database. 
Subfamily Contig 
number
Preliminary 
name
Length 
(bp)
Number of 
ESTs 
combined
Best BLASTX hit Domains E value
ABCB 
(half)
Contig 6 N/A 1080 5 ATP-binding cassette sub-family B, member 7 
[Rattus norvegicus]
NBD 3.00E-89
ABCB 
(half)
Contig 9 N/A 1245 3 ATP-binding cassette sub-family B, member 8 
[Danio rerio]
TM(partial)-
NBD
4.00E-169
ABCB 
(full)
Contig 11 SL-PGY1 921 2 Multidrug resistance protein 3 [Rattus norvegicus] NBD 1.00E-89
ABCC Contig 5 SL-MRP1 937 5 Multidrug resistance-associated protein 1 [Mus 
musculus]
NBD2 7.00E-73
ABCC Contig 7 SL-MRP2 1558 4 Multidrug resistance-associated protein 1 [Macaca 
fascicularis]
NBD2 2.00E-110
ABCC Contig 13 SL-MRP3 1232 2 Multidrug resistance-associated protein 1 [Homo 
sapiens]
NBD2 1.00E-121
ABCC Contig 14 SL-MRP4 830 1 Multidrug resistance-associated protein 4 [Homo 
sapiens]
NBD2 3.00E-77
ABCD Contig 18 N/A 850 1 ATP-binding cassette sub-family D member 4 
[Homo sapiens]
NBD 0.22
ABCE Contig 3 N/A 1299 10 ATP-binding cassette sub-family E member 1 
[Homo sapiens]
NBD(partial)-
NBD
0.0
The potential role of ABC transporters as factors influencing drug susceptibility in the salmon louse, Lepeophtheirus salmonis (Krøyer, 1837)
Jan Heumann- May 2015
Isolation and characterisation of four partial cDNA sequences encoding multidrug resistance-associated proteins (MRPs) in the salmon louse 
Lepeophtheirus salmonis (Krøyer, 1837) 123
ABCF Contig 1 N/A 2048 27 ATP-binding cassette sub-family F member 2 [Mus 
musculus]
NBD-NBD 0.00
ABCF Contig 4 N/A 1549 9 ATP-binding cassette, sub-family F member 3 
[Rattus norvegicus]
NBD(partial)-
NBD
1.00E-170
ABCF Contig 12 N/A 1077 2 ATP-binding cassette, sub-family F, member 1 
[Rattus norvegicus]
NBD 2.00E-97
ABCF Contig 17 N/A 827 1 ATP-binding cassette, sub-family F member 3 
[Homo sapiens]
NBD 8.00E-20
The potential role of ABC transporters as factors influencing drug susceptibility in the 
salmon louse, Lep
Figure 8: Phylogenetic analysis
transporter NBDs. Nucleotide binding domain sequences of ABC proteins were aligned with 
ClustalX and phylogeny established by
(Tamura et al. 2007) with bootstrapping set to 
individual branches is given in percent. “HABC” indicates human ABC transporters, the 
following letter gives the subfamily and number of the member within the subfamily. For full 
transporters, the “_C” and “_N” su
respectively. Partial cDNA sequences from 
“con”.
eophtheirus salmonis (Krøyer, 1837)
Jan Heumann - May 2015
of human H. sapiens and salmon louse L. salmonis
generating a tree using the neighbour
5,000 replicates. Relative support for the 
ffix are added to indicate the C-terminal or N
L. salmonis ABC transporter
124
ABC 
-joining method 
-terminal NBD, 
NBDs are named 
The potential role of ABC transporters as factors influencing drug susceptibility in the 
salmon louse, Lepeophtheirus salmonis (Krøyer, 1837)
Jan Heumann- May 2015
Isolation and characterisation of four partial cDNA sequences encoding multidrug 
resistance-associated proteins (MRPs) in the salmon louse Lepeophtheirus salmonis 
(Krøyer, 1837) 125
Sequences of L. salmonis clustered together with H. sapiens sequences of the same subfamily, 
supporting the previous assignments to ABC subfamilies (Table 4). ABC drug transporters are 
known to be found among the full transporters of subfamily B, as well as among members of 
subfamilies C and G. Accordingly, five out of the 13 isolated contigs, belonging to subfamilies 
B and C, were proposed as candidates for potential drug transporters in salmon lice.
The contig representing an L. salmonis ABCB full transporter has been fully cloned and 
characterised previously (Heumann et al., 2012). In this study, we investigated the mRNA 
expression of L. salmonis transporters of the ABCC subfamily showing similarities to MRPs in 
other organisms. For the purpose of identification within this study, the partial salmon louse 
MRP sequences were termed SL-MRP1 to SL-MRP4 (Table 4). The definitive naming of the 
transporters will require further research, including isolation of the full sequences.
3.3.2 Expression analysis
RT-qPCR was used to quantify mRNA levels of the isolated MRPs in salmon louse strains 
differing in their susceptibility to EMB. In addition to determining transcript levels in salmon 
lice prior to drug exposure, different exposure scenarios were used to study whether exposure to 
EMB increased expression of the MRPs over time. RPS20 or eEF1α were used as reference 
genes for relative quantification. Because essentially identical results were obtained with both 
reference genes, data are shown only after normalisation with eEF1α.
Following exposure of salmon lice to 200 µg L-1 EMB for 3 hours, no significant effects of the 
treatment was found on transporter mRNA expression levels regardless of strain (Figure 9).
The potential role of ABC transporters as factors influencing drug susceptibility in the 
salmon louse, Lepeophtheirus salmonis (Krøyer, 1837)
Figure 9: Messenger RNA expression levels of four MRPs in salmon lice with different genetic
backgrounds and previous EMB exposure history. Adult male salmon lice of the drug
susceptible S strain or the moderately EMB
EMB for 3 h, seawater (controls) or 0.01% DMSO (solvent controls). Relative expr
of the four MRPs transporters were measured with RT
and EMB-treated salmon lice. 
(eEF1α). Mean relative expression ratios and standard deviation
total RNA samples obtained from independent pools of four salmon lice. Variation of mRNA 
among treatments was not significant (p > 0.05).
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µg EMB kg-1 fish day-1) for 7 days in the treated group (Stone et al., 2000), while louse-bearing 
fish of the control group continued to receive a control diet. Host fish were then maintained for 
a further three weeks before salmon lice were collected for transcript expression analysis. No 
significant differences in MRP relative expression ratios were observed between lice from 
treated and untreated salmon (Figure 11).
Figure 11: Effect of long-term exposure to SLICE® on relative expression ratios of four MRPs 
in salmon lice. Fish bearing salmon lice of the SF strain were fed SLICE®-fortified food (50 µg 
EMB kg-1 fish day-1) or a control diet for seven days and were then maintained under control 
conditions for another three weeks before salmon lice were collected for RT-qPCR analysis. 
Data were normalised with eukaryotic elongation factor 1 alpha (eEF1α). Means with standard 
deviations are shown for each group (n = 12 lice).
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3.3.3 Co-administration of EMB and ABC transporter inhibitors
The mRNA expression studies above provided no evidence for an increased expression of the 
four salmon louse MRPs following exposure to SLICE® or for their enhanced expression in 
moderately EMB-resistant strains of salmon lice. Apart from a slight up-regulation in response 
to 410 µg L-1 of EMB, similar negative results have been previously reported for expression 
changes of SL-PGY1 (Heumann et al., 2012). However, further ABC drug transporters may 
exist in salmon lice and could have remained undetected by the bioinformatic approach adopted 
here.
To investigate the potential involvement of ABC drug transporters in the toxicology of EMB in 
salmon lice, a pharmacological approach based on inhibitors of ABC transporter activity was 
adopted. If ABC drug transporters mediate the efflux of EMB and thus reduce the intracellular 
concentrations of the drug in exposed animals, the inhibition of ABC drug transporter activity
could be expected to lead to higher intracellular levels of EMB and subsequently enhanced toxic 
effects. The calcium channel blocker, verapamil (VER), and the immunosuppressant drug,
cyclosporin A (CSA), are known as inhibitors of P-gp (MDR1/ABCB1), but also inhibit MRPs 
(Barrand et al., 1993; Twentyman, 1992). In standard aqueous exposure bioassays, the median 
effective concentration (EC50) of EMB in the S strain was 125 µg L
-1 (95% confidence limits: 
83-194) in the absence of inhibitors, 35.7 µg L-1 (23.4-53.8) in the presence of 10 µM CSA and 
82.3 µg L-1 (46.1-129.7) in the presence of 20 µM VER (Figure 12 and 13). For the PT strain, 
the EMB EC50 was 289 µg L
-1 (189-439) in the absence of inhibitors, 108 µg L-1 (71-167) in the 
presence of 10 µM CSA and 49.3 µg L-1 (13.2-92.9) in the presence of 20 µM VER. CSA,
therefore, caused a significant shift (p=0.006) of the EMB dose-response curve towards lower 
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concentrations (left shift) in both the S and the PT strain (Figure 12). In contrast, verapamil 
significantly (p=0.001) increased the toxic effect of EMB in the PT strain but not the S strain 
(Figure 13).
Figure 12: Effect of cyclosporin A (CSA) on acute EMB toxicity in salmon lice. Adult male 
salmon lice were exposed for 24 h to different EMB concentrations, provided alone or in 
combination with the ABC transporter inhibitor CSA (10 µM). Motility behaviour was then 
assessed and median effective concentrations (EC50s) obtained by probit analysis. In the 
absence of inhibitors, the EMB EC50 was 125 µg L-1 (95% confidence limits: 83-194) in the S 
strain and 289 µg L-1 EMB (189-439) in the PT strain. In the presence of CSA the EMB EC50 
was 35.7 µg L-1 (23.4-53.8) in the S strain and 108 µg L-1 (71-167) in the PT strain. Inhibitory 
effects were considered significant when the probability value P was below 0.05. One 
representative of three experiments is shown. Each data point summarises observations made on 
10-20 lice.
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Figure 13: Effect of verapamil (VER) on acute EMB toxicity in salmon lice. Adult male 
salmon lice were exposed for 24 h to different EMB concentrations, provided alone or in 
combination with the ABC transporter inhibitor VER (20 µM). In the presence of VER, the 
EMB EC50 was 82.3 µg L-1 (95% confidence limits: 46.1-129.7) in the S strain and 49.3 µg L-1
(13.2-92.9) in the PT strain. EC50 values obtained in the absence of inhibitors and further 
details are given in the legend of figure 12.
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3.4 Discussion
In this study, four L. salmonis MRPs of the ABCC subfamily of ABC transporters were 
identified. MRPs are potential drug transporters and could have relevance as factors modifying 
the efficacy of EMB. However, in the absence of EMB exposure, mRNA expression levels of 
the four MRPs were similar between salmon louse strains differing in EMB susceptibility, and 
MRP mRNA levels did not change following exposure to EMB. Accordingly, this study does 
not provide evidence for potential roles of the studied MRPs in EMB toxicity or drug resistance 
in salmon lice. To complement mRNA expression studies, an inhibitor-based approach was 
used to reveal potential roles of ABC transporters in EMB toxicity. CSA and VER are inhibitors 
of both P-gp and MRPs. CSA enhanced EMB toxicity in both the drug susceptible S strain and 
the EMB hyposensitive PT strain, whereas VER increased EMB toxicity only in the PT strain.
The underlying causes for the apparent selectivity of the inhibitors is currently unknown and 
should be addressed in a separate study.
ABC drug transporters have been implicated to be involved in the resistance of nematodic
parasites against avermectins (Wolstenholme et al., 2004). Most metazoan species possess 
multiple ABC drug transporters with overlapping substrate specificities. For instance, 15 P-gp 
homologues and 8 MRP homologues are present in the nematode model species C. elegans
(Sheps et al., 2004). Due to the presence of multiple proteins with similar function, the specific 
roles of individual ABC drug transporters can be challenging to ascertain, especially in species 
lacking an available genome assembly. While the full number of ABC proteins in salmon lice is 
unknown, different studies have aimed to isolate ABC drug transporter cDNA sequences from 
this species. Two putative salmon louse homologues of the full transporter P-gp 
(MDR1/ABCB1) have been reported in an earlier study (Tribble et al., 2007). However, one of 
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the sequences seems to belong to the ABCF subfamily, which is involved in ribosome assembly 
and does not contain drug transporters, while the second sequence appears to be an ABCB 
subfamily half transporter, which localises to intracellular membranes and has, to our 
knowledge, not been associated with drug transport (Heumann et al., 2012; Dean et al., 2001). A 
subsequent study isolated a P-gp homologue called SL-PGY1 from salmon lice (Heumann et al.,
2012). However, exposure of salmon lice to EMB provoked, at best, only a moderate up-
regulation of the pump, and no significant differences in SL-PGY1 mRNA levels were found 
between salmon louse strains of differing EMB susceptibilities (Heumann et al., 2012). In 
contrast, a Canadian study observed, among historical salmon louse samples from farms in New 
Brunswick, an increase of SL-PGY1 mRNA levels between 2002 and 2011, coinciding with a 
decrease in EMB susceptibility and suggesting possible links between SL-PGY1 expression and 
EMB susceptibility (Igboeli et al., 2012). The present study adds four more sequences encoding 
MRPs to the list of potential ABC drug transporters in salmon lice. The measurement of mRNA 
expression of the MRPs in salmon lice of different genetic background and EMB exposure
history, however, did not provide evidence for a role of salmon louse MRPs in EMB toxicity or 
resistance. 
ABC drug transporters are found in cell membranes, where they function as drug efflux pumps 
decreasing the intracellular levels of transport substrates. ABC drug transporters are usually 
predominantly expressed in organs involved in excretion, such as kidneys and liver, and in 
tissues forming external or internal boundaries, such as the gut epithelium or the capillary 
endothelia of the blood-brain barrier (Leslie et al., 2005). This expression pattern is in 
accordance with roles of ABC drug transporters in limiting the uptake and enhancing the 
excretion of toxic compounds. Indeed, animals lacking P-gp as the result of natural or targeted 
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null mutations show a greatly enhanced susceptibility to toxic P-gp substrates such as 
ivermectin (Roulet et al., 2003; Schinkel et al., 1994). Similar changes in susceptibility to P-gp 
substrates can be provoked by the pharmacological blockage of P-gp with inhibitors (Mayer et 
al., 1997). In the present study, the P-gp inhibitor CSA enhanced the toxicity of EMB in both 
salmon louse strains studied. We speculate that ABC transporters inhibited by CSA in sea lice 
may play important roles in the biochemical defence against toxicants, for example limiting the 
effects of EMB in salmon lice, but may not show significant expression differences between the 
studied strains. In contrast, VER caused an increase in EMB toxicity in the studied 
hyposensitive strain PT, but had no effects in the drug-susceptible strain S. This observation is 
in accordance with the hypothesis that VER inhibits a biochemical mechanism contributing to 
the detoxification of EMB, possibly involving an ABC transporter. Paralleling the results from 
this study, VER has been reported to increase the efficacy of ivermectin and moxidectin in an 
avermectin-resistant strain of the sheep gastrointestinal nematode, H. contortus, showing 
elevated P-gp expression in vivo (Xu et al., 1998). We speculate that several ABC transporters 
showing distinct, but overlapping, patterns of inhibitor specificity could be involved in EMB 
detoxification in the salmon louse, and show differential expression between the studied strains. 
In addition to P-gp, different MRPs have been shown to transport ivermectin in mammalian cell 
culture systems. Moreover, two P-gps and four MRPs showed increased mRNA expression 
levels in two ivermectin-selected C. elegans strains. However, the putative role of genes ABCB 
and ABCC transporters in L. salmonis with decreased EMB susceptibility is currently not 
sufficiently understood.
The results of this study support the need for further research, involving both gene expression 
studies and toxicity tests involving ABC inhibitors, in order to ascertain the identity of ABC 
transporters affecting EMB toxicity in salmon lice.
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Abstract
The salmon louse causes significant economic damage in the mariculture of Atlantic salmon. In 
addition to farm management measures and biological control by cleaner fish, chemicals are 
used for the treatment of L. salmonis infections at fish farms. However, with only a restricted
number of salmon delousing agents being available, the continued reliance on a limited range of 
parasiticidal drugs may favour the development of drug resistance in L. salmonis. Indeed, 
decreased treatment efficacies have been reported, at least locally or temporarily, for a number 
of substance classes including organophosphates, pyrethroids and avermectins. The ATP-
binding cassette (ABC) gene superfamily is found in all biota and contains membrane proteins 
functioning as transporters, which include drug efflux pumps that can constitute drug resistance 
factors by reducing the internal exposure to biocidal drugs. In this study, we used next 
generation RNA sequencing (RNAseq) to construct a reference transcriptome representing key 
stages of the L. salmonis life cycle, and to support a genome-wide survey of the ABC gene 
superfamily of this economically important parasite. High-throughput sequencing of a pooled 
mRNA library (RNA-Seq) generated over 300 million sequence reads that were assembled into 
37,681 transcripts, consisting of 33,833 unique genes. 
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4.1 Introduction
The large gene family of ATP-binding cassette (ABC) proteins has members in all biota 
(Higgins, 1992). Typical ABC proteins are composed of transmembrane and conserved 
nucleotide binding domains and function as primary transporters in trafficking processes across 
biological membranes (Higgins, 1992; Igarashi, 2004). The wide range of substrates transported 
by ABC proteins includes inorganic ions, metals, sugars, amino acids, peptides, lipids and 
organic chemicals (Dean, 2001; Higgins, 1992). ABC proteins functioning as drug transporters 
can contribute to chemical resistance phenotypes in cancers, pathogens and pests. Multidrug 
resistance (MDR) is defined as the reduced susceptibility of tumours to structurally and 
functionally unrelated cytostatic drugs and can be based on the expression of ABC efflux 
transporters reducing cellular drug accumulation (Gottesman et al., 2002). ABC transporters 
have further been linked to drug resistance in parasitic protozoans (Sanchez et al., 2010; 
Sauvage et al., 2009) and nematodes (Dicker et al., 2011; Prichard & Roulet, 2007), and to 
pesticide resistance in insects (Bariami et al., 2012; Heckel 2012; Lanning et al., 1996).
In metazoans, the ABC family is divided into eight subfamilies named ABCA to ABCH (Annilo 
et al., 2006; Dean, 2001; Sheps et al., 2004). Drug transporters are found in subfamilies ABCB, 
ABCC and ABCG and include the MDR-conferring proteins ABCB1 (also called MDR1 or P-
glycoprotein), ABCC1 (also known as Multidrug resistance associated protein, MRP1) and 
ABCG2 (also known as the breast cancer resistance protein, BCRP) (Cole et al., 1992; Doyle et 
al., 1998; Gros et al., 1986; Roninson et al., 1984). In non-cancerous tissues, ABC drug 
transporters have physiological roles within the biochemical defence against toxicants (Leslie et 
al., 2005; Schinkel & Jonker, 2003). ABC drug transporters are predominantly expressed in 
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tissues involved in excretion or constituting internal or external body boundaries. At these sites, 
ABC drug transporters often localise to the apical membranes of polarised epithelia and 
endothelia, resulting in directional transport of substrates into excreta (e.g., bile fluid or urine) 
and out of sanctuary sites (e.g., at blood-tissue barriers). 
Caligid copepods, also called sea lice, are ectoparasites of wild and farmed marine fish 
(Boxaspen, 2006). In the Northern hemisphere, sea louse infections of farmed Atlantic salmon 
(Salmo salar Linnaeus, 1758) are mostly by the salmon louse, Lepeophtheirus salmonis
(Krøyer, 1837) (Torrissen et al., 2013). In addition to farm management measures and the use of 
cleaner fish (Sayer et al., 1996; Skiftesvik et al., 2014), sea louse control relies heavily on 
chemical treatments applied as baths or through feed (Haya et al., 2005), causing estimated 
treatment costs of €305 million per annum globally (Costello, 2009). However, the continuous
use of the same medicinal agents, or different agents with the same mode of action, can favour 
the development of drug resistance (Denholm et al., 2002). In L. salmonis, losses of efficacy 
have been reported for different treatments including hydrogen peroxide (Treasurer et al., 2000), 
organophosphates (Jones et al., 1992; Roth et al., 1996), pyrethroids (Sevatdal & Horsberg, 
2003) and avermectins (Espedal et al., 2013; Lees et al., 2008). 
At present, little is known about the molecular mechanisms of drug resistance in L. salmonis. 
Changes in the expression and/or sequence of molecular target sites have been suggested to 
contribute to decreased susceptibility of L. salmonis to organophosphates, pyrethroids and 
emamectin benzoate (Carmichael et al., 2013; Fallang et al., 2004; Fallang et al., 2005). 
Furthermore, it has been suggested that altered drug metabolism is by the activity of multiple 
cytochromes P450 in H. contortus (Laing et al., 2015) and has been proposed to affect 
pyrethroid toxicity in L. salmonis (Sevatdal et al., 2005). Moreover, two partial L. salmonis
cDNA sequences have been suggested to represent homologues to ABCB1 potentially involved 
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in EMB resistance (Tribble et al., 2007). However, subsequent studies revealed that these 
sequences were unrelated to ABCB1 and represented homologues of ABCF1 (Tribble et al., 
2008) and ABCB8 (Heumann et al., 2012), two ABC proteins not functioning as drug 
transporters. Later, one ABCB1 homologue called SL-PGY1 and four MRPs have been isolated 
in L. salmonis (Heumann et al., 2014, Heumann et al., 2012). Sublethal EMB exposures 
provoked an up-regulation of the SL-PGY1 transcript (Heumann et al., 2012; Igboeli et al., 
2012) but had no effect on mRNA levels of L. salmonis MRPs (Heumann et al., 2014). In 
summary, knowledge on L. salmonis ABC transporters is still fragmentary, and obtaining a 
more comprehensive picture of the ABC family in L. salmonis will be invaluable for research 
efforts aiming at unravelling the molecular determinants of drug resistance in this parasite.
Currently, a genome assembly exists only for one crustacean species, the waterflea, Daphnia 
pulex (Colbourne et al., 2012). Genomic resources available in other crustaceans mainly 
consists of publicly available expressed sequence tags (ESTs), generated from sequencing 
tissue- and stage-specific normalised (Qiao et al., 2012; Yasuike et al., 2012), non-normalised 
(O’Leary et al., 2006) or subtracted cDNA libraries (Hansen et al., 2007; Zhao et al., 2007). 
Available studies of transcriptomic responses in copepod to pollutants and environmental 
stressors include the analysis of Tigriopus californicus (Baker, 1912) responses to trace metal 
exposure by microarray techniques (Ki et al., 2009) and a study of Calanus finmarchicus
(Gunner, 1765) responses to thermal stress by suppression subtractive hybridisation
(Voznesensky et al., 2004).
In the present study, a de novo transcriptome was created in L. salmonis using Illumina RNA-
Seq technology in order to carry out a comprehensive survey of the ABC gene family in this 
economically important fish parasite. Sequencing was based on a total RNA pool representing 
key stages of the L. salmonis life cycle, ensuring representation of major transcriptional events 
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in this custom sequence resource. This L. salmonis transcriptome was functionally annotated 
and characterised to allow the identification of novel candidate genes in L. salmonis ABC 
transporters, for further characterisation to establish any potential involvement in reduced drug 
susceptibility.
4.2 Materials and Methods
4.2.1 Salmon lice 
L. salmonis samples from the different points of the life cycle were obtained from a laboratory-
maintained strain (S) of the parasite that is susceptible to all major current salmon delousing 
agents. Details of L. salmonis husbandry conditions are provided elsewhere (Heumann et al., 
2012). In brief, parasites were maintained on Atlantic salmon in circular tanks supplied with 
fresh seawater at ambient temperature, using a photoperiod corresponding to natural day length. 
To propagate cultures, egg strings were obtained from gravid females and allowed to develop to 
copepodids, which were used to infect fresh batches of host fish. Infection rates were 
maintained at levels that were unlikely to compromise fish welfare. Prior to the collection of 
L. salmonis from hosts, fish were anaesthetised with 100 mg L-1 2-phenoxyethanol for 3 min. 
All laboratory infections were carried out under UK Home Office licence and appropriate 
veterinary supervision. 
Twenty-one L. salmonis samples of the S strain were collected, representing different points in 
the life cycle of the parasite (Johnson & Albright, 1991b). The collected material comprised of
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egg strings, nauplius and copepodid larvae, chalimus stages I to IV, as well as preadult I and II 
and adult stages, with some of these stages being further differentiated according to sex or age 
(Appendix S1). Samples representing earlier stages of the life cycle (nauplius – chalimus IV) 
consisted of pools of parasites. All samples were preserved in RNAlater, a high-salt RNA 
stabilisation solution (4.54 mol L-1 ammonium sulphate, 25 mmol L-1 trisodium citrate, 
20 mmol L-1 EDTA, pH 5.4), immediately after collection and then stored at -70°C. The two 
nauplial stages of L. salmonis develop relatively quickly (30.5 hours from nauplius 1 to 2 at 
10°C) and are difficult to differentiate by size (0.54 – 0.56 mm) (S. C. Johnson & Albright, 
1991a, 1991b). In order to obtain a set of samples collectively covering different points in the 
early larval development, egg strings obtained from gravid females were incubated in aerated 
seawater at two temperatures (8 and 10.5°C), and in each condition the emerging parasite larvae 
were collected at two time points (24 and 48 hours) by filtration. Free-living copepodids were 
obtained from cultures after 5 days of incubation (10.5°C). The host-attached stages were 
collected at the appropriate time points post-infection from anaesthetised salmon using forceps 
under low magnification microscopy, with stages being differentiated according to the criteria 
given by Johnson and Albright (Johnson & Albright, 1991b).
4.2.2 RNA Extraction and purification
Frozen samples were ground in liquid nitrogen using a pestle and mortar, and total RNA was 
immediately extracted from the homogenised sample using TRI Reagent® (Sigma-Aldrich, UK), 
following the manufacturer’s protocol. After phase separation, RNA was precipitated from the 
aqueous phase by addition of 0.25 volumes isopropanol and 0.25 volumes of a high salt buffer 
(0.8 mol L-1 trisodium citrate; 1.2 mol L-1 sodium chloride), as recommended for samples with 
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high polysaccharide content (Chomczynski & Mackey, 1995) and resuspended in nuclease-free 
water. Total RNA was extracted from 21 different L. salmonis samples taken from key stages of 
the life cycle where each sample consisted of pools of individuals (Appendix S1). UV 
spectroscopy (NanoDrop ND-1000, Thermo Scientific, USA) was used to confirm purity of the 
RNA samples and establish concentrations, whereas RNA integrity was assessed by agarose gel 
electrophoresis and ethidium bromide staining.
4.2.3 Library construction and sequencing
A total RNA pool was created that included samples from the egg string, nauplii, copepodid, 
preadult (I and II) and adult stages for male and female L. salmonis, and incorporated 2.5 µg 
total RNA from each of 21 salmon louse samples (Appendix S1). This total RNA pool was 
further purified using RNeasy columns (Qiagen, UK). Transcriptome sequencing of the pool 
(EBI Sequence Read Archive (SRA) study ERP002482) was performed using Illumina RNA-
Seq, with the sequencing library being prepared using the TruSeq™ RNA Sample preparation 
kit. Library preparation and sequencing was performed by The GenePool Genomics Facility, 
University of Edinburgh.
4.2.4 Data filtering and assemblies
Transcriptome sequencing requires high quality sequence reads for optimal assembly as 
sequencing errors can often create difficulties for short-read assembly algorithms. Therefore, a
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stringent filtering was performed to remove low-quality reads containing ambiguous nucleotides 
(“N”) or with a Phred score under 20. The sequences were also screened to remove any 
duplicates or low complexity sequences using PRINSEQ v0.20 (Schmieder & Edwards, 2011). 
The genome sequence for Pacific and Atlantic L. salmonis strains (NCBI assembly 
ASM18125v2) were retrieved from the salmon louse genome project website 
[http://sealouse.imr.no/] (Accessed: July 2012) and used for all subsequent transcriptome 
assembly processes. Two complementary sequence read assembly methods were chosen for this 
study. Firstly, TopHat v2.0.4 (Kim et al., 2013) was used to establish a reference-based 
assembly. Then, any unaligned reads were used by Trinity (release 2012-06-08) (Grabherr et al., 
2011) in order to build a de novo assembly of the remaining reads or to extend reference-based 
transcripts. Finally, to lower the redundancy resulting from de novo assemblies, all transcripts 
shorter than 300 bp or exhibiting repeats, as detected by TRF 4.07b (Benson, 1999), were 
removed.
4.2.5 Gene annotation and analysis
To annotate the sequences obtained, we performed sequence similarity searches using the 
BLAST algorithm (Altschul 1990). The longest coding DNA sequences were determined for 
each transcript using getorf from the EMBOSS v6.5.7 package (Rice et al., 2000). ESTScan v2 
(Iseli et al., 1999; Lottaz et al., 2003) was then used to confirm transcript coding regions and to 
determine sequence orientation. The coding sequences of the predicted transcripts were 
annotated using BLASTp (Basic Local Alignment Search Tool) searches against the GenBank
Reference Proteins database (refseq_protein; 03/03/2013 release) from the National Centre for 
Biotechnology Information (NCBI), with an expectation value (e-value) cut-off of 10-4 and 
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minimum alignment length of 33 amino acids being considered significant. Additionally, the 
transcripts were annotated using BLASTn searches against the UniGene/EST (L. salmonis
datasets, 2013-12-18 release) databases. 
The inferred annotations were used to retrieve Gene Ontology (GO) annotation for molecular 
function, biological process and cellular component (Ashburner et al., 2000). To avoid 
redundant functional assignments, the best-rated similarity hit with at least one GO annotation 
was chosen. A custom pipeline converted GO terms to GO Slim terms, using the Protein 
Information resource and Generic GO Slim files (Gene Ontology Consortium, 2014).
4.2.6 ABC transporter identification
The coding sequences of the predicted transcripts and downloaded EST dataset were searched
using HMMER v3.1b1 (Eddy, 2011) for ABC transporter hidden Markov models (Appendix
S2) from Pfam v27.0 (Finn et al., 2014), PRINTS v39.0 (Attwood et al., 2003), SMART v7.0
(Letunic, Doerks, & Bork, 2012), SUPERFAMILY v1.75 (Wilson et al., 2009) and PANTHER
(Mi, Muruganujan, & Thomas, 2012). For each locus identified, a subsequent manual 
annotation was also carried out using BLASTp searches against the GenBank Reference 
Proteins database (Refseq_Proteins; 2014-04-07 release) from the NCBI.
4.2.7 Phylogenetic tree
Amino acid sequences of the NBDs were aligned using GramAlign v3.0 (Russell 2014); the 
multiple sequence alignment of proteins was converted into corresponding codon alignment 
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using PAL2NAL v14 (Suyama 2006). Phylogenetic tree topology was estimated by a maximum 
likelihood search implemented in RAxML version 7.8.6 (Stamatakis 2006) using both the WAG 
and CAT models. One thousand bootstrap replicates were used to evaluate the support for 
different aspects of the optimal topology.
4.2.8 Data access
The raw sequence data from the study have been submitted to the EBI Sequence Read Archive 
(SRA) study ERP002482. The Annotated transcriptome has been deposited at the EBI European 
Nucleotide Archive (ENA) reference ERZ019407.
4.3 Results and Discussion
4.3.1 Paired-end sequencing and transcriptome assembly
To create a L. salmonis transcriptome sequence resource representing all key stages of the life 
cycle, including major metamorphosis steps, a total RNA pool was generated that included key 
stages of the salmon louse life cycle. This total RNA pool was subjected to Illumina paired-end 
sequencing using the Illumina HiSeq 2000 platform. In total, 389,927,940 raw sequence reads 
were obtained (194,963,970 paired-end reads; length 101 nt) (EBI SRA study ERP002482). Of 
those, 338,243,772 reads passed quality control filtering and were then used to generate a 
reference-based transcriptome assembly of 33,537 transcripts using the Atlantic L. salmonis
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Table 5: Statistics of the assembled sequences.
Raw data
Number of reads 389,927,940
Read length 101
Total size of reads 39,382,721,940
After assembly
Number of transcripts 37,681
N50 2,060
Total size of transcripts 50,718,754
After filtering (> 300 bps)
Number of transcripts 33,933
Number of unique genes 30,159
Unique transcripts 27,086
Multiple transcripts 3,073
N50 2,100
Total size of transcripts 49,850,662
Shortest transcript 300
Longest transcript 24,684
Mean size 1,469
Median size 9,79
Mean GC% 36.9%
N% 0.03%
Finally, the 33,933 unique transcripts have an N50 length of 2,100 bp and a total length of 
49,850,662 bp. Each gene had, on average, one splicing form per gene, with some genes having 
up to five (Table 5). To evaluate the quality of the assembled transcripts, all the usable 
sequencing reads were realigned to the transcripts. The sequencing depth ranged from one to 
519,299 reads, with an average of 795 reads across whole transcripts. About 77% of the 
transcripts were supported by more than 10 reads, while 35% were supported by more than 100 
reads.
4.3.2 Functional inference by searching against public databases
The assembled transcripts were annotated using BLASTp and BLASTn searches against the 
refseq_protein and UniGene databases, respectively. The results indicated that out of 30,159 
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genes, 28,547 (95%) and 8,640 (29%) showed significant similarity to known proteins or gene 
transcripts in refseq_protein and UniGene databases, respectively. To evaluate the coverage of 
the assembled transcriptome, 128,783 ESTs (> 100 bp) publicly available for L. salmonis 
(Yazawa et al., 2008) were aligned to the 33,933 transcript sequences generated in this study 
and vice versa. In total, 97,785 (76%) of all L. salmonis ESTs aligned to at least one transcript, 
while 15,507 (46%) of the transcripts had at least one corresponding L. salmonis EST.
4.3.3 GO functional classification analysis
GO annotations were assigned to the assembled L. salmonis transcripts/genes on the basis of 
refseq_protein annotations. In total, 28,547 genes had similarity to known gene products; 
however, only 4,954 (17%) were assigned GO annotations. A total of 3,009 different functional 
terms were assigned, with protein binding (25%) and nucleic acid binding (24%) identified as 
highly represented biological functions (Figure 15).
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which 20 were found both in the transcriptome and the existing EST, while 13 were found only 
in the transcriptome and 6 only in the set of ESTs (Yazawa et al., 2008).
Table 6: Identification of drug resistance candidate genes in the L. salmonis transcriptome
ABC
sub-group
EST supported
transcriptome
Transcriptome
only
EST contigs
only Total gene
A 1 2 0 3
B 2 1 0 3
C 7 7 1 15
D 1 1 2 4
E 1 0 0 1
F 3 0 3 7
G 5 2 0 7
Total 20 13 6 39
For a number of genes, alternative splicing forms were supported by alternative versions of 
ESTs (see full details, Appendix S3). The isolated ABC superfamily sequences are reported in 
Table 7 with preliminary names, accession numbers and detected domain architectures, based 
on the sequence range available. A maximum likelihood phylogenetic analysis grouped the L. 
salmonis ABC proteins into known ABC subfamilies with high bootstrap support (Figure 16). 
The subfamily assignment was re-evaluated and in all cases confirmed based on the presence of
conserved protein motifs, domain architecture and manual annotation through BLASTp
searches (Table 7).
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Table 7: Characterised 39 L. salmonis ABC proteins.
Subfamily ID Predicted Classification aa length Identified topology
A Lsa.1758 ABCA1 1583 TM - NBD - TM - NBD
A Lsa.14583 ABCA4 127 TM
A Lsa.1680 ABCA4 615 NBD - TM
B Lsa.26127 ABCB10 (mitochondrial HT) 566 TM - NBD
B Lsa.7262 ABCB7 (mitochondrial HT) 669 TM - NBD
B Lsa.643 ABCB8 (mitochondrial HT) 687 TM - NBD
B
C
Lsa.4043
EST_Contig_6
ABCB1
MRP14 / MRP1
1448
339
TM - NBD - TM - NBD
NBD
C Lsa.11278 ABCC1 / MRP1 1531 TM - NBD - TM - NBD
C Lsa.22810 ABCC1 / MRP1 979 TM - NBD - TM
C Lsa.29272* ABCC1 / MRP1 185 TM
C Lsa.4043 ABCC1 / MRP1 1448 TM - NBD - TM - NBD
C Lsa.6310 ABCC1 / MRP1 1175 TM - NBD - TM
C Lsa.8882* ABCC1 / MRP1 1563 TM - NBD - TM - NBD
C Lsa.23107* MRP4 1381 TM - NBD - TM - NBD
C Lsa.3521* MRP4 926 TM - NBD - TM
C Lsa.3522 MRP4 1293 TM - NBD - TM - NBD
C Lsa.14264 MRP5-like 169 NBD
C Lsa.4564 ABCC7 1466 TM - NBD - TM - NBD
C Lsa.14261 ABCC8/9 (SUR) 198 TM
C Lsa.14262 ABCC8/9 (SUR) 220 NBD
C Lsa.14263 ABCC8/9 (SUR) 374 TM
D EST_Contig_1 ABCD4 (peroxisomal membrane) 265 NBD
D EST_Contig_2 ABCD4 (peroxisomal membrane) 355 TM - NBD
D Lsa.10176 ABCD4 (peroxisomal membrane) 455 TM
D Lsa.5856 ABCD4 (peroxisomal membrane) 656 TM - NBD
E Lsa.1035* ABCE1 670 NBD - NBD
F Lsa.20458 ABCF1 109 NBD
F Lsa.9678 ABCF2 660 NBD - NBD
F EST_Contig_3 ABCF3 162 NBD
F EST_Contig_4 ABCF3 125 NBD
F EST_Contig_5 ABCF3 120 NBD
F Lsa.8082 ABCF3 758 NBD - NBD
G Lsa.12984 ABCG20 825 NBD - TM
G Lsa.14023 ABCG20 737 NBD - TM
G Lsa.21408 ABCG20 683 NBD - TM
G Lsa.23267 ABCG20 716 NBD - TM
G Lsa.23269* ABCG20 773 NBD - TM
G Lsa.2606* ABCG5 702 NBD - TM
G Lsa.25615 ABCG8 1001 TM - NBD - TM
EST_Contig_X: sequence provided in Appendix S3; peroxisomal membrane; TM: transmembrane 
domain; NDB: nucleotide binding domain. * Alternative splice forms exists
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4.3.5 Representation of ABC subfamilies
ABCA proteins are full transporters involved in lipid transport. In humans, ABCA1 is involved 
in the formation of high density lipoprotein, while ABCA3, ABCA4 and ABCA12, respectively, 
have roles in pulmonary surfactant secretion, retinal integrity and keratinisation processes in the 
skin (Wenzel et al., 2007). Three members of the ABCA subfamily were identified in L. 
salmonis (Table 9).
The ABCB subfamily comprises both half and full transporters. ABCB half transporters often 
localise to intracellular membranes, particularly mitochondrial, and have cellular roles unrelated 
to drug transport, whereas ABCB full transporters, also called P-glycoproteins, are found in the
cell membrane and include drug transporters (Dean, 2001). Three ABCB half transporters and 
one ABCB full transporter were found in L. salmonis in this study (Table 9). The half
transporter Lsa.643 has previously been cloned and designated SL-Pgp1 (Tribble et al., 2007). 
However, Lsa.643 shows greater homology to ABCB8 than to the drug transporter MDR P-
glycoprotein (ABCB1). Further L. salmonis half transporters represent homologues of the 
human mitochondrial transporters ABCB7 and ABCB10 (Table 9). ABCB7, ABCB8 and 
ABCB10 have roles in iron homeostasis and transport of Fe/S protein precursors (Dean, 2001).
The full transporter Lsa.4043 (Table 9) is identical to SL-PGY1, an ABCB1 homologue cloned 
and characterised in a previous study (Heumann et al., 2012). SL-PGY1 is up-regulated in 
response to emamectin benzoate (EMB) exposure and has been reported to show greater mRNA
levels in some L. salmonis isolates showing EMB resistance (Heumann et al., 2012; Igboeli et 
al., 2012).
The ABCC subfamily contains full transporters called multidrug resistance associated proteins 
(MRPs), the transport substrates of which include organic xenobiotics, xenobiotic conjugates 
The potential role of ABC transporters as factors influencing drug susceptibility in the 
salmon louse, Lepeophtheirus salmonis (Krøyer, 1837)
Jan Heumann- May 2015
Identification of ATP-binding cassette (ABC) proteins in a salmon louse (Lepephtheirus 
salmonis) transcriptome 159
and different metals (Deeley et al., 2006). Further ABCC subfamily members include the cystic 
fibrosis transmembrane conductance regulator (CFTR, ABCC7) and the sulfonylurea receptors 
(SUR1/2, ABCC8/9) (Deeley et al., 2006) . In L. salmonis, 14 ABCC sequences were identified, 
which comprise 11 MRPs and three SUR homologues (Table 9). MRPs have roles in 
biochemical defence against toxicants in mammals Deeley et al., 2006; Vlaming et al., 2009)
and invertebrates (Luedeking et al., 2005). In the free-living nematode C. elegans, mrp-1 
contributes to heavy metal resistance (Broeks et al., 1996), while in D. melanogaster (fruit fly) 
dMRP transports typical MRP1 (hABCC1) substrates (Szeri et al., 2009). The up-regulation of 
MRPs has been reported, together with that of P-glycoproteins and/or cytochromes P450, in 
drug-resistant nematodes (James & Davey, 2009; Yan et al., 2012) and pesticide-resistant 
mosquitoes (Bariami et al., 2012). Four of the 11 L. salmonis MRPs reported here
(EST_Contig_6, Lsa.4564, Lsa.8882, Lsa.23107) have been identified during a previous study 
(Heumann et al., 2014), which failed to detect differences in transcript levels of these 
transporters between EMB-resistant and a drug-susceptible L. salmonis. Both mammalian and
arthropod SURs have roles in regulating potassium channels (Bryan et al., 2007; Nasonkin et al., 
1999). The apparent failure of this study to identify L. salmonis CFTR homologues was not 
unexpected. CFTR is lacking in arthropod and nematode genomes analysed so far (Dermauw et 
al., 2013; Sheps et al., 2004; Sturm et al., 2009), and is believed to have emerged following a 
gene duplication in the vertebrate lineage (Dassa & Bouige, 2001; Sebastian et al., 2013).
Four sequences of the ABCD subfamily were identified in L. salmonis in this study (Table 9). 
ABCD proteins are half transporters involved in the import of fatty acids and their precursors 
into the peroxisome (Theodoulou et al., 2006). Illustrating the vital function of ABCD proteins, 
silencing of ABCD expression by simultaneous knock-down using RNA interference (RNAi) 
almost completely suppressed production of progeny in C. elegans (Oi et al., 2002).
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Subfamilies ABCE and ABCF contain highly conserved atypical ABC proteins composed of a 
pair of linked nucleotide binding domains, but lacking transmembrane domains (Kerr, 2004).
The present study found one ABCE and seven ABCF sequences in L. salmonis (Table 9). 
ABCE proteins have central roles in translation initiation (Chen et al., 2006), while ABCF 
proteins adopt functions in ribosome assembly and/or protein translation (Tyzack et al., 2000).
The ABCG subfamily contains half transporters showing a “reverse” domain order, with the 
NBD being located N-terminally to the TMD. Transport substrates of ABCG proteins include 
sterols and drugs (Kusuhara & Sugiyama, 2007). In human, ABCG1 and ABCG4 mediate the 
cellular transport of cholesterol to high-density lipoprotein, while ABCG5 and ABCG8 
facilitate the intestinal and biliary efflux of cholesterol, plant, and shellfish sterols. In contrast,
human ABCG2 (also called BCRP) is a drug efflux transporter (Krishnamurthy & Schuetz, 
2006). In D. melanogaster, the ABCG proteins white, brown and scarlet form subunits of 
transporters of eye pigment precursors (Mackenzie et al., 1999), while ET23 is believed to 
regulate cellular ecdysone levels (Hock et al., 2000). In L. salmonis, seven ABCG sequences 
were identified (Table 9); however, phylogenetic analyses could not detect one-to-one 
orthologous relationships to vertebrate and D. melanogaster transporters (data not shown).
Members of the ABCH subfamily resemble ABCG proteins in domain organisation and are 
found in Daphnia magna, insects, nematodes and teleost fish (Annilo et al., 2006; Dean, 2001;  
Sheps et al., 2004; Sturm et al., 2009). No functions have so far been attributed to ABCH 
subfamily transporters. No members of the ABCH subfamily were found in L. salmonis ABC 
genes in this study (Table 9).
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4.3.6 Conclusion
The annotation of expressed ABC proteins in L. salmonis represents a significant step towards 
an improved understanding of potential drug resistance factors in this species and related 
parasites. In particular, the high number of potential drug transporters identified will be 
invaluable to research efforts towards unravelling resistance mechanisms and improving control 
strategies.
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This chapter is a draft for publication, but further experiments will be conducted and an 
enhanced version will be submitted.
“Time course toxicity analysis as a method for drug susceptibility assessment in salmon lice”
Heumann J1, Carmichael SN1, Christie HRL1, Green D G1, Bassett DI2, Bron JE1, Sturm A1
1Institute of Aquaculture, School of Natural Sciences, University of Stirling, Stirling FK9 4LA, 
Scotland, UK.
2Marine Environmental Research Laboratory, University of Stirling, Machrihanish, Argyll, 
PA28 6PZ, Scotland, UK
(J. Heumann developed the design and carried out the experiments, analysed the results and 
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supervised the work and helped with the analysis and writing.)
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Abstract
Sea lice are marine fish ectoparasites belonging to the family Caligidae (Copepoda, Crustacea). 
A number of sea louse species are known to compromise the health and welfare of wild and 
farmed Atlantic salmon (Salmon salar L.). Currently, sea louse control on fish farms relies 
mostly on veterinary medicines. With only a limited range of drugs available for control, the 
continued use of compounds belonging to a restricted number of drug classes can promote the 
development of drug resistance. Successful resistance management requires the deployment of 
well-established methods to assess the drug susceptibility status of sea louse populations. 
Current standardised sea louse bioassays provide such a methodology, but require relatively 
large numbers of suitable stages of parasites, which can be difficult to obtain. The present study 
aims to investigate the feasibility of an alternative bioassay design based on time course toxicity 
analyses, which require significantly fewer test animals than standard 24-h dose-response 
bioassays. This could be advantageous under conditions where availability of suitable sea louse 
stages is restricted. Two well-characterised laboratory strains of the salmon louse, 
Lepeophtheirus salmonis, S (susceptible) and R (resistant), were employed for the study. These
differ in their susceptibility to the drug emamectin benzoate (EMB) according to median 
effective concentrations (effective concentrations affecting half of the test population) obtained 
in standard dose-response bioassays. A similarly clear distinction between the two strains was 
observed when comparing their median exposure time (Elapsed time until half of the test 
population is affected at a certain concentration). Furthermore, drug susceptibility for individual 
salmon lice can be estimated, a feature that may be useful in studies aiming to examine 
heterogeneity of response or to identify molecular determinants of resistance.
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5.1 Introduction
Sea lice (Caligidae: Copepoda) are marine fish ectoparasites feeding on the mucus and skin 
tissues of their hosts (Boxaspen, 2006). Sea louse infections of farmed Atlantic salmon (Salmo 
salar) mostly involve Lepeophtheirus salmonis (salmon louse) and Caligus elongatus in the 
Northern hemisphere and Caligus rogercresseyi in Chile (Costello, 2006). Currently, sea louse 
control on salmon farms mostly relies on the use of veterinary drugs, supplemented by farm 
management measures (Costello, 2009) and the use of cleaner fish (Sayer et al., 1996). Further 
alternative control methodologies have been suggested and include efforts to reduce host fish 
susceptibility through vaccination or selective breeding (Gharbi et al., 2009; Raynard et al., 
2002), but, as of 2015, no commercial application is available. Other attempts to disrupt parasite 
host detection and/or attachment (Ingvarsdóttir et al., 2002) or to mechanically remove parasites 
using water jets (prototype stage) (Grydeland et al., 2013). However, these supplementary 
approaches to sea louse control are currently not sufficiently well developed to allow full 
replacement of the use of chemical delousing agents; therefore, the use of antiparasitics 
presently remains essential for sea louse control on fish farms (Burridge et al., 2010).
Only a limited number of anti-sea louse drugs is currently available (Burridge et al., 2010), 
minimising the options for rotation between drug classes with different modes of action 
(Denholm et al., 2002). The continued use of the same or a few related types of control agent 
can increase the likelihood for resistance to those drugs may develop in the parasite. The 
development of drug resistance is well documented in L. salmonis, and compounds for which 
loss of efficacy has been reported include organophosphates (Jones et al., 1992; Roth et al., 
1996), pyrethroids (Sevatdal & Horsberg, 2003), hydrogen peroxide (Treasurer et al., 2000) and 
emamectin benzoate (Lees et al., 2008). Emamectin benzoate (EMB) resistance has further been 
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reported for C. rogercresseyi (Bravo et al., 2008; Bravo et al., 2010). Accordingly, there is an 
urgent need to develop drug resistance monitoring and management strategies in salmon lice. 
This will assist in observing and constraining extant resistance as well as prevention of future 
resistance development.
Successful resistance management requires fast and reliable methods to assess the drug 
susceptibility status of parasite populations. Bioassays are used to monitor the reduction of drug 
susceptibility of a parasite population (ffrench-Constant & Roush, 1990). Usually, a test 
population is exposed to different drug concentrations, and results are usually summarised as a 
median exposure level, i.e. the degree of exposure causing toxic effects in 50% of the test 
population. Assuming an aquatic organism takes up a toxicant from water at a stable rate and 
excretes it at a rate lower than the uptake rate, the resulting internal exposure is proportional to 
both the toxicant’s concentration and exposure time. Standard salmon louse bioassays achieve 
gradual exposure levels by testing different toxicant concentrations while keeping exposure time 
constant (Sevatdal & Horsberg, 2003; Westcott et al., 2008), to derive median lethal or median 
effective concentrations (LC50, EC50) of the toxicant, i.e. the concentrations causing the relevant 
toxic effect in 50% of the parasites. Alternatively, different exposure levels can be obtained by 
combining a fixed toxicant concentration with variable exposure times, in which case the 
susceptibility of the population of test organisms to the toxicant can be expressed as the median 
lethal or median effective time (LT50, ET50).
While the requirement for multiple observations can account for increased workload required
per test in time course analyses, fewer test organisms than in standard bioassays are needed per
assay as the same batch of animals can be observed repeatedly. The availability of the 
appropriate developmental stages of salmon lice suitable for bioassays can be restricted at 
production sites when parasite levels approach the legal threshold for mandatory control 
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interventions. Alternative bioassays involving only one drug concentration applied for a fixed 
exposure period have been proposed to allow for drug susceptibility assessment under such 
circumstances (Helgesen & Horsberg, 2013b; Whyte et al., 2013). While single dose/single 
exposure-time bioassays may be appropriate in many situations, their ability to resolve 
susceptibility differences between salmon louse populations is limited. In situations where more 
detailed information is required on drug susceptibility status, alternative salmon louse bioassays 
based on time course toxicity analyses could be extremely useful when parasite numbers do not 
permit the performance of standard salmon louse bioassays. However, to our knowledge, assay 
protocols based on time course toxicity analysis have not been established for this group of 
parasites.
The aim of the present study is to investigate the potential of a time course toxicity analysis as 
an alternative approach to conducting salmon louse drug sensitivity assessments. Two well-
characterised laboratory strains of L. salmonis differing in susceptibility to the salmon delousing 
agent emamectin benzoate (Carmichael et al., 2013; Heumann et al., 2012) were used as 
biological models to establish a suitable protocol. Time course toxicity results were compared to 
standard dose-response bioassays with respect to their ability to detect differences in EMB 
susceptibility among salmon louse strains.
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5.2 Materials and Methods
5.2.1 Salmon louse (Lepeophtheirus salmonis) strains and husbandry
Two L. salmonis laboratory-maintained strains differing in susceptibility to EMB (Heumann et 
al., 2012) were used in this study. The susceptible S strain was established in 2003 using salmon 
lice from a Scottish farm site where no chemical control agents other than hydrogen peroxide 
had been used. The EMB-resistant strain R was established in December 2008 using salmon lice 
from a different Scottish production site reporting variable EMB treatment efficacies. The 
strains have since been cultured under identical laboratory conditions using Atlantic salmon 
(Salmo salar) as host fish, as described in detail elsewhere (Heumann et al., 2012). To 
propagate cultures, L. salmonis egg strings were collected from gravid females and allowed to 
hatch and develop to copepodids, which were used to inoculate tanks containing fresh host fish. 
To collect L. salmonis, host fish were anaesthetised with 100 mg L-1 2-phenoxyethanol (99%; 
Sigma-Aldrich, Dorset, UK) in seawater for 3 minutes and parasites removed into clean aerated 
seawater using fine forceps. Infection rates were maintained at levels compatible with good fish 
welfare. All laboratory infections were carried out under UK Home Office licence and 
appropriate veterinary supervision.
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5.2.2 Standard dose-response bioassay
Prior to use in bioassays, adult male L. salmonis, freshly collected from host fish, were allowed 
to recover in the dark for 2-4 h in filtered aerated seawater (SW) equilibrated to 12 °C. In 
previous experiments, when comparing results between parasites collected as described above 
and parasites collected from fish euthanized by a UK home office approved schedule 1 method 
(stunning followed by cervical dislocation), no effects of host fish anaesthesia on salmon louse 
motility or the ability of parasites to adhere to host skin or other surfaces were observed (data 
not shown). Exposure was performed in a temperature-controlled incubator set to 12 °C using 
polystyrene Petri dishes containing 70 mL of exposure solutions. Each vessel contained ten 
adult male salmon lice. EMB (technical grade, a gift from MSD Animal Health) was solubilised 
using polyethylene glycol 300 (PEG 300; Ph. Eur., Merck Chemicals, UK) before being diluted 
in filtered, aerated SW. Trials showed that PEG 300 had no effect on test animals. A stock 
solution was prepared and all other concentrations were made by serial dilution. Exposure 
solutions contained a final concentration of 0.01% (v/v) PEG 300 in all cases (except seawater 
controls). Each assay comprised of a series of five EMB concentrations (100, 130, 180, 230 and 
300 µg L-1 for S strain; 100, 200, 400, 800 and 1,600 µg L-1 for R strain), SW controls as well as 
solvent controls containing 0.01% (v/v) PEG 300. Salmon lice were assigned to treatments at 
random. Three replicate vessels with ten animals each were used per combination of strain and 
experimental or control treatment (180 animals per strain). After 24 h of exposure, salmon lice 
were visually examined, carefully touched with a brush and their behaviour assessed matching 
one of three categories. Parasites rated as “live” were considered not affected, while those 
animals rated as “moribund” or “dead” were affected by EMB (see Table 8). Encryption of 
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treatment labelling was used to ensure unbiased rating. Selected dishes were rated by two 
independent examiners to ensure consistency and independence of ratings. 
Table 8: Effect criteria used by different authors to define sublethal responses in salmon louse 
bioassays.
Sublethal effect definition I1 Sublethal effect definition II2
Live - normal swimming 
behaviour (swim in a 
straight line), securely 
attaches to Petri dish, 
normal movement of 
extremities
Unaffected
Live – normal swimming 
behaviour (swim in a straight 
line), securely attaches to Petri 
dish, normal movement of 
extremities
Unaffected
Moribund – disabled 
swimming, but capable 
of weak, uncoordinated 
movement (loop 
swimming), inability to 
firmly adhere to Petri 
dish (short time, then
drops off), minimal 
movement of extremities
Affected
Weak – poor or irregular 
swimming, inability to attach to 
Petri dish
Immotile – immotile, minimal 
movement of extremities 
(twitching)
Affected
Dead – inability to 
swim, floating in Petri 
dish, no movement of 
extremities
Dead - Inability to swim, 
floating in Petri dish, no 
movement of extremities
1 (Sevatdal & Horsberg, 2003; Westcott et al., 2008)
2 (Igboeli et al., 2012; Saksida et al., 2013)
5.2.3 Time course bioassays
Salmon lice were exposed in a similar fashion to different EMB concentrations as for the 
standard bioassay. Experimental treatments and controls were run as triplicates (experiment 1) 
or duplicates (experiment 2 and 3) of ten adult males in disposable polystyrene Petri dishes 
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containing 70 mL of the relevant test or control solution, using a total of 60 animals per strain.
Susceptible salmon lice (S) were exposed to 400 and 800 µg L-1 EMB, while resistant lice (R) 
were tested at 800 and 1,600 µg L-1 EMB. At set time intervals throughout the exposure period,
parasites were examined visually and allocated to one of four categories describing their 
swimming behaviour: “Live”, “weak”, “immotile” or “dead”. Lice affected by treatment 
belonged to categories “immotile” or “dead” (sublethal effect II, see Table 8). All animals were 
distributed randomly to each Petri dish containing seawater. After allocating all animals, 
seawater was carefully decanted and test solutions were added immediately. Furthermore, two 
sets of solvent and seawater controls were prepared. One set was examined at the same time as 
dishes containing EMB solutions, serving as internal control. These animals were repeatedly 
assessed in parallel to the drug-treated parasites. The other set of controls was wrapped with 
aluminium foil for protection against visual stimuli and left untouched over the course of the 
experiment; to be assessed only once when the final rating of the other treatments took place. A 
comparison between internal and external control would give an indication of whether repeated 
examination of salmon lice behaviour had an influence on behavioural responses.
In time course bioassays, the main factor controlling toxic response is the length of exposure, 
which cannot be concealed to the evaluator by encryption. Still, encryption of all labels was 
used to ensure unbiased assessment. All other experimental conditions were identical to those 
described above for the standard bioassay.
5.2.4 Statistics
In standard bioassays, median effective concentrations (EC50) of EMB, i.e. concentration of the 
drug causing immobility in 50% of the tested parasite strains, were derived from experimental 
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data by probit analysis using the statistical programme Minitab 15.1 (MiniTab Inc., UK). In 
time course bioassays, median effective times (ET50) and 95% confidence intervals were 
calculated using the reliability/survival time module of the commercial statistical programme 
Minitab (version 16.1), assuming a log-normal distribution. Fisher’s exact test was used to 
compare bioassay outcomes between internal and external controls in a 2x2 contingency table 
design, in which categories “weak”, “immotile” and “dead” were pooled and compared to the 
category “live”. Fisher’s exact test was carried out using the programme InStat3 (Graph Pad Inc., 
La Jolla, USA).
5.3 Results
Two laboratory strains of L. salmonis differing in EMB sensitivity served as biological models 
in this study. In 24 h standard bioassays with adult male parasites, EMB half-maximal effective 
concentrations (EC50) were 160 μg L-1 (95% confidence intervals: 148 - 173 μg L-1) in the drug-
susceptible strain S and 712 μg L-1 EMB (592 - 852 μg L-1) in the EMB-resistant strain R 
(Figure 17). In these bioassays, parasites are rated as “live”, “moribund” or “dead” at the end of 
the test and moribund and dead animals are considered affected by the toxicant (sublethal effect 
definition I, Table 8).
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Figure 17: Dose-response bioassay testing for acute toxicity of emamectin benzoate (EMB) in
two strains of L. salmonis (S = susceptible, R = resistant). Symbols represent the average 
immotility response among three replicate batches of ten adult male parasites following 24 h of 
aqueous exposure to the drug. Dashed curves represent 95% confidence intervals.
Based on the above estimates of strain sensitivities, EMB concentrations of 400 and 800 μg L-1 ( 
S strain) and 800 and 1,600 μg L-1 (R strain) were selected for time course experiments 
addressing the temporal dependence of the toxicity response. In these tests, the behaviour of 
animals exposed to the toxicant was examined repeatedly at set time points, using similar 
criteria to those applied in standard bioassays. However, in order to allow for a more gradual 
assessment of parasite responses, the criterion “moribund” was subdivided into two categories 
called “weak” and “immotile” (Table 8). When results are summarised using the sublethal effect 
definition I, which is employed in standard bioassays, response levels in seawater controls were 
high (~45-90%) and showed no clear relationship to exposure time, while responses in EMB-
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exposed animals increased from initial values of ~30-60% to final values of 100% during the 
course of the experiment (Figure 18A-B). Solvent controls showed similar response levels as 
observed in seawater controls (data not shown).
Figure 18: Time course of the acute toxicity of emamectin benzoate (EMB) in two strains of L. 
salmonis. Adult male parasites were exposed to 800 µg L-1 of EMB or seawater as control and 
their behaviour assessed regularly. Graphic representation of response using sublethal effect 
criteria I (A, B) or sublethal effect criteria II (C, D) for S strain and R strain parasites, 
respectively. Symbols represent average immotility response among three replicates of ten 
parasites with standard deviation.
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Next, data were re-analysed using a recently suggested revised definition of the sublethal 
response in sea louse bioassays (Igboeli et al., 2012; Saksida et al., 2013), in which immotility 
or death of parasites is counted as toxic effect whereas live or weak animals are considered 
unaffected (sublethal effect definition II; Table 8). Using these effect criteria, response levels in 
the controls were close to zero (< 10%), while in parasites exposed to EMB an increase of 
response levels with time was observed (Figure 18C-D), allowing to estimate time required for 
50% of the parasites to become affected during exposure to a given drug concentration. With 
800 μg L-1 EMB, the median effective time (ET50) for sublethal effect II was 3.5 h (95% 
confidence intervals: 3.3 – 3.6 h) in the S strain and 9.6 h (9.0 – 10.3 h) in the R strain. In the S 
strain, 400 μg L-1 EMB elicited a similar apparent time course of toxicity as 800 μg L-1 EMB, 
but data obtained with the former concentration of the drug did not allow calculation of an ET50. 
Compared to 800 μg L-1 EMB, 1,600 μg L-1 EMB had a greater apparent effect in the R strain, 
as reflected by an ET50 of 3.4 h (3.0 – 3.9 h) (Figure 18C-D) (Table 9).
Table 9: Overview of three independent time course bioassays conducted between December 
2011 and May 2014. Susceptible (S) and resistant (R) lice were exposed to 800 μg L-1 EMB and 
the half maximal response time (ET50) and 95% confidence intervals calculated.
ET50 (95% confidence interval)
Experiment (Date) S strain R strain
1 (December 2011) 12.9 h (11.2-14.9) 25.3 h (22.6-30.5)
2 (July 2012) 6.9 h (6.3-7.6) 23.5 h (20.6-26.7)
3 (May 2014) 3.5 h (3.3-3.6) 9.6  h (9.0-10.3)
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The time course bioassay involved multiple examinations of the same parasites, which could 
have affected behavioural responses. To control for potential effects of repeated assessments, 
external untreated controls and EMB treatments were included for both strains, which were 
examined only once at the end of the experiment. Compared to experimental controls subjected 
to repeated rating, more sea lice categorised as “live” and fewer animals rated as “weak” were 
observed in external controls (Figure 19). The difference in response between the two types of 
controls was significant in the assay with the R strain, but not for the S strain. In both types of 
controls, the number of sea lice showing a response according to sublethal effect definition I 
clearly exceeded 10%, the maximum response level allowed in the original protocols for 
standard sea louse bioassays. However, when using sublethal effect definition II, the response in 
both types of controls was below the 10% threshold (Figure 19).
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Figure 19: Average number and standard deviation of parasites per behavioural category for 
experimental seawater (SW) and external seawater (SW ext) controls. External controls were 
assessed once at the end of the time course bioassay, while experimental controls were rated 
multiple times before the final assessment. Triplicates of 10 adult male lice (S strain, R strain) 
were used. Different letters denote significant (ρ<0.05) difference between two means.
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In order to test the consistency of the time course bioassay, both strains were investigated 
multiple times between 2011 and 2014. While ET50 values showed significant variability within 
each strain, a significant susceptibility difference between the two strains was detectable in all 
trials (Table 9).
5.4 Discussion
Bioassays are used to assess the toxicity of chemicals in aquatic organisms. They are usually 
based on analysing the relationship between different concentrations of a substance and its toxic 
effect over a fixed time period, and results are usually expressed as median lethal or effective 
concentrations (Pascoe & Edwards, 1989; Sprague, 1969). An alternative approach involves 
time course toxicity analyses, in which the manifestation of a toxic effect is established over a 
certain time period by repeated observations of a batch of organisms exposed to a fixed toxicant 
concentration, allowing the calculation of a median effective or lethal time (Rand, 2008;
Sprague, 1969). Results obtained in the present study suggest, in principle, the feasibility of 
salmon louse bioassays based on time course toxicity analysis, which could complement current 
dose-response salmon louse bioassays in drug susceptibility assessments. The results of this 
study further highlight the importance of consistent and robust effect criteria in bioassays, an 
issue that recently has been the subject of debate (Igboeli et al., 2012; Saksida et al., 2013).
While mortality is a clear and specific bioassay endpoint, it shows limitations in terms of 
sensitivity (Sevatdal & Horsberg, 2003). Tests based on sublethal behavioural effects potentially 
offer improved sensitivity; however, clear definitions of such effects are required. The original 
definition of sublethal effects in toxicity tests with sea lice (sublethal effect I, Table 8) comprise 
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a wide range of behaviours indicating sublethal effects, ranging from subtle alterations in 
swimming and/or attachment behaviour to complete impairment of locomotion. Standardised 
tests based on these criteria (SEARCH Consortium, 2006; Sevatdal & Horsberg, 2003; Westcott 
et al., 2008) have been found to perform well under laboratory conditions. However, in certain 
instances (e.g. field bioassays on salmon farms), elevated response levels of up to 60% in 
control treatments have been observed (Westcott et al., 2008). While the use of probit regression 
models incorporating “natural responsiveness” has been suggested to allow for sensitivity 
assessment in such cases (Westcott et al., 2008), effect levels of greater than 10% invalidate test 
results according to current international guidelines (SEARCH Consortium, 2006). High 
response levels in control treatments (>10%) were also observed during time course assays in 
the present study, and are reported to occur occasionally in the summer months during standard 
bioassays both at MERL (Dr William Roy, personal communication) and elsewhere (Gregg 
McArthur, North Atlantic Fisheries College, Shetland, UK). To improve the reliability of 
bioassays, revisions of sublethal effect criteria have recently been suggested (Igboeli et al., 
2012; Saksida et al., 2013). The revised categories differentiate between subtle changes in 
parasite behaviour (“weak”) and more pronounced alterations (“immotile”), and only regard the 
latter as indicative of toxicant effects. Applying the revised criteria in time course bioassays in 
the present study allowed clear differentiation between drug treatments and controls, with 
control responses now being less than 10%, demonstrating the suitability of the revised criteria 
to detect sublethal effects.   
Dose-response bioassays based on behavioural criteria usually involve only one assessment of 
animal behaviour, which takes place at the end of a defined exposure period. In contrast, time 
course bioassays require repeated examination of parasites. The repeated gentle probing of test 
animals could cause changes in their motivation to react to stimulation. Moreover, impaired 
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swimming in time course bioassays could be due to fatigue caused by the examination 
procedure. To address this point, experimental (continuous assessment) and external controls 
(assessment only once) were compared. More weak animals were counted in experimental as 
compared to external controls, and these differences were significant for the test with strain R, 
but not strain S. Accordingly, repeated assessment may have reduced the responses of test 
animals to a certain degree. However, under sublethal effect criteria I, the number of weak 
animals by far exceeded the threshold of 10% in both internal and external controls. In contrast, 
the observed response according to the revised criteria was practically zero in both types of 
controls, suggesting that repeated examination of sea lice did not affect test results based on 
sublethal effect criteria II.
Apart from handling-induced stress, other potentially interfering factors in bioassays include the 
possibility of a decline of toxicant concentration over time. A recent study reported significant 
losses of EMB from solutions prepared in seawater over 24 h, with the degree of EMB depletion 
being dependent on the material of the container and the incubation time (Helgesen & Horsberg, 
2013a). In glass containers, 41.9% of an initial concentration of 150 µg L-1 EMB was still 
present in seawater after 24 h. Slightly higher recoveries (48.9%) were obtained with high-
density polyethylene dishes, whereas less EMB was detected at the end of the test when teflon 
or silanised glass containers were used (27.4% and 24.0%, respectively) (Helgesen & Horsberg, 
2013a). It was not possible to cover this aspect in the present study. However, in an earlier study 
of our group using similar conditions as those employed in this report, 49.7% of a nominal 
EMB concentration of 200 µg L-1 was found in seawater after 3 h (Carmichael et al., 2013). 
These data demonstrate that, during salmon louse bioassays, actual concentrations of EMB in 
seawater can deviate significantly from nominal concentrations, presumably due to adsorption 
to the walls. 
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In situations where only a limited number of test organisms is available, time course toxicity 
analyses allow the assessment of the susceptibility of a population to a chemical based on a 
limited number of test animals. Such a scenario is common for salmon farms, where continuous 
monitoring of salmon lice susceptibility to employed antiparasitics is required; yet, due to the 
low threshold of parasite abundance triggering therapeutic interventions, information about the 
drug susceptibility status of salmon lice is sometimes required when parasite stages suitable for 
bioassays, i.e. pre-adult II and adult salmon lice, are scarce. Single-dose bioassays employing a 
fixed exposure time have been proposed as a method of susceptibility assessment requiring 
fewer test organisms (Helgesen & Horsberg, 2013b; Whyte et al., 2013). While straightforward, 
such approaches are limited, however, with respect to the resolution achievable in detecting 
differences in drug susceptibility. Time course toxicity bioassays are currently labour-intensive. 
It might be feasible to employ automated image analysis systems for the assessment of parasite 
movement. Such a system (termed WormAssay) has been successfully used to monitor filarial 
nematode parasites like Brugia malayi (Marcellino et al., 2012). It is inexpensive, has increased 
throughput and allows the screening of macroparasites (Marcellino et al., 2012); and if found
suitable, this technology might reduce the labour required for time course toxicity analysis.
With improvements regarding standardisation and labour requirements, the time course toxicity 
bioassay could provide a complementary methodology for situations where detailed information 
is required concerning the susceptibility phenotype. In addition, time course toxicity analyses 
offer the advantage that the response times of the different exposed organisms provide estimates 
of their individual drug susceptibilities, which may be useful in characterising heterogeneity of 
response and identifying molecular markers related to drug resistance. 
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Considering earlier data obtained with the standard dose-response bioassay, one would expect to 
observe a 50-60% response of R strain lice after 24 h when exposed to 800 µg L-1 EMB (EC50 is
712 µg L-1, which is comparable to 779 µg L-1 found for the R strain in other standard bioassays 
(Carmichael et al., 2013)).  However, a faster response was observed, where half of R strain lice 
showed responses after 10 h when exposed to 800 µg L-1 EMB. We suspect that seasonally 
changing environmental conditions during the parasite’s development could play a role in the 
apparent variability of the salmon lice population investigated. A repeat of this experiment, 
possibly with a dose-response bioassay at the same time, could shed light on this phenomenon. 
Variability between experimental repeats has been observed not only for time course bioassays 
(Table 9), but also in dose-response bioassays (Carmichael et al., 2013; Espedal et al., 2013; 
Heumann et al., 2012; Igboeli et al., 2012). Potential factors leading to observed variability 
could be a) examiner’s subjectivity when assessing salmon lice, b) variation in test chemicals 
used, c) inherent biological variability or d) seasonal influences and overall viability of the test 
animals. While training of examiners and experimental design strives to minimise these 
influence, it might not be possible to exclude them. Therefore, the extent of their influence 
should be further assessed.
In conclusion, the present study investigated the overall feasibility of using an altered bioassay 
design to assess the susceptibility of two strains of sea lice to the delousing agent EMB. The 
employed time course toxicity analyses require significantly fewer test animals, when compared 
to current sea lice bioassays using dose-response analyses. We found that this altered bioassay 
design delivered a similarly clear distinction regarding the EMB susceptibility of the two model 
strains as with the standard dose-response bioassay. This alternative methodology could be 
applicable in situations where the available number of test animals is too restricted to carry out
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standard bioassays. A further advantage of this modified bioassay is the estimation of a “time-
to-response” for each individual animal, thus providing data for each parasite’s drug 
responsiveness. However, the time course bioassay is more labour-intensive and the procedure 
is not as established and tested as the standard dose-response bioassay. Further experiments 
using the modified bioassay should be aimed at improving standardisation and reducing 
expenditure of human labour, which would improve repeatability and make this bioassay more 
competitive.
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Production of farmed salmon has increased over the years (FAO, 2012) and so has resistance of 
sea lice to delousing agents (Denholm et al., 2002). Prevalence of infection increases with host 
density – an important theory of epidemiological research (Anderson & May, 1991). Empirical 
studies in human, agricultural and wild systems support this theory (Anderson & May, 1991; 
Arneberg et al., 1998; Burdon & Hilvers, 1982). Higher stocking density allows parasites to be 
faster and more successful in locating new hosts and often procreate more successfully
(Arneberg et al., 1998). Delousing using chemical compounds is an important tool for salmon 
farmers to keep salmon lice burden under control. However, prolonged use of a single 
compound, like EMB, will lead to drug resistance as the compound’s efficacy decreases and 
delousing becomes less effective (Bravo et al., 2008). Using a single class of chemical 
continuously is favouring parasites that survive the treatment cycle (ffrench-Constant & Roush, 
1990). As there is less natural competition, they will propagate with greater success and can 
eventually become dominant within the population. EMB was introduced in 2000 as being 
highly effective against all stages of salmon louse and has become widely used since (Bravo et 
al., 2008; Westcott et al., 2004). It has been used for many years to control infections with 
salmon lice and is only the latest drug losing its efficacy. Other delousing agents, with different 
modes of action, like the organophosphates or pyrethroids, have also lost their efficacy for 
delousing in some salmon production areas (Denholm et al., 2002), when resistant salmon lice 
strains emerged. Resistance to EMB has emerged in salmon lice populations in Europe and 
Canada (Hjelmervik et al., 2010; Westcott et al., 2010). Therefore, it is vital to improve our 
knowledge of the mechanisms conferring drug resistance in salmon lice, particularly at a 
molecular level. Other delousing methods independent of drugs, are currently developed – e.g. 
co-culturing with wrasse -, but, while promising, have not replaced chemical delousing 
(Skiftesvik et al., 2013). Having a better understanding of the processes conferring resistance 
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could lead to improved monitoring tools and earlier detection of developing resistance. 
Furthermore, it could provide crucial insight for the development of new drugs for delousing.
Several studies suggest that ABC transporters (such as P-gp) play a major role in nematodes 
resistant to IVM, a compound chemically very similar to EMB (Prichard & Roulet, 2007). One 
study suggested that increased expression of P-glycoproteins in the gut epithelium of L. 
salmonis would decrease the absorption of EMB from ingested mucus (Tribble et al., 2007). 
Additional knowledge about P-gp homologues in salmon lice would be beneficial for 
understanding the molecular mechanisms conferring EMB resistance. 
During this project, we identified a novel salmon louse P-gp. Rapid amplification of cDNA ends 
(RACE) was used to obtain its full-length open-reading frame. The predicted gene product has a 
length of 1,438 amino acids, was named SL-PGY1 and has high homology with P-gps in other 
species. P-gps, belonging to the ABCB subfamily, act as efflux pumps with a wide range of 
substrates, including toxicants (Epel et al., 2008). Overexpression of P-gp has been found to be 
one of the causative factors for drug resistance in human cancer cells (Ueda et al., 1987). They 
are also suspected factors contributing towards avermectin resistance observed in parasites
(Williamson & Wolstenholme, 2012; Wolstenholme & Kaplan, 2012). In fact, co-administration 
of avermectins and an ABC transporter inhibitor (verapamil) lead to an increase in treatment 
efficacy in avermectin-resistant parasites (Kerboeuf et al., 2003). Therefore, drug efflux
transporters belonging to the ABCB subfamily have been implicated as factors contributing to 
avermectin resistance in nematodes such as C. elegans or H. contortus (James & Davey, 2009; 
Sangster et al., 1999; Xu et al., 1998).
SL-PGY1 shares a high structural similarity with P-gps of vertebrate and invertebrate origin and 
a role for SL-PGY1 in EMB detoxification was investigated. In the absence of EMB, SL-PGY1 
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mRNA expression level in S and R strain lice did not significantly differ from each other. 
However, EMB exposure had a variable effect on the expression of this P-gp, depending on 
length and mode of exposure. Three hours of exposure to 200 µg/L EMB in bioassays had no 
effect on the mRNA expression ratio of both model strains. Salmon lice of the moderately 
resistant SF strain were exposed to EMB while attached to their hosts, which had been fed 
EMB-fortified food. After three weeks, no differences in SL-PGY1 expression ratios were 
found when comparing treated and untreated parasites. However, sublethal exposure to 410 
µg/L EMB in a 24 h standard bioassay resulted in a 2.9-fold increase in SL-PGY1 mRNA 
expression in parasites of the R strain. An investigation of single-nucleotide polymorphisms did 
not find any changes possibly associated with EMB resistance. We conclude that SL-PGY1 is 
not the sole factor responsible for reduced susceptibility to EMB, although it could play a role, 
as expression levels were increased in the R strain upon acute exposure to EMB. It appears that 
there is no single ABC drug transporter functioning as the major determinant for avermectin 
drug resistance (Heumann et al., 2012; Le Jambre et al., 1999; Lespine et al., 2012; Yan et al., 
2012), suggesting the involvement of multiple factors, not necessarily limited to P-gps. 
Interestingly, the expression of SL-PGY1 differed between male and female parasites of the 
same strain, with males expressing significantly more mRNA. This could indicate that this 
transporter has additional physiological functions, which might differ between the sexes. 
Further research regarding the role of SL-PGY1 and other ABC transporters in L. salmonis is 
required.
Therefore, the role of other ABC drug transporters was also investigated. Multidrug-resistance 
proteins, part of the ABCC subfamily, are known to act as drug transporters in humans (Cole et 
al., 1992) and mice (Johnson et al., 2001) and could potentially also play a role in EMB 
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resistance. During this project, we identified four novel MRPs in L. salmonis. We examined the 
relative expression levels of all four transporters in the two model salmon louse strains differing 
in their susceptibility to EMB. MRP levels did not differ between strains in the absence of EMB 
and did not change after exposure to the drug. There was no molecular evidence for a potential 
role of those four MRPs in EMB resistance. Further experiments involved a pharmacological 
approach employing well-documented inhibitors of ABC transporters. CSA and VER are 
known to inhibit ABC transporters, including human P-gps and MRPs (Meier et al., 2006; Saeki 
et al., 1993). This approach was chosen as these integral membrane proteins facilitate the export 
of substrates from the cytoplasm and form the “first line of defence” against toxicants (Epel et 
al., 2008). Therefore, they are predominantly expressed in tissues involved with excretion or in 
boundary-forming tissues, such as placenta, gut epithelia or blood-brain barrier (Leslie et al.,
2005). They often localise to the apical membrane domain of polarised cells, which underlines 
their function in restricting uptake and facilitating efflux of cytotoxic substances (Zaja et al.,
2008). Furthermore, lack of functioning ABC drug efflux transporters can result in 
hypersensitivity to substrates of those transporters, as was observed for P-gp-deficient Collie 
dogs (Roulet et al., 2003) and mice (Schinkel et al., 1994) becoming highly susceptible to IVM. 
We investigated whether co-administration of ABC inhibitors would lead to a change in EMB 
susceptibility in L. salmonis. CSA increased the toxic effect of EMB in both tested salmon lice 
strains. Apparently, the targets of CSA are part of the defence mechanisms against toxic 
substances, and CSA’s presence is decreasing their capacity to limit the effects of EMB on the 
parasite. Furthermore, we assume they are expressed at comparable levels, as a similar effect 
was observed in both strains. Interestingly, VER increased the toxic effect of EMB in the 
resistant strain, but had no significant effects on the EMB-susceptible strain. We suspect that 
VER inhibits the function of biochemical factors involved in EMB detoxification, possibly ABC 
The potential role of ABC transporters as factors influencing drug susceptibility in the 
salmon louse, Lepeophtheirus salmonis (Krøyer, 1837)
Jan Heumann- May 2015
General Discussion 205
transporters. A similar result was observed in a study with the ruminant parasitic nematode H. 
contortus. There, VER co-administration increased the toxic effect of IVM and moxidectin in an 
avermectin-resistant strain with increased P-gp expression (Xu et al., 1998). Furthermore, co-
administration of VER increased EMB toxicity in a laboratory-reared Canadian strain of L. 
salmonis (Igboeli et al., 2012). We hypothesise that a number of ABC transporters with distinct, 
yet overlapping patterns of inhibitor specificity are affected by those inhibitors. This reduces 
their capacity to remove EMB from the parasite, leading to an increased EMB concentration in 
L. salmonis. 
The observed differences in EMB susceptibility between the S and R strains could also be
linked to varying degrees of expression of resistance-conferring proteins, which are targeted by 
ABC transporter inhibitors like cyclosporin A and verapamil. For example, increased expression 
of four MRP mRNAs was associated with IVM resistance in C. elegans (James & Davey, 
2009). With EMB being chemically very similar to IVM, use of inhibitors reversing IVM 
resistance could represent a way to reverse EMB resistance in L. salmonis, because inhibitor-
mediated reversal of drug resistance was successful in IVM-resistant H. contortus (Bartley et 
al., 2009; Molento & Prichard, 2001). 
The capability of ABC transporters to remove a wide variety of substances is a major obstacle 
for treating salmon louse infections. Combination therapies, whereby two or more drugs are 
simultaneously administered, are successfully used to treat nematodes infecting ruminants and 
horses (Geary et al., 2012). Combining several delousing agents to treat L. salmonis infections
have been tested since 2009. In Norway, pyrethroids (deltamethrin, cypermethrin) and 
organophosphates (azamethiphos) have been used for combination therapy in several areas and 
there are signs for increasing resistance, especially against azamethiphos (S Sevatdal, 
http://www.veso.no/sea-lice-selection-study). Resistance to a triple combination of 
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anthelmintics was also observed in the parasitic nematode Ostertagia circumcincta (Wrifley et 
al., 2006) and it is possible that the activity of ABC transporters is, at least partially, responsible 
for the limited success of combination therapy. This highlights the need to improve our 
understanding of the intricate role ABC transporters play in protecting L. salmonis from 
toxicants such as EMB. Future experiments could employ different, probably second- and third-
generation ABC transporter inhibitors to do so.
The candidate gene approach, which yielded one P-gp (Chapter 2) and four MRP homologues 
(Chapter 3) in L. salmonis, was unlikely to be exhaustive, due to limited genetic information 
available for this parasite. In fact, as of 2014, the total number of ABC transporters in L. 
salmonis remains unknown. Known are: The previously mentioned P-gp homologue SL-PGY1 
(Heumann et al., 2012); a protein showing homology with mitochondrial ABC transporters (SL-
Pgp1) (Heumann et al., 2012; Tribble et al., 2008); four MRPs (Heumann et al., 2014) and 
SL0525, belonging to the ABCF subfamily, which is not known for drug transporters (Tribble et 
al., 2007).
A systematic, genome-wide survey of ABC transporters in L. salmonis was used to find 
additional members of this important gene family (Chapter 4). For this purpose, next-generation 
high-throughput RNA sequencing (RNA-seq) was employed. The reference transcriptome was 
created from a total RNA pool derived from salmon lice at key developmental stages. It was 
assembled against the L. salmonis genome (version July 2012) and encompassed 33,933 
transcripts, corresponding to 30,159 putative genes, with 27,086 single transcripts, while the 
remaining transcripts were splicing variants. The transcriptome was annotated using BLASTn 
searches against the UniGene and BLASTp searches ref_seq databases. For 29 and 95 per cent 
of the transcripts, matching data was found in public databases, respectively. Furthermore, 76 
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per cent of the 128,783 ESTs for L. salmonis aligned with at least one transcript. In addition, 
gene ontology analysis revealed that 95 per cent of the putative genes of the L. salmonis 
transcriptome had similarities to known gene product; yet only 17 per cent were annotated. 
Screening of the transcriptome for ABC transporters yielded 33 transcripts assumed to be 
members of the ABC transporter superfamily, while 186 ESTs were assembled into 28 
contiguous sequences, putatively representing ABC transporters. Thereby, we identified a total 
of 39 putative ABC transporters in L. salmonis. Phylogenetic analysis placed all sequences into 
groups of known ABC transporters with high boot-strapping values and, when possible, domain 
structure was analysed. This, and manual annotation, was used to confirm membership to the 
respective ABC subfamily of each sequence. Of further interest were subfamily B, C and G, as 
these contain drug-transporting ABC proteins (Dean et al., 2001). 
For the ABCB subfamily, we found one full and three half transporter transcripts. Only full 
transporters, like mammalian P-gp, are known to contribute to the biochemical defence against 
toxicants (Leslie et al., 2005). The full transporter is identical to SL-PGY1, which was 
identified in a previous study (Chapter 2). Expression of this P-gp homologue was shown to 
increase upon EMB exposure and differs between sexes (Heumann et al., 2012; Igboeli et al., 
2012). The half transporters show homology to human mitochondrial proteins ABCB7 and 
ABCB10, which are involved in iron metabolism and transport of Fe/S protein precursors (Dean 
et al., 2001).
For the ABCC subfamily, we found 14 sequences – 11 MRPs and 3 homologues to sulfonylurea 
receptors. Of particular interest are the MRPs, as they contribute to detoxification in humans 
(Deeley et al., 2006) and invertebrates. In zebra mussels, Dreissena polymorpha, expression of 
an MRP1 homologue is increased in response to heavy metal- and pesticide-induced stress 
(Navarro et al., 2012), while in C. elegans, an MRP1 homologue plays a role in protecting the 
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nematode from heavy metal toxicity (Broeks et al., 1996). Increased expression of MRPs, in 
conjunction with P-gps and cytochromes P450, was observed in IVM-resistant C. elegans
(James & Davey, 2009; Yan et al., 2012). Four out of 11 MRPs had been identified in previous 
EST searches and their expression ratios did not differ between S and R strain parasites 
(Chapter 3). 
Seven sequences belonging to ABCG subfamily were found. Human ABCG transporters 
facilitate the transport of steroid alcohols and drugs (Kusuhara & Sugiyama, 2007). For 
example, ABCG1 and ABCG4 are involved in loading of cholesterol to high-density 
lipoprotein, while ABCG2 (also known as BCRP) is a drug transporter (Krishnamurthy & 
Schuetz, 2006). However, none of the L. salmonis ABCG transcripts identified showed 
sufficient homology to known drug transporters in other species.
The transcriptome-wide search and annotation of ABC transporters has substantially added to 
the current knowledge of ABC transports in L. salmonis. The increased number of putative drug 
transporters could allow for a deeper and more comprehensive understanding of this important 
gene family. Subsequently, this might enable researchers to improve efforts aimed at elucidating 
the underlying molecular mechanisms of factors involved in drug resistance in salmon lice. 
Bioassays are a valuable tool to assess the toxicity of chemicals on aquatic organisms. The toxic 
effect is observed in relationship to the compound’s concentration over a pre-defined period. 
The results are normally given as the effective concentration, where 50% of the test animals are 
immobilised or as lethal concentration, at which 50% of the test population has are dead. This 
dose-response-based approach has become the standard for monitoring the sensitivity of salmon 
lice to EMB (SEARCH Consortium, 2006; Sevatdal & Horsberg, 2003). Tests are usually 
conducted with pre-adult II or adult parasites to ensure the same developmental stage. However, 
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relatively large numbers of parasites (~150) are required to conduct a dose-response bioassay, 
which may not always be feasible. Especially in a farm context, where animal welfare is 
paramount, chemical intervention happens at relatively low levels of infection. Therefore, it can 
be difficult to secure sufficient numbers of test animals.
To address this issue, single-dose bioassays using a fixed time of exposure have been proposed 
as an alternative requiring fewer test animals (Helgesen & Horsberg, 2013; Whyte et al., 2013). 
However, such a design might be insufficient for detecting differences in EMB susceptibility. 
Therefore, we tested the feasibility of an alternative bioassay design requiring fewer test animals 
than the dose-response bioassay, while being sufficiently sensitive to discriminate between L. 
salmonis strains with differing EMB susceptibility. This alternative approach uses time course 
toxicity analysis, where the toxic effect of a fixed chemical concentration is monitored over 
time. This yields the median time that has to elapse before 50% of test animals are affected or 
dead. 
Similar to the standard dose-response bioassay, for the time course bioassay, a researcher 
observes behavioural changes of salmon lice in response to EMB. In order to ensure 
consistency, it is important to clearly define what constitutes an effect. Mortality as an endpoint 
is specific, but lacks sensitivity (Sevatdal & Horsberg, 2003). Observing sublethal behavioural 
effects has the potential to improve sensitivity, but requires exact definitions of those effects. 
For the widely used dose-response standard bioassay, the sublethal effect criteria encompass a 
wide range of behavioural effects, ranging from minor changes of the parasite’s swimming 
performance over changes in their capacity to adhere to surface to full impairment of 
swimming. Under laboratory conditions, bioassays using these criteria (Sevatdal & Horsberg, 
2003; Westcott et al., 2008) performed well. However, under certain circumstances, for example 
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when performing field bioassays on fish farms, elevated response levels were observed in 
untreated controls (Westcott et al., 2008), exceeding the recommended threshold of 10% 
(SEARCH Consortium, 2006). During the course of this project, high response levels in 
controls were occasionally observed, which is apparently seasonal and occurs elsewhere (Gregg 
McArthur, North Atlantic Fisheries College, Shetland, UK), too. The cause is currently 
unknown (Dr William Roy, University of Stirling, personal communication). A revision of the 
wide range of sublethal effect criteria was recently recommended, in order to increase the 
reliability of bioassays (Igboeli et al., 2012; Saksida et al., 2013). The revised criteria would 
exclude parasites with minor behavioural alterations such as loop-swimming from being 
counted as affected by EMB. When applying these modified sublethal effect criteria, it was 
possible to clearly differentiate between animals of the S and R strain.
The time course bioassay requires multiple assessments over the observation period, while for 
dose-response bioassays, there is only a single assessment at the end of the experiment. 
Repeated examination is likely to be stressful for the test animals and the potential influence of 
the disturbance was assessed using two sets of controls. While there was an increased number of 
animals with minor behavioural changes, none of them was considered affected (chapter 5). The 
alternative bioassay design allowed for a clear distinction between the EMB-susceptible and 
EMB-resistant strain as the standard dose-response bioassay. Therefore, time course toxicity 
bioassays could be used to assess EMB susceptibility under circumstances when the number of 
available test animals is limited. However, as it is even more labour-intensive than the standard 
bioassay, it also lacks the possibilities for high throughput or automatisation in its current form. 
Computer-assisted image analysis might be useful to simplify the time course toxicity bioassay, 
when it is employed for the assessment of swimming behaviour, as it was done for nematodes 
(Marcellino et al., 2012). Still, an additional benefit of the proposed design is the possibility to 
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record the response time of each exposed animal, which allows for conclusions regarding their 
individual susceptibility to EMB. This could be useful to investigate the individual responses 
within the test population and might help to identify molecular markers that indicate drug 
resistance.
In conclusion, the work presented in this thesis has significantly expanded the number of ABC 
transporters in salmon lice and investigated their potential role in EMB resistance. The genes 
identified here could become the foundation for future research intended to identify molecular 
markers associated with reduced EMB susceptibility. 
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APPENDIX S1 – SUMMARY OF THE INDIVIDUAL SAMPLES USED TO GENERATE THE L. SALMONIS
TOTAL RNA POOL.
Sample ID Salmon louse stage
1 Egg strings (light colouration)
2 Egg strings (dark colouration)
3 Nauplius (24 h growth at 8°C)
4 Nauplius (24 h growth at 10.5°C)
5 Nauplius (48 h growth at 8°C)
6 Nauplius (48 h growth at 10.5°C)
7 Free-living copepodid
8 Attached copepod (24 h dpi)
9 Attached copepod (48 h dpi)
10 Chalimus I (72 h dpi)
11 Chalimus I (96 h dpi)
12 Chalimus II
13 Chalimus III
14 Chalimus IV
15 Preadult I male
16 Preadult II male
17 Adult male
18 Preadult I female
19 Preadult II female
20 Adult virgin female 
21 Adult gravid female
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APPENDIX S2 – SUMMARY OF PROTEIN MODELS USED TO IDENTIFY ABC TRANSPORTS.
Motif ID Description
PF00005 ABC transporter
PF00664 ABC transporter transmembrane region
PF06472 ABC transporter transmembrane region 2
PPTHR11384 ATP-binding cassette, sub-family D member
PTHR19211 ATP-binding transport protein-related
PPTHR19229 ATP-binding cassette transporter subfamily A
PF12698 ABC-2 family transporter protein
PR01868 ABC transporter family E signature
PS50893 ATP-binding cassette, ABC transporter-type domain
PS51012 ABC transporter integral membrane type-2 domain
SM00382 ATPases associated with a variety of cellular activities
SSF90123 ABC transporter, transmembrane domain, type 1
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APPENDIX S3–DETAILS OF THE CHARACTERISED 39 L. SALMONIS ABC PROTEINS
Subfamily Accession Transcript_ID Predicted_Member_Name Predicted_gene_acronym Predicte_Location Domain_structure_detected Notes
A HACA01002058 Lsa.1758 ABCA1 ABCA1 TM - NBD - TM - NBD partial
A HACA01016690 Lsa.14583 ABCA4 ABCA4 TM partial
A HACA01001963 Lsa.1680 ABCA4 ABCA4 NBD - TM partial
B HACA01029620 Lsa.26127
ABCB10 (mitochondrial 
HT) ABCB10 mitochondrial TM - NBD
B HACA01008343 Lsa.7262 ABCB7 (mitochondrial HT) ABCB7 mitochondrial TM - NBD
B HACA01000740 Lsa.643 ABCB8 (mitochondrial HT) ABCB8 mitochondrial TM - NBD partial
B HACA01004649 Lsa.4043 ABCB1 ABCC1 TM - NBD - TM - NBD
C EST_Contig_6 MRP14 / MRP1 ABCC1 NBD partial
C HACA01012937 Lsa.11278 ABCC1 / MRP1 ABCC1 TM - NBD - TM - NBD
C HACA01025969 Lsa.22810 ABCC1 / MRP1 ABCC1 TM - NBD - TM partial
C HACA01033013 HACA01033014 Lsa.29272* ABCC1 / MRP1 ABCC1 TM partial
C HACA01007250 Lsa.6310 ABCC1 / MRP1 ABCC1 TM - NBD - TM partial
C HACA01010189 HACA01010190 Lsa.8882* ABCC1 / MRP1 ABCC1 TM - NBD - TM - NBD
C HACA01026296 HACA01026297 Lsa.23107* MRP4 ABCC4 TM - NBD - TM - NBD
C HACA01004060 HACA01004061 Lsa.3521* MRP4 ABCC4 TM - NBD - TM partial
C HACA01004062 Lsa.3522 MRP4 ABCC4 TM - NBD - TM - NBD
C HACA01016337 Lsa.14264 MRP5 ABCC5 NBD partial
C HACA01005249 Lsa.4564 MRP7 ABCC10 TM - NBD - TM - NBD
C HACA01016334 Lsa.14261 ABCC8/9 (SUR) ABCC8 TM partial
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C HACA01016335 Lsa.14262 ABCC8/9 (SUR) ABCC9 NBD partial
C HACA01016336 Lsa.14263 ABCC8/9 (SUR) ABCC9 TM partial
D EST_Contig_1
ABCD4 (peroxisomal 
membrane) ABCD4
peroxisomal 
membrane NBD partial
D EST_Contig_2
ABCD4 (peroxisomal 
membrane) ABCD4
peroxisomal 
membrane TM - NBD
D HACA01011675 Lsa.10176
ABCD4 (peroxisomal 
membrane) ABCD4
peroxisomal 
membrane TM partial
D HACA01006738 Lsa.5856
ABCD4 (peroxisomal 
membrane) ABCD4
peroxisomal 
membrane TM - NBD
E HACA01001204 HACA01001205 Lsa.1035* ABCE1 ABCE1 NBD - NBD
F HACA01023315 Lsa.20458 ABCF1 ABCF1 NBD partial
F HACA01011095 Lsa.9678 ABCF2 ABCF2 NBD - NBD
F EST_Contig_3 ABCF3 ABCF3 NBD partial
F EST_Contig_4 ABCF3 ABCF3 NBD partial
F EST_Contig_5 ABCF3 ABCF3 NBD partial
F HACA01009266 Lsa.8082 ABCF3 ABCF3 NBD - NBD
G HACA01014872 Lsa.12984 ABCG20 ABCG20 NBD - TM
G HACA01016058 Lsa.14023 ABCG20 ABCG20 NBD - TM
G HACA01024391 Lsa.21408 ABCG20 ABCG20 NBD - TM
G HACA01026477 Lsa.23267 ABCG20 ABCG20 NBD - TM
G HACA01026479 HACA01026480 Lsa.23269* ABCG20 ABCG20 NBD - TM
G HACA01003008 HACA01003009 Lsa.2606* ABCG5 ABCG5 NBD - TM partial
G HACA01029057 Lsa.25615 ABCG8 ABCG8 TM - NBD - TM partial
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File is also available under
http://www.biomedcentral.com/imedia/1993560421420311/supp2.csv
